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SUMMARY 
VII 
Summary 
The apicomplexan parasite Plasmodium falciparum is the causative agent of the most 
severe form of malaria with more than 600 000 death cases per year, mainly among 
young children and pregnant women. The development of the parasite within human 
erythrocytes is accompanied by extensive remodelling of the host cells. The 
establishment of nutrient acquisition pathways, the genesis of membranous structures 
within the red blood cell (RBC) cytosol and the formation of a cytoadherence complex 
on the surface of the host cell represent important examples of these modifications that 
contribute both to parasite survival and virulence. For this purpose P. falciparum exports 
hundreds of effector proteins into the RBC with the majority of them bearing a 
characteristic pentameric sequence termed Plasmodium export element (PEXEL), which 
is cleaved in the parasite after the third and N-terminally acetylated at the fourth amino 
acid position. To gain a better understanding of this important export signal, a 
mutagenesis screen on the PEXEL motif (
48
RLLAQ
52
) of a GFP-tagged model protein 
(STEVOR
1-80
) was conducted in this study. The localization of the mutant proteins to 
different compartments of the parasitized erythrocyte was determined by fluorescence 
microscopy. In addition, mass spectrometric analysis of representative mutants 
confirmed a correlation between processing of the export motif and protein trafficking.  
In summary, amino acid replacements within position 1
1
 (R
48
) and 3 (L
50
), representing 
the most conserved amino acids, had detrimental effects on PEXEL cleavage and protein 
export. In contrast, positions 2 (L
49
) and 5 (Q
52
) proved to be more permissive towards 
mutations and mostly maintained the wild-type export phenotype. Special attention was 
paid to position 4 (A
51
), which is acetylated after cleavage and appeared more restricted 
than originally assumed. One interesting finding was the deficiency of non-acetylated 
mutant proteins to be exported into the host cell indicating N-terminal acetylation as a 
prerequisite for proper targeting of PEXEL proteins. Consequently, the second part of 
this study focussed on the characterization of a putative N-acetyltransferase (PfNAT) 
that might be responsible for this allegedly important post-translational modification. 
The localization of the candidate transferase to the parasite endoplasmic reticulum, the 
compartment of PEXEL processing, was confirmed by single crossover integration of a 
GFP tag into the endogenous locus. Despite the use of two different approaches, the 
attempted deletion of the gene for loss-of-function studies was unsuccessful. However, a 
conditional downregulation of protein levels by ~50% was achieved using a 
destabilization domain, which facilitated further investigations. 
                                                 
1
 The data for this position were almost all obtained in previous work by Dr. P. Henrich (2008) and are 
shown for the sake of completeness. Amino acid single letter codes see Abbreviations. 
ZUSAMMENFASSUNG 
VIII 
Zusammenfassung 
Plasmodium falciparum aus dem Stamm der Apicomplexa ist der Hauptverursacher von 
schwerwiegender Malaria, an der jährlich über 600 000 Menschen sterben, darunter vor 
allem Kleinkinder und schwangere Frauen. Während seiner asexuellen Entwicklung in 
menschlichen Erythrozyten modifiziert der Parasit seine Wirtszellen, was maßgeblich zu 
seinem Überleben als auch zu seiner Virulenz beiträgt. Der Aufbau von 
Nährstofftransportwegen, die Bildung eines membranösen Netzwerkes im Zytoplasma 
des roten Blutkörperchens sowie eines Zytoadherenzkomplexes an dessen Oberfläche 
stellen einige dieser Veränderungen dar. Zu diesem Zweck transportiert der Parasit 
hunderte von Effektorproteinen in den Erythrozyten, von denen die Mehrheit das 
sogenannte Plasmodium Export-Element (PEXEL) besitzt. Diese Sequenz besteht aus 
fünf aufeinanderfolgenden Aminosäuren, welche im Parasiten nach der 3. Position 
proteolytisch gespalten und daraufhin an der 4. Position N-terminal acetyliert werden.  
Um dieses wichtige Exportsignal besser zu verstehen, wurde in dieser Doktorarbeit das 
PEXEL-Motiv (
48
RLLAQ
52
) eines GFP-markierten Modellproteins (STEVOR
1-80
) einer 
ausführlichen Mutagenese unterzogen, gefolgt von einer fluoreszenzmikroskopischen 
Analyse zur Lokalisation der mutierten Proteine in intra-erythrozytären Parasitenstadien. 
Massenspektrometrische Untersuchungen an ausgewählten Mutanten konnten außerdem 
einen Zusammenhang zwischen enzymatischer Prozessierung des PEXEL-Motivs und 
dem Proteinexport nachweisen.  Zusammenfassend wurde festgestellt, dass der 
Austausch von stark konservierten Aminosäuren an Position 1
2
 (R
48
) und 3 (L
50
) sich 
nachteilig auf den Proteintransport auswirkte. Dagegen wurden Mutationen an Position 2 
(L
49
) und 5 (Q
52
) überwiegend toleriert ohne den Export zu beeinflussen. Spezielles 
Interesse galt der Aminosäure an Position 4 (A
51
), welche nach der proteolytischen 
Spaltung acetyliert wird. Interessanterweise wurden nicht-acetylierte Proteine nicht über 
die parasitophore Vakuole hinaus transportiert, was auf eine wichtige Rolle von N-
terminaler Acetylierung im Exportprozess hinweist. Folglich konzentrierte sich der 
zweite Teil der Studie auf die Charakterisierung der mutmaßlich verantwortlichen N-
Acetyltransferase (PfNAT). Das Enzym konnte mit Hilfe von genetischer Integration 
eines GFP-Markers im endoplasmatischen Retikulum des Parasiten nachgewiesen 
werden. Des Weiteren wurde die Deletion des Genes mit zwei verschiedenen Methoden 
ohne Erfolg versucht. Dennoch gelang es, die Proteinmenge von PfNAT mithilfe einer 
destabilisierenden Domäne um 50% zu reduzieren und für weitere funktionelle Studien 
zu nutzen. 
 
                                                 
2
 Diese Position wurde von Dr. P. Henrich (2008) mutiert und zum Zwecke der Vollständigkeit integriert. 
Aminosäuren siehe Abkürzungsverzeichnis. 
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INTRODUCTION 
1 
1 Introduction 
 Malaria 1.1
Malaria is a vector-borne disease that is caused by infection with the protozoan parasite 
Plasmodium (Phylum: Apicomplexa, Class: Sporozoa, Order: Coccidia, Suborder: 
Haemosporidiae, Family: Plasmodiidae) and transmitted by the infectious bite of a 
female Anopheles mosquito. From the 120 Plasmodium species that parasitize land 
vertebrates, only 5 species infect humans: P. falciparum, P. vivax, P. ovale, P. malariae 
and P. knowlesi (Boddey & Cowman, 2013; Carter & Mendis, 2002).  
The parasites develop in liver hepatocytes and red blood cells of the human body and 
reproduce sexually in the midgut of the blood-feeding female Anopheles mosquito. 
There are 400 species of Anopheles mosquitoes worldwide, about 60 transmit malaria 
under natural conditions and 30 of these are of major importance especially the 
Anopheles gambiae and A. funestus complex (Tuteja, 2007). Infection with P. 
falciparum causes the most severe form of the disease representing most of the death 
cases and is the predominant malaria parasite in Africa (WHO, 2013). According to the 
World Health Organization (WHO) 3.4 billion people representing 48% of the world’s 
population live in 104 endemic countries at constant risk of infection with Plasmodium 
parasites, including Africa, Southeast Asia, Oceania, the Indian Subcontinent, Central 
and South America (Figure 1). Around 207 million people suffered from malaria 
worldwide in 2012 with an estimated number of 627 000 malaria deaths, 77% of these in 
children under 5 years of age (WHO, 2013). 
 
Figure 1. Classification of countries by stage of malaria elimination (WHO, 2012) 
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The majority of cases (80%) and deaths (90%) occurred in sub-Saharan Africa. Malaria 
is among the top ten causes of deaths in low-income countries, disproportionally 
affecting the poorest populations, and poses a major health problem and essential 
hindrance to economic development (Barat et al, 2004; WHO, 2011). One estimate of 
the impact of malaria on the national income in Africa put the economic burden at 0.6–
1.0% of the gross domestic product (GDP) with many social and economic fields 
influenced such as population growth, investments, worker productivity, agriculture, 
tourism, premature mortality and medical costs (Chima et al, 2003; Sachs & Malaney, 
2002; Tuteja, 2007; WHO, 1999). Fortunately, residents in endemic countries with 
regular transmission acquire partial immunity that potentially protects them from severe 
disease progression. However, non-immune individuals such as infants, children and 
pregnant women (in pregnancy-associated malaria) are at higher risk (Boddey & 
Cowman, 2013). Despite successful intervention strategies implemented during the last 
decades, resistances to previously effective treatments such as anti-malarial drugs or 
insecticides have spread, which render malaria-freed countries endangered and pose a 
serious problem to the control and eradication of the disease (Alonso & Tanner, 2013; 
Mendis et al, 2009). Furthermore, more countries are increasingly affected as a 
consequence of expanding habitats of the vector mosquitoes (Anopheles spec.) due to 
climate change, forest clearings, increased precipitation, floods, slum development in big 
cities and mismanaged irrigation systems (Ramasamy & Surendran, 2012; Stich et al, 
2000).  
The disease was recorded in many civilized societies throughout history as early as 2700 
years Before Christ (B.C.) (Cox, 2010). Among others Hippocrates left detailed 
descriptions in 400 B.C. and Chinese physicians used the healing properties of the 
quinghao plant, which contains the antimalarial artemisin, against fever and malaria as 
early as 2000 years ago (Cox, 2002; Dhingra et al, 2000; van Agtmael et al, 1999). The 
term ‘Malaria’ originates from the Italian ‘mal’aria’, which literally means ‘bad air’. 
This naming is based on the so-called miasmic theory, which persisted throughout the 
19
th
 century and accused the gases rising from swamps and floodplains as being the 
causative agent of the feverish disease (Mehlhorn & Piekarski, 2002; Retief & Cilliers, 
2006). In contradiction to this theory, the appearance of the protozoan parasite in a 
patient’s blood was first noticed in 1880 by the French army surgeon  Charles Louis 
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Alphonse Laveran. Furthermore, Dr. Ronald Ross, a British officer in the Indian Medical 
Service, revealed in 1897 the transmission of avian malaria by mosquitos. This finding 
was complemented by the Italian scientists Giovanni Batista Grassi, Amico Bignami and 
Guiseppe Bastianelli who identified female Anopheles mosquitos as the vectors for 
human malaria and demonstrated the complete blood-mosquito cycles of P. falciparum, 
P. vivax and P. malariae. Finally, Henry Shortt and Cyril Garnham contributed the 
discovery in 1948 that malaria parasites develop in the liver before entering the blood 
stream (Cox, 2010). 
 The malaria parasite Plasmodium falciparum 1.1.1
Plasmodium belongs to the phylum Apicomplexa, a diverse group of unicellular 
protozoans, which are obligate, intracellular parasites with motile stages (Ravindran & 
Boothroyd, 2008). Apicomplexa are characterized by an apical complex that harbours 
the conoid, rhoptries, micronemes and dense granules for the invasion of host cells. 
Furthermore, this phylum is marked by a unique organelle termed the apicoplast that 
emerged from secondary endosymbiosis of a red alga with subsequent reduction in 
photosynthetic capabilities (Deponte et al, 2012). The remnant 4-membrane enclosed 
plastid of cyanobacterial origin retained a small circular genome (35 kilo base pairs, kb), 
whereas most genes became nuclear encoded and are involved in metabolic pathways 
such as biosynthesis of fatty acids, isoprenoids, haem and iron-sulphur clusters (Parsons 
et al, 2009). The absence of these prokaryote-like pathways in the human host render 
this organelle a potential drug target. The life cycle of P. falciparum is quite complex, 
with sexual reproduction in the invertebrate Anopheles vector and solely asexual 
replication cycles in the human host (Figure 2). During the blood meal of the mosquito, 
infective parasitic sporozoites are released from the arthropod salivary glands into the 
human host where they gradually leave the skin and enter the circulatory system to 
invade the liver. Remarkably, the parasites traverse several hepatocytes before final cell 
invasion, a process, which is not entirely understood, but seems to be a prerequisite for 
establishing a successful infection (Amino et al, 2008; Mota et al, 2001b; Mota & 
Rodriguez, 2001a). The sporozoites use surface proteins for invasion (e.g. 
circumsporozoite protein and thrombospondin-related adhesins), which specifically bind 
to heparin sulphate proteoglycans on hepatocytes in the region opposing the sinusoidal 
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endothelium and the Kuppfer cells (Frevert et al, 1993). The subsequent asexual 
replication cycles within the liver cells (exoerythrocytic schizogony) are marked by 
massive release of thousands of new merozoites that enter the bloodstream and initiate 
the erythrocytic proliferation phase (Sturm et al, 2006; Yamauchi et al, 2007). P. vivax 
and P. ovale additionally develop hypnozoites in the liver, latent forms of the parasites 
that can remain dormant in the liver cells for years until reactivated causing relapse of 
the disease (Cogswell, 1992). The asymptomatic period between sporozoite inoculation 
until appearance of parasites in the blood (prepatence) varies among the different species 
from 8-30 days (Tuteja, 2007). 
 
Figure 2. Life cycle of Plasmodium falciparum (Boddey & Cowman, 2013). 
 
Invasion of erythrocytes by merozoites is a multi-step process that occurs within minutes 
to minimize contact with the host immune system. It includes target cell receptor 
binding, apical reorientation, formation of a tight junction, active invasion and 
intracellular signalling (Aikawa et al, 1978; Chitnis, 2001; Dvorak et al, 1975). Once 
inside the red blood cell (RBC) the parasites develop within a parasitophorous vacuole 
(PV) and differentiate from merozoites to ring (0 – 5 h), trophozoite (10 – 40 h) and 
finally schizont stage (40 – 48 h) (Figure 3) (Bannister et al, 2000; Boddey & Cowman, 
2013). Particularly the trophozoite stage is marked by increased metabolism with active 
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glycolysis and proteolysis of haemoglobin (Miller et al, 2002). The detoxification of 
haem, a potentially harmful reactive by-product of haemoglobin digestion, is achieved 
through the formation of hemozoin crystals that are deposited in the food vacuole (Shio 
et al, 2010). During intracellular development parasite-induced modifications reduce the 
deformability of infected red blood cells (iRBCs) and lead to the sequestration of 
erythrocytes along the endothelium of blood vessels as well as intererythrocytic 
aggregation called rosetting. This cytoadherent phenotype is caused by the appearance of 
knob structures on the surface of iRBCs that facilitate the proper display of the major 
virulence determinant P. falciparum erythrocyte membrane protein 1 (PfEMP1) 
(Knuepfer et al, 2005b; Pasternak & Dzikowski, 2009; Rug et al, 2006; Wickert et al, 
2003). This variant adhesion protein is intracellularly anchored to the cytoskeleton via 
binding to the knob-associated histidine-rich protein (KAHRP). 
 
Figure 3. The blood-stage cycle of malaria parasite development (Boddey & Cowman, 2013) 
Pictures: Electron micrograph; GFP fluorescence of a soluble exported protein (no name provided); Bright 
field. Abbreviations: C: cytostome; FV: food vacuole; K: knobs; MC: Maurer’s cleft; N: nucleus; PM: 
parasite membrane; PV: parasitophorous vacuole; PVM: parasitophorous vacuolar membrane; RB: 
residual body. 
INTRODUCTION 
6 
The extracellular part of PfEMP1 consists of a cysteine-rich region and a variable 
number of duffy binding-like (DBL) domains, which interact with different host 
receptors on the vascular endothelium, such as chondroitin sulphate A (CSA), heparin 
sulphate, ICAM-1, thrombospondin, E-/P-Selectins, CD36 and more (Kyes et al, 2007; 
Scherf et al, 1998). PfEMP1 is encoded by the var multi-gene family, whose roughly 60 
genes are mainly located in subtelomeric regions of chromosomes, a precondition in 
favour of recombinatorial events. Switching of var gene expression from one locus to 
the other in minor parasite subpopulations facilitates antigenic variance thereby 
circumventing specific humoral immune responses directed against the previous variant 
of PfEMP1 (Pasternak & Dzikowski, 2009). Furthermore, the cytoadherence induced by 
the parasite represents an effective immunoevasion technique by impairing circulation 
through the spleen and preventing subsequent destruction of the infected cells by splenic 
macrophages (Engwerda et al, 2005). However, sequestration of iRBCs can lead to 
occlusion of blood flow and infiltration of immune effector cells into affected areas such 
as the brain or placenta, which is linked to severe pathogenesis and death (Boddey & 
Cowman, 2013). The final schizont stage of intraerythrocytic development is 
characterized by multiple rounds of nuclear division and subsequent cytokinesis, which 
is completed by rupture of the host cell and the release of 8-24 merozoites into the blood 
stream (Tuteja, 2007). In the course of the infection a minor part of blood merozoites in 
iRBCs differentiates into gametocytes, which are ingested by a female Anopheles 
mosquito upon a blood meal (Mehlhorn, 2012). Several factors during this switch from 
the warm-blooded host to the arthropod mosquito such as a drop in temperature or the 
presence of xanthurenic acid trigger gametocyte activation. Subsequent gamete 
formation (micro- and macrogametes) and fertilization characterizes sexual reproduction 
in the midgut (Kuehn & Pradel, 2010). The resulting zygote becomes a motile ookinet 
that actively traverses the midgut endothelium before settling down between epithelium 
and basal lamina, where it develops into the oocyst. Many sporozoites are produced 
within the oocyst by asexual replication, are released into the haemolymph and invade 
the salivary glands for transmission into the next mammalian host. These motile salivary 
gland sporozoites are usually present in the mosquito glands from 10-18 days after the 
initial blood meal and remain infective for 1-2 months (Tuteja, 2007).  
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 Clinical manifestation 1.1.2
There are different types of malaria that vary in their prepatence period, their severity of 
symptoms, their distribution and their mortality rate. Malaria tertiana (P. vivax, P. ovale) 
is characterized by sudden periodic fever lasting 3-4 hours, separated by 48 hours and is 
usually not lethal. These species also tend to form dormant hypnozoites in the liver, 
which can be reactivated years later. P. vivax, which preferentially infects reticulocytes 
by binding to Duffy blood group antigens, has the largest geographic distribution. 
However, the high frequency of the Duffy negativity trait among the majority of the 
African population reduced this parasites’ occurrence in this area (Langhi & Bordin, 
2006; WHO, 2013). The rarest type of malaria causing less than 10% of all infections is 
the quartan malaria (P. malariae). The feverish periods that are displayed every fourth 
day usually last 4-5 hours. Relapse of the disease is recorded as late as 30 years after 
infections by small long-lasting erythrocytic forms of the parasites (Tuteja, 2007). The 
most dangerous type of infection with a high mortality rate, Malaria tropica, is caused by 
P. falciparum and is responsible for more than half of the total malaria infections 
(Engwerda et al, 2005). Although the course of the disease can consist of periodic fevers 
(every 48 hours), it often displays unsynchronized egress with persistent fever at high 
temperatures. Infections with P. falciparum can display mild to severe symptoms 
resulting in minor clinical outcome or even death. Different factors influence the 
severity of the disease such as host immunity, genetic traits, age, pregnancy, access to 
medical treatment, social and geographic factors as well as parasite strain, infectivity, 
initial parasitic numbers, antigenic variance, drug resistance and others (Mackinnon & 
Read, 2004; Miller et al, 2002). Initial symptoms of malaria infections are rather 
unspecific including tiredness, diarrhoea, nausea, sweat periods, chills and dizziness. 
With the onset of disease, recurrent periods of a cold stage (sensation of cold, chills), a 
hot stage (fever, vomiting, headaches, and seizures) and a sweating stage (sweats, 
tiredness) are characteristic. The massive simultaneous release of merozoites into the 
blood stream coincides with a sharp incline in body temperature during the typical 
feverish periods. This reaction is caused by the activation of the immune system upon 
contact with erythrocytic cell debris, hemozoin and parasite antigens such as the 
merozoite surface protein (MSP-1) (Shio et al, 2010). Consequently, innate as well as 
adaptive immune responses are triggered such as release of pro-inflammatory cytokines 
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(e.g. tumor necrosis factor (TNF) by activated macrophages or T-cell activation and 
antibody production (Engwerda & Good, 2005; Ramasamy, 1998). However, the 
interplay between parasite and host immune system during infection is very complex and 
still subject to intense research (Chua et al, 2013; Malaguarnera & Musumeci, 2002; 
Scholzen et al, 2010; Yazdani et al, 2006). Characteristic signs of severe late-onset 
malaria are high parasitaemia, severe anaemia and neuronal complications. Furthermore, 
symptoms can include pulmonary oedema, kidney failure, tissue damage, black water 
fever, haemoglobinuria, enlarged spleen, liver damage and acidosis. Sequestration of 
infected erythrocytes with subsequent blockage of blood flow, oxygen deprivation and 
inflammation in the capillaries can induce multi-organ failure. If localized to the 
microvasculature of the brain, severe cerebral malaria is established. This leads to 
impaired vision, coordination and movement and usually is lethal after a short period of 
time (White et al, 2014). Pregnancy-associated malaria, which is caused by binding of 
conserved PfEMP1 motifs to pregnancy-specific host receptors (CSA), can lead to 
miscarriage, premature delivery, low birth weight and increased mortality in the new-
born as well as severe anaemia or even death of the mother (Tuteja, 2007). Adult 
individuals living in endemic areas usually acquire semi-immunity after multiple 
infections, which protects them from the severe consequences of recurrent malaria 
(Ramasamy, 1998). 
 Prevention and treatment 1.1.3
According to the World Malaria Report in 2013 the estimated malaria mortality rates fell 
worldwide between 2000 and 2012 by 42% in all age groups and by 48% in children 
under 5 years of age. This result was also representative for the WHO African Region 
(49% and 54%, respectively) (WHO, 2013). This reduction is attributed to several 
successful interventions including extensive vector control through the use of 
insecticide-treated bed nets (ITNs), indoor residual spraying (IRS) and larval control. 
Furthermore, increased surveillance and chemoprevention for the most susceptible 
populations, particularly children and pregnant women, as well as improved access to 
public health systems for rapid diagnosis and subsequent treatment with appropriate 
antimalarials reduced the number of clinical cases. However, despite these 
improvements there were still an estimated 627 000 malaria deaths worldwide in 2012 
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(uncertainty interval, 473 000–789 000) (WHO, 2013). This high number is a warning 
sign that the disease is still a major health problem with no general solution and requires 
future investigations on governmental, financial, public, medical and scientific levels to 
be combated. 
Despite decades of research, no vaccine against malaria is currently available and the 
only candidate in phase 3 trials (RTS,S/AS01, targets P. falciparum circumsporozoite 
protein) proved less efficient than originally assumed (Goldstein & Shapiro, 1997; 
Salvador et al, 2012). In addition to the evaluation of new antigenic targets (such as e.g. 
parasite MSP-1, AMA-1), approaches for next-generation vaccines include whole-
sporozoite vaccines, virosome/nanoparticle-based mimetope combination vaccines and 
the various facets of adjuvants and prime-boost concepts (Alonso & Tanner, 2013; 
Macraild et al, 2011; Sutherland, 2007).  
Serious problems for the treatment of malaria are the emerging parasite resistance 
mechanisms towards nearly all of the few effective anti-malarial drugs (Mendis et al, 
2009; Turschner & Efferth, 2009). The most prominent drug for a long time was 
chloroquine (4-aminoquinoline), a chinine derivative that interferes with haemoglobin 
metabolism. It was in wide-spread use due to its low price, effectiveness and safety until 
the 1960s when resistant parasites emerged probably as a consequence of mutations in 
the P. falciparum chloroquine resistance transporter (PfCRT) (Bray et al, 2005; Sanchez 
et al, 2005). Further anti-malarial drugs include antifolates (e.g. pyrimethamine, 
proguanil), which were introduced in the 1940s and target the folate biosynthetic 
pathway of the parasite. However, resistances occurred rapidly, probably conferred by 
mutations in the genes encoding P. falciparum dihydrofolate reductase (PfDHFR) and 
dihydropteroate synthetase (PfDHPS) (Baird, 2005). Nevertheless, sulfadoxine-
pyrimethamine is still successfully used as intermittent preventive treatment for pregnant 
women living in areas of high malaria transmission and monthly doses of amodiaquine-
sulfadoxine-pyrimethamine given to children (3 months – 5 years old) represent a 
promising chemopreventive strategy to protect from severe malaria infections during the 
rainy season (White et al, 2014). Two other types of drugs are increasingly used: 
atovaquone (a mitochondrial inhibitor) and artemisin, a derivative from the Chinese herb 
quinghao that acts on haemoglobin metabolism. Especially artemisinin and its 
derivatives (e.g. artemether, artesunate) are the most potent compounds widely used in 
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combination therapy and by June 2008 all but four countries and territories with a high 
burden of the disease had adopted artemisinin-based combination therapy as the first-line 
treatment for malaria tropica (WHO, 2009). Unfortunately, parasite resistance to this 
drug has recently been detected in 4 countries of southeast Asia (Cambodia, Myanmar, 
Thailand and Viet Nam). However, artemisinin-based combination therapies remain 
highly effective in almost all settings, as long as the partner drug in the combination is 
locally effective (WHO, 2013). For this purpose, current efforts in the identification of 
new drugs, especially suited for combination therapy, must be intensified (Alonso & 
Tanner, 2013). Furthermore, research on non-toxic, long-lasting and affordable 
insecticides for indoor residual spraying that counteract the emerging resistances of 
mosquitos to pyrethroid insecticides needs to be expanded (Alonso & Tanner, 2013; 
Breman, 2009). The combat of malaria poses a big challenge to the international 
community and despite remarkable progress, the sustainment and expansion of political 
commitment, financial investments, health infrastructures, surveillance systems and 
pharmaceutical investigations should be devoted to the support of the people that suffer 
most from the disease (WHO, 2013). 
 Modifications of the host erythrocyte 1.2
The replication of Plasmodium in red blood cells, which lack the capability of MHC-
related antigen presentation, allows the parasite to hide from the immune system, an 
advantage that is further expanded by parasite-induced cytoadherence. Furthermore, the 
high amounts of haemoglobin in these cells represent a major nutritional source for 
amino acids. However, the residence in a terminally differentiated enucleated host cell 
that is small, prone to lysis, subject to permanent quality control and devoid of protein 
synthesis and transport systems is challenging (Elsworth et al, 2014). To circumvent 
these obstacles the parasites induce extensive modifications of the host cell for 
nutritional as well as immune evasive purposes including the establishment of export 
pathways to translocate multiple effector proteins into the erythrocyte cytoplasm 
(Boddey & Cowman, 2013). The insertion of transporters into host-derived membranes, 
the assembly of a tubovesicular network (TVN) and Maurer’s clefts (MCs) as 
intermediate trafficking compartments in the RBC cytosol and especially the formation 
of surface knobs harbouring the major variant antigen PfEMP1 represent some examples 
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of these parasite-induced alterations outside its own boundaries (Figure 4) (Elsworth et 
al, 2014).  
 
Figure 4. Modifications of the erythrocyte (Bernhard-Nocht-Institute, 2009) 
Schematic drawing of asexual blood stages of P. falciparum modifying their host cell . The parasite (blue) 
resides in a parasitophorous vacuole (PV) formed by the PV membrane (PVM) separating it from the red 
blood cell (red). C: cytostomes. FV: food vacuole. mCS: modified cytoskeleton of the red blood cell. 
MC: flattened membranous structures called Maurer's clefts. N: nucleus. NPP: new permeation pathways 
in the red blood cell membrane. PPM: parasite plasma membrane. V: transport vesicles and protein 
aggregates. 
 Maurer’s clefts 1.2.1
Maurer’s clefts, first observed in 1902 by Georg Maurer as a dotted pattern within the 
cytoplasm of infected erythrocytes, are membranous structures of heterologous 
morphology and number that derive early after invasion from the PVM as mobile 
entities, which become tethered beneath the RBC membrane at ~20 hours post invasion 
(Lanzer et al, 2006; Maurer, 1902; McMillan et al, 2013; Sam-Yellowe, 2009). They 
usually consist of single disks or stacks of single-membrane-enclosed slits of ~30 nm 
height and at least 500 nm width surrounded by an electron-dense coat of round vesicle-
like structures (Figure 5) (Frischknecht & Lanzer, 2008; Maier et al, 2009; Wickert & 
Krohne, 2007). In contrast to previous assumptions, there seems to be no fluid 
connection between the TVN and MCs and these compartments represent separate 
entities concerning transport of macromolecules (Frischknecht & Lanzer, 2008; Hanssen 
et al, 2008; Sam-Yellowe, 2009). The association with the RBC plasma membrane is 
facilitated by actin filaments that connect the clefts to the knobs as well as protein 
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interactions (e.g. MAHRP2) with the host membrane and cytoskeleton (Cyrklaff et al, 
2011; Mbengue et al, 2012).  
Functionally Maurer’s clefts represent parasite-induced intermediate ‘sorting’ 
compartments for proteins en route to the erythrocyte membrane and is it assumed that 
the majority, if not all, exported proteins transiently passage through it (Mbengue et al, 
2012; Tilley et al, 2008). Different mechanisms of protein trafficking to and from the 
clefts have been proposed including diffusion of membranous proteins during MC 
genesis, vesicular transport or transfer as chaperone-mediated soluble complexes 
(Hanssen et al, 2008; Kriek et al, 2003; Mbengue et al, 2012; Mundwiler-Pachlatko & 
Beck, 2013). An increasing number of proteins have been identified that reside in the 
Maurer’s clefts, such as skeleton binding protein 1 (SBP1), membrane-associated 
histidine-rich protein 1 (MAHRP1) and ring-exported proteins 1 and 2 (REX1/2). Others 
are transiently associated with this organelle such as PfEMP1 and PfEMP3, knob-
associated histidine-rich protein (KAHRP) and members of variant protein families such 
as the subtelomeric variable open reading frame family (STEVOR) (Sam-Yellowe, 
2009). Most of these proteins are involved in MC architecture, cytoadherence, 
trafficking of PfEMP1 and knob formation (Dixon et al, 2011). Further studies revealed 
important roles of MC proteins by acting as chaperones (P. falciparum migration 
inhibitory factor, PfMIF) or enzymes (protein phosphatase 1, PP1) (Blisnick et al, 2006; 
Sam-Yellowe, 2009) and additional involvement in phospholipid biosynthesis, cell 
signalling and merozoite egress has been implicated (Lanzer et al, 2006).  
 
Figure 5. Adhesion of an infected RBC to an endothelial cell (Maier et al, 2009) 
Electron micrograph of a knobby P. falciparum-infected RBC adhering to an endothelial cell. Left: 
Overview. Right: Detail of the interface between an infected red blood cell (top) and the endothelial cell 
(bottom). EN: endothelial cell. MC: Maurer’s cleft. arrows: knobs. Scale bar 1 µm (left), 100 nm (right). 
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 Knobs 1.2.2
The development of Plasmodium within the erythrocyte is accompanied by the 
emergence of protrusions, so-called knobs, on the surface of the host cells from about 16 
hours post-invasion (Figure 6) (Maier et al, 2009). These structures harbour the major 
virulence determinant protein, PfEMP1, which is displayed in an elevated manner 
facilitating binding to host tissue-specific receptors along the vascular endothelium for 
subsequent cytoadherence of iRBCs (Rug et al, 2006) (Horrocks et al, 2005). This 
parasite-induced adhesion process prevents splenic clearance and is associated with 
severe signs of malarial infections. The formation of knobs is a dynamic process with 
increasing knob density throughout parasite maturation from trophozoite to schizont 
stages (from 10–35 to 45–75 knobs/µm2) while their size varies inversely (from 160–110 
to 70–100 nm in diameter) (Mbengue et al, 2012). The knobs consist of a complex of 
different proteins such as KAHRP, PfEMP3 and mature-parasite-infected erythrocyte 
surface antigen (MESA) that are connected to the sub-membrane cytoskeletal 
components spectrin, actin and ankyrin (Maier et al, 2009). These interactions probably 
result in increased rigidity and adhesiveness of the RBC membrane thereby contributing 
to parasite survival (Sanyal et al, 2012). KAHRP is an essential component of the knobs 
as knockout studies of this gene revealed a knob-less phenotype with a dramatic 
reduction in cytoadherence under flow conditions. Although the protein is dispensable 
for the delivery of PfEMP1 to the erythrocyte surface, their physical interaction seems 
important for the proper presentation of the adhesin (Crabb et al, 1997; Rug et al, 2006).  
 
Figure 6. Knob structure and the cytoskeleton in P. falciparum-infected RBCs (Maier et al, 2009) 
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 New permeation pathways 1.2.3
Parasite development within the erythrocytes requires extensive nutrient acquisition as 
well as waste exchange. The major food source, haemoglobin, is not sufficient for 
parasite survival since it does not contain isoleucine and several other amino acids, such 
as glutamate, methionine, cysteine and proline are underrepresented (Mbengue et al, 
2012). Since the erythrocyte is impaired in nutrient uptake, the parasite establishes new 
permeation pathways (NPP) to import essential molecules such as glucose, pantothenic 
acid and choline (Baumeister et al, 2006; Kirk & Saliba, 2007; Saliba & Kirk, 2001). 
The induced activity of specific transporters leads to increased permeability of the RBC 
membrane to low molecular weight solutes including amino acids, sugars, nucleosides, 
vitamins as well as organic and inorganic ions (Boddey & Cowman, 2013; Ginsburg & 
Stein, 2004). The origin of these pathways is still under debate and studies in favour of 
parasite-induced reactivation of host transporters or insertion of new transporters 
encoded by Plasmodium exist (Baumeister et al, 2010; Mbengue et al, 2012). The 
identification of two parasitic anion channels in the erythrocyte membrane 
(CLAG3.1/3.2) is consistent with the latter hypothesis (Nguitragool et al, 2011). 
Interestingly, expression switching of these proteins was observed, which may assist in 
evading host immune responses (Boddey & Cowman, 2013). Furthermore the 
establishment of the TVN, a membranous system in the erythrocyte cytosol extending 
from the PVM to the RBC membrane, is suggested to facilitate nutrient transport 
(Haldar, 2005; Sherman, 2005; Tamez et al, 2008). 
 Protein transport in intraerythrocytic stages of P. falciparum 1.3
The establishment of a delicate protein transport system is a prerequisite for the survival 
in this terminally differentiated host cell. Therefore, Plasmodium parasites target a 
diversity of cellular compartments for protein trafficking. Apart from the common 
secretory system, these destinations include intracellular organelles such as rhoptries, 
micronemes, the digestive vacuole and the apicoplast as well as extracellular targets 
including the parasitophorous vacuolar membrane, the erythrocyte cytosol, Maurer’s 
clefts and the RBC membrane (Deponte et al, 2012).. 
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 Intracellular trafficking 1.3.1
Although the secretory pathways of malaria parasites share similarities with other 
eukaryotic systems, unique protein destinations indicate these specialized organelles as 
potential targets for intervention (Figure 7) (Tonkin et al, 2006a). The genome of 
Plasmodium harbours many homologues of core secretory proteins such as the Ras-
related proteins in brain (Rabs), the ADP ribosylation factors (ARFs), the coat protein 
complex components (COP) and the secretion (Sec) apparatus, but there is still a lack of 
information on functionality of these components (ibid.). In general, most proteins enter 
the secretory pathway via an N-terminal signal peptide that guides translocation into the 
endoplasmic reticulum (ER). These signal peptides, usually 15-30 hydrophobic amino 
acids (aa) in length, are recognized by the signal recognition particle (SRP) upon 
emergence from the ribosome followed by subsequent binding of SRP to its ER receptor 
and co-translational insertion of the nascent protein into the ER lumen or membrane. In 
many cases, the signal peptide is cleaved by signal peptidase (Alberts, 2010). 
Alternatively to the classical signal sequence, many secreted parasite proteins contain 
recessed signal sequences in some distance from the amino (N)-terminus. The exact 
relevance of these non-canonical sequences is not entirely understood but may involve 
post-translational translocation or differential timing in export of certain proteins 
(Deponte et al, 2012). Furthermore, many proteins lack a typical signal peptide and 
instead use internal hydrophobic core regions or transmembrane domains for recruitment 
into the secretory pathway (Cooke et al, 2004). The ER resembles a simple perinuclear 
structure with two protruding ‘horns’ that extends upon parasite maturation  (van Dooren 
et al, 2005). Entry of soluble as well as membranous proteins into the ER is 
accompanied by chaperone-mediated folding into the correct tertiary structure necessary 
for subsequent trafficking steps (Shonhai et al, 2007). Interestingly, Plasmodium has 
only a limited or absent capacity for N-glycosylation, a common post-translational 
modification within the ER. Although components of the ER-associated degradation 
pathway (ERAD) of terminally misfolded proteins are conserved among Plasmodium 
species, this process of proteasomal targeting is not well studied (Deponte et al, 2012). 
In accordance with other eukaryotic systems, the ER seems to be compartmentalized into 
regions with accumulation of the COPII coat complex for vesicle-budding and protein 
exit (transitional ER) (Lee et al, 2008). Retention of ER-resident proteins is achieved by 
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classical C-terminal signals such as the KDEL-sequence (alternatively SDEL) that is 
recognized by the Golgi-based receptor ER Retention Defective 2 (ERD2) (Elmendorf & 
Haldar, 1993; Kulzer et al, 2009; Kumar & Zheng, 1992; Tonkin et al, 2006b). Although 
the Golgi apparatus appears rudimentary in Plasmodium its existence and basic cis-
/trans-structure was established using typical Golgi markers (Struck et al, 2005; Struck 
et al, 2008). The exact function of this organelle is still controversial and many 
trafficking routes seem to circumvent a traditional Golgi passage (Bannister et al, 2000; 
Mattei et al, 1999). The late secretory steps from the trans-Golgi are less understood 
despite the presence of homologues encoding clathrin coat components, multiple clathrin 
adaptors, soluble N-ethylmaleimide-sensitive-factor attachment receptors (SNAREs) and 
Rab proteins in the plasmodial genome (Deponte et al, 2012). Apart from the signal 
sequences guiding ER entry, additional motifs provide necessary information for 
subsequent targeting of proteins to their final destinations (Tonkin et al, 2006a).  
A unique organelle of apicomplexa is the previously-mentioned apicoplast, which is of 
endosymbiotic origin and enclosed by 4 membranes (Parsons et al, 2009). Most 
apicoplast proteins are nuclear encoded and post-translationally translocated into this 
organelle using a plant-like transit peptide that becomes exposed after cleavage of the 
signal peptide in the ER (Tonkin et al, 2008). Malaria parasites possess one single 
mitochondrion that extends into a branched tubular network throughout intraerythrocytic 
development. Apart from three genes in the desoxyribonucleic acid (DNA) of the 
mitochondrion all of the mitochondrial proteins are nuclear encoded and have to be 
reimported after cytosolic translation. In general, most mitochondrial proteins contain an 
N-terminal mitochondrial presequence that is characterized by a net positive charge and 
is predicted to form an amphiphilic helix. This assumption is transferred to Plasmodium 
and in silico analysis predicts a significant number of proteins (over 300) that are 
potentially targeted to the mitochondrion (Bender et al, 2003; Deponte et al, 2012). 
However, there is little experimental data on the import machinery of this organelle. 
Targeting of proteins (e.g. Plasmepsin proteases) to the food vacuole (FV), the 
lysosomal compartment involved in haemoglobin digestion, requires an N-terminal 
signal peptide along with a heterologous prodomain. Interestingly, the trafficking route 
of these proteases includes the release into the PV with subsequent re-uptake via 
endosomes (Tonkin et al, 2006a). From 38 hours after invasion, merozoites are formed 
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and apical organelles essential for new cell invasion, such as rhoptries, micronemes and 
dense granules are established. Proteins destined to traffic to these compartments enter 
the secretory pathway either through a classical signal sequence or an internal 
hydrophobic domain (Bannister et al, 2000). Although post-Golgi sorting through 
special vesicle-mediated transport of these proteins is indicated, no conserved motifs 
have been identified so far (Deponte et al, 2012). 
 
Figure 7. Intracellular secretory transport in P. falciparum (Tonkin et al, 2006a) 
Ap: apicoplast. Cy: cytostomes. DG: dense granules. ER: endoplasmic reticulum. FV: food vacuole. Gg: 
Golgi apparatus. Mn: micronemes. Nu: nucleus. PM: (parasite) plasma membrane. PRh: pre-rhoptry 
compartments. PV: parasitophorous vacuole. PVM: parasitophorous vacuolar membrane. Rh: rhoptries. 
SP: signal peptide. TP: transit peptide. YXX: tyrosine-based sorting motif for rhoptry proteins in 
Toxoplasma gondii. 
 Protein export into the host cell  1.3.2
The remarkable ability of Plasmodium to remodel the erythrocyte according to its 
developmental needs is facilitated by expression of a large repertoire of specialized 
proteins that are trafficked through a complex export pathway into the host cell (Boddey & 
Cowman, 2013). The identification of a pentameric N-terminal sequence called 
Plasmodium export element (PEXEL, RxLxE/Q/D)
3,4
 marked an important milestone in 
the characterization of the parasite’s ‘exportome’ of more than 400 soluble and membrane 
PEXEL proteins (~8 % of protein coding genome) that are translocated beyond the PVM 
(Boddey et al, 2013; de Koning-Ward et al, 2009; Hiller et al, 2004; Marti et al, 2004). 
Among these proteins are the main knob-forming protein KAHRP, variant proteins of the 
                                                 
3
 The export motif is also named Vacuolar Targeting Signal (VTS) or Host Cell Targeting Signal (HCT).  
4
 Amino acid codes see Abbreviations, x is any non-charged amino acid. 
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repetitive interspersed family (RIFIN), Plasmodium helical interspersed sub-telomeric 
(PHIST) and STEVOR families, putative serine/threonine kinases, heat shock proteins as 
well as other virulence determinants particularly involved in cytoadhesion and host cell 
modification (Boddey et al, 2013; Sijwali & Rosenthal, 2010). Although an increasing 
number of PEXEL-negative proteins (PNEPS) are identified, the PEXEL motif still 
characterizes the majority of exported proteins known today. Interestingly, non-falciparum 
Plasmodium species have a 5-10 fold smaller predicted PEXEL exportome with an 
increased number of PNEPS assumed to mark protein export in these organisms (Haase & 
de Koning-Ward, 2010; Heiber et al, 2013; Pasini et al, 2013). The explanation for this 
gene expansion and radiation is probably the functional dedication of many PEXEL 
proteins to support PfEMP1-mediated cytoadhesion, a process that is unique to 
P. falciparum (and P. reichenowi) (Boddey & Cowman, 2013). From the proportion of 
conserved PEXEL proteins between human and rodent malaria parasites half were shown 
to be essential in the rodent P. berghei model system (19 out of 33 orthologous genes) 
indicating substantial involvement in parasite survival (Matz et al, 2013; van Ooij et al, 
2008). While the export motif is conserved among Plasmodium species it is apparently 
absent in this particular form in other Apicomplexans, apart from Toxoplasma gondii 
(Hsiao et al, 2013; Sargeant et al, 2006). A similar recessed motif (RxRL) was identified 
in effector proteins of oomycete plant pathogens (Whisson et al, 2007). However, in 
contrast to previous studies, recent evidence excludes a functional connection between 
these two export machineries (Bhattacharjee et al, 2006; Boddey & Cowman, 2013; Ellis 
& Dodds, 2011). The presence of PEXEL-exported proteins seems not restricted to 
asexual blood stage parasites. A functional role in gametocytogenesis has been implicated 
based on the overrepresentation of this group, such as members of the PHIST family, in 
the proteome of young gametocytes (Silvestrini et al, 2010). Furthermore, some PEXEL 
proteins are found in sporozoites including the liver-stage antigen-3 (LSA-3) and the 
major immunodominant circumsporozoite protein (CSP) and there is increasing evidence 
that host cell remodelling processes during liver-stage development are driven by the same 
export machinery as in the blood stages (Ingmundson et al, 2014; Ingmundson et al, 2012; 
Matthews et al, 2013; Singh et al, 2007).   
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1.3.2.1 The PEXEL motif 
For successful export of proteins into the host cell cytoplasm two motifs are needed: a 
signal sequence for entry into the secretory pathway of the ER and the PEXEL motif for 
further translocation across the PVM (Goldberg & Cowman, 2010). The core export 
motif consists of five amino acids with the consensus sequence RxLx(x)E/Q/D and is 
located 20-30 amino acids C-terminal from the signal sequence (Hiller et al, 2004; Marti 
et al, 2004). After co- or posttranslational insertion into the ER the PEXEL motif is 
recognized by the ER-resident protease Plasmepsin V and cleaved after the conserved 
leucine residue (substrate residue P1)
5
 (Figure 8) (Boddey et al, 2010; Crabb et al, 2010; 
Klemba & Goldberg, 2005; Russo et al, 2010). Plasmepsin V is one of ten aspartic 
proteases in P. falciparum and functionally distinct from the other members, which are 
mainly involved in haemoglobin degradation in the parasitic food vacuole or indicated in 
host spectrin degradation (Klemba & Goldberg, 2005). The enzyme is conserved in 
Plasmodium species, but absent in higher eukaryotes. It has a C-terminal transmembrane 
region with the protease domain presumably protruding into the lumen (Boddey et al, 
2010). It was shown that cleavage occurred in the ER due to its sensitivity to Brefeldin 
A, an inhibitor of anterograde protein transport from ER to Golgi, which led to the 
accumulation of processed PEXEL proteins in this compartment (Chang et al, 2008; 
Osborne et al, 2010). Furthermore, Plasmepsin V seems dominant and exclusive over 
signal peptidase in cleavage activity, which highlights its important ‘gatekeeper’ role in 
freeing PEXEL cargo from the ER (Boddey et al, 2010; Russo et al, 2010). A spatial and 
temporal connection of the enzyme with downstream components of the export 
machinery such as chaperones or receptors was previously implicated as an important 
prerequisite for proper targeting of the PEXEL proteins to the PV and beyond (ibid.). In 
accordance with structural active-site predictions (Guruprasad et al, 2011), several 
mutagenic studies revealed the importance of the P3 arginine and P1 leucine of the 
PEXEL motif in mediating proper processing by the protease, with cleavage and export 
deficiency in various proteins bearing alanine replacements (Boddey et al, 2010; Boddey 
et al, 2009; Hiller et al, 2004; Marti et al, 2004; Tarr et al, 2013). In contrast, the P2’ 
conserved residue (E/Q/D) is dispensable for proteolysis but seems important for 
                                                 
5
 By convention, amino acid residues in a substrate undergoing cleavage are designated P1, P2, P3 etc. in 
the N-terminal direction from the cleaved bond (P1-P1’). Likewise, the residues in C-terminal direction 
are designated P1', P2', P3' (Schechter & Berger, 1967). 
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downstream trafficking steps (Boddey et al, 2010; Tarr et al, 2013). A recent study using 
in vitro cleavage assays rejected previous assumptions that lysine could replace arginine 
at P3 and consequently excluded PfEMP1 proteins from the PEXEL repertoire. The 
authors could also show that proteins with ‘relaxed’ PEXEL motifs (RxLxxE/Q/D) were 
successfully cleaved, which resulted in a redefined exportome of 463 proteins (Boddey 
et al, 2013).  
After cleavage, the new N-terminus (xE/Q/D) is subsequently N
α
-terminal acetylated (N-
acetylated) by an unknown N-acetyltransferase (Chang et al, 2008; Osborne et al, 2010). 
The processed proteins are further trafficked to the parasitophorous vacuole where they 
are translocated into the RBC via a recently identified translocon (de Koning-Ward et al, 
2009; Riglar et al, 2013). The functional relevance of the acetylated N-terminus in 
guiding protein export from the ER to the PV as well as the nature of the secretory 
machinery involved is not well understood and some studies are controversial (Boddey 
et al, 2009; Tarr et al, 2013). Different models are suggested including receptor- or 
chaperone-mediated vesicular escort to specialized export-competent zones at the 
parasite surface in close proximity to the translocation complex. Alternatively, exported 
proteins may enter the default secretion pathway with subsequent recognition by 
chaperones or the translocon complex in the PV (Boddey & Cowman, 2013; Crabb et al, 
2010; Elsworth et al, 2014). 
 
Figure 8. PEXEL-mediated protein export (Boddey et al, 2010) 
 
INTRODUCTION 
21 
1.3.2.2 Translocation into the host cell 
For the successful translocation into the host erythrocyte protein unfolding and energy in 
form of adenosine triphosphate (ATP) are required and the recent identification of the 
putative Plasmodium translocon of exported proteins (PTEX) in the PVM confirmed 
these indications of a membrane-pore containing protein complex (Ansorge et al, 1996; 
de Koning-Ward et al, 2009; Gehde et al, 2008). The components of the PTEX are 
conserved among Plasmodium species but are absent from other apicomplexan parasites 
(Ingmundson et al, 2014). In addition to blood stages, expression of the complex was 
detected in gametocytes, sporozoites and late liver stages indicating a putative functional 
activity of the translocation machinery during these stages of infection (Matthews et al, 
2013; Vaughan et al, 2012).  
The translocon is a >1.2 megadalton (MDa) complex that consists of five components 
found on the vacuolar side of the PVM (Figure 9) (Bullen et al, 2012). Three of these 
proteins, exported protein 2 (EXP2), heat shock protein 101 (HSP101) and PTEX150, 
are essential core components, whereas two, thioredoxin 2 (Trx2) and PTEX88, are non-
essential accessory components since their genes can be deleted in P. berghei (Matthews 
et al, 2013; Matz et al, 2013). The pore is most likely assembled through oligomerization 
of EXP2. HSP101, an AAA+ ATPase, forms a hexameric ring with a central port. Like 
other members of the HSP101/clpB family it probably functions as a chaperone in 
unfolding of the proteins prior to translocation (de Koning-Ward et al, 2009). The novel 
protein PTEX150 binds strongly to HSP101 and EXP2 and might fulfil a structural role. 
The role of Trx2 has not been experimentally determined yet but it may help to redox-
regulate the complex or hydrolyse disulphide bonds during unfolding of cargo proteins 
(Elsworth et al, 2014). PTEX88 has no homologues outside of the Plasmodium genus 
and despite lacking information on its function in PTEX ptex88
-
 deletion parasites show 
a severe growth defect of ~50% compared to wild-type parasites (Matz et al, 2013).  
PTEX components are secreted into the nascent PV as early as 10 minutes after invasion, 
where they rapidly assemble in distinct foci along the PVM (Bullen et al, 2012; Riglar et 
al, 2013). The export of the ring-infected erythrocyte surface antigen (RESA) from the 
merozoites into the erythrocyte within minutes after invasion impressively represents 
this rapid timing of events (Riglar et al, 2013). The translocon preferentially binds 
exported over non-exported proteins and colocalizes with artificially trapped reporter 
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proteins (de Koning-Ward et al, 2009; Riglar et al, 2013). Interestingly, soluble PEXEL 
proteins and PNEPs are trapped in the PV when unfolding is inhibited by specific 
dihydrofolate reductase domains, whereas similarly blocked TM-containing PNEPs are 
trapped at the parasite plasma membrane (PPM) (Elsworth et al, 2014; Gruring et al, 
2012; Heiber et al, 2013). This observation indicates that either a second translocon in 
the PPM is promoting transfer of TM proteins or PTEX may commonly facilitate export 
of all these proteins by spanning both the PPM and the PVM (Elsworth et al, 2014). 
After translocation through the pore in an unfolded manner PEXEL proteins are refolded 
in the erythrocyte cytoplasm by host as well as parasite-derived chaperones such as 
HSP70-x/HSP40-like family members (Boddey & Cowman, 2013).  
Several different modes are identified for the subsequent trafficking steps depending on 
the proteins as well as their final destinations (RBC cytosol, cytoskeleton, MCs, RBC 
surface, knobs, TVN etc.) and there seems to be considerable diversity (Elsworth et al, 
2014). While some soluble proteins move through bulk flow, integral (and probably 
many soluble) proteins are either chaperoned or transported in vesicles, sometimes the 
solubility profiles even change as shown for PfEMP1 (Haase & de Koning-Ward, 2010; 
Tilley et al, 2008). Most of the exported proteins transiently or permanently associate 
with the parasite-induced Maurer’s clefts, which represent intermediate sorting 
compartments that are indispensable for proper assembly of the cytoadherence complex 
(Dixon et al, 2011; Mundwiler-Pachlatko & Beck, 2013).  
 
Figure 9. Model of the Plasmodium translocon of exported proteins (Boddey & Cowman, 2013) 
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1.3.2.3 Alternative export pathways 
There is a growing number of PEXEL-negative proteins (PNEPS) identified and 
although only a few are characterized so far, they likely comprise a much larger 
repertoire than originally assumed. This seems especially relevant for non-falciparum 
Plasmodium species that contain fewer PEXEL proteins (Heiber et al, 2013; Pasini et al, 
2013). Most of the known PNEPS localize to Maurer’s clefts, such as MAHRP1 and 2 , 
SBP1 or REX1 and 2 and recently PfEMP1 was added to this group (Boddey et al, 2013; 
Mundwiler-Pachlatko & Beck, 2013). The dissection of PNEP export signals is 
challenging, since they lack a common conserved motif. Several studies revealed that 
hydrophobic regions or transmembrane domains as well as certain other sequences 
within the N-terminal half of the proteins are required for proper entry into the ER and 
subsequent trafficking into the host cell (Dixon et al, 2008; Gruring et al, 2012; Haase et 
al, 2009; Pachlatko et al, 2010; Saridaki et al, 2009). PNEPS cannot be cleaved by 
Plasmepsin V and are not N-acetylated (Boddey & Cowman, 2013). Interestingly, 
unfolding of these proteins seems to be equally important suggesting a similar mode of 
translocation across the PVM as observed in PEXEL proteins (Heiber et al, 2013). This 
hypothesis of a convergence of PEXEL and non-PEXEL protein export at some point is 
further supported by a recent study that showed how the processed N-terminus of a 
PEXEL protein functionally replaced the unprocessed N-terminus of a PNEP in 
promoting the export of a reporter protein (Gruring et al, 2012). However, so far no 
direct interaction between PNEPs and the PTEX translocon could be confirmed (Boddey 
& Cowman, 2013).  
1.3.2.4 The STEVOR protein family 
The protein used in this study (gene ID: PF3D7_0631900, PlasmoDB) belongs to the 
PEXEL-positive variant subtelomeric variant open reading frame (STEVOR) protein 
family (Aurrecoechea et al, 2009). This group contains 30-40 members of 
transmembrane domain proteins that are localized to the Maurer’s clefts and erythrocyte 
membrane (Cheng et al, 1998). As a putative function of these proteins the modification 
of the erythrocytic deformability has been suggested to support vascular sequestration, 
Furthermore, antigenic variation is implicated to contribute to immune evasion of the 
parasite (Blythe et al, 2004; Lavazec et al, 2007; Sanyal et al, 2012). According to the 
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name the corresponding genes are located in proximity to other variant families such as 
var or rif genes within the terminal 50 kb of Plasmodium chromosome telomers, a 
precondition that commonly facilitates duplication and recombination events (Cheng et 
al, 1998; Mok et al, 2008; Przyborski et al, 2005). Only a subset of stevor genes is 
transcribed in the parasite population at a time, with occasional switching of expression 
to a different locus (Sanyal et al, 2012). Stevor and rif genes are related with each other 
and share a common gene structure consisting of 2 exons that encode a signal peptide in 
the first exon followed by a PEXEL motif and up to two transmembrane domains in the 
second exon (Przyborski et al, 2005). A highly polymorphic region within the outer loop 
between the two transmembrane domains is assumed to confer antigenic variation in 
these proteins (Sanyal et al, 2012). The expression of STEVOR proteins peaks at 22 to 
28 hours post invasion and protein expression was detected in trophozoite, schizont, 
gametocyte and sporozoite stages as well as in the apical complex of merozoites (Sanyal 
et al, 2012). The P. falciparum 3D7 strain possesses 31 stevor genes plus 10 pseudo 
genes (PlasmoDB, version11.0). The variant used in this study, PF3D7_0631900 (1023 
bp), has been investigated before and encodes a ~34 kilodalton (kDa) protein of 303 
amino acids with 2 transmembrane domains that primarily localizes to Maurer’s clefts in 
its full-length version (Figure 10A) (Henrich, 2008; Przyborski et al, 2005).  
 
Figure 10. Full-length STEVOR and STEVOR
1-80
 tagged to GFP (Przyborski et al, 2005) 
Left: schematic drawing of the protein with ER signal sequence (red), transmembrane domains (blue) and 
GFP tag (green). The PEXEL motif is from aa 48-52. Right: Fluorescence images of iRBCs with 
P. falciparum transfectants expressing the (A) full-length and (B) shortened version of STEVOR
 
tagged to 
GFP. Left, differential interference contrast (DIC); middle, GFP fluorescence; right, overlay. Middle 
panel of (A) shows IFA using α-GFP antibodies against STEVORGFP or α-PfSBP1 antibodies against the 
Maurer’s clefts marker PfSBP1. Modified from Przyborski et al (2005).  
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In this study a shortened version comprising the first 80 amino acids including the signal 
peptide, the PEXEL motif (
48
RLLAQ
52
) and enough linker region to separate it from an 
otherwise interfering green fluorescent protein (GFP) tag was used, as previously 
published (Knuepfer et al, 2005a; Przyborski et al, 2005). This 9.8 kDa protein 
(STEVOR
1-80
) is soluble and gets exported via the PEXEL-mediated pathway into the 
RBC cytosol (Figure 10B). 
 Nα-terminal protein acetylation 1.4
N-terminal acetylation is a very common protein modification in eukaryotes with 50-
70% of yeast and 70-90% of human proteins being co-translationally N-acetylated by 
around 6 classes of N-acetyltransferase complexes (NatA-NatF) with different substrate 
specificities (Van Damme et al, 2011a). Also ~75% of the plant kingdom proteomes 
show this chemical modification, which is characterized by the transfer of an acetyl 
group from acetyl-Coenzyme A (acetyl-CoA) to the α–amino group of the first amino 
acid residue of a protein (Figure 11A) (Starheim et al, 2012). The acetylation removes 
the positive charge of the terminal amino group, thus changing the chemical properties 
of the protein N-terminus (ibid.). Despite the observed abundance, the exact biological 
role has remained enigmatic (Hollebeke et al, 2012). However, gene inactivation of NAT 
complex components in human cell lines was detrimental with oncogenesis and cell 
division defects thereby pointing to the importance of this mechanism (Bienvenut et al, 
2012). Functional relevance in protein stability, localization and interaction has been 
determined for an increasing amount of cases such as proteasomal targeting by increased 
ubiquitination or induction of protein interactions such as the components of the 
neddylation complex (Figure 11B) (Hwang et al, 2010; Shemorry et al, 2013; Starheim 
et al, 2012). In the context of protein export interesting examples include acetylation-
dependent membrane targeting of small GTPases and increased membrane affinity of 
acetylated alpha-synuclein (Dikiy & Eliezer, 2014; Scott et al, 2011). Remarkably, co-
translational N-acetylation following initiator methionine removal seems to inhibit ER-
translocation of cytosolic proteins (Forte et al, 2011). In contrast, post-translational 
acetylation occurs less frequent and is not well understood. Some published examples 
include certain plant chloroplast proteins (Bienvenut et al, 2012; Zybailov et al, 2008), 
regulatory peptides and hormones including the α-melanocyte-stimulating hormone and 
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b-endorphin in mammals (Polevoda & Sherman, 2000) as well as acetylation of actin 
(Van Damme et al, 2011b). The connection between acetylation and cellular metabolism 
through its substrate, acetyl-CoA, is intriguing. It was shown that different acetyl-CoA 
levels influenced cellular proliferation by regulating acetylation-dependent apoptosis-
regulatory proteins similar to the observed regulation of histone lysine acetylation and 
subsequent gene activation (Starheim et al, 2012). The involvement of NATs in cancer is 
controversial with studies pointing towards oncogenic as well as tumour suppressor 
function (ibid.). It is still unknown, if N-terminal acetylation is irreversible, as 
previously assumed, or reversible by yet undiscovered deacetylases like in the case of 
histones (HDACS).  
Different NATs of diverse subunit composition facilitate the acetylation of their specific 
substrates, and especially higher eukaryotes show an increase in complexity through 
gene duplications and different splice variants (Hollebeke et al, 2012). Most of the 
enzymes are found in association with ribosomes and facilitate co-translational catalysis, 
but some of them also exist in a non-ribosomal state, especially in higher eukaryotes, 
where they act on different targets or independent of the complex as single subunits 
(Starheim et al, 2012). The major NAT representing the largest class of substrates with a 
strong evolutionary sequence conservation from lower to higher eukaryotes is the NatA 
complex, which is composed of the catalytic subunit Naa10p (Ard1p) and the auxiliary 
subunit Naa15p (Nat1p) (Arnesen et al, 2009). NatA acetylates S-, A-, T-, G-, V- and C-
N termini after the initiator methionine is removed by aminopeptidases (Arnesen et al, 
2009). The other NATs (NatB-NatF) acetylate the initiator methionine dependent on the 
following second amino acid residue. The NatB complex acetylates substrates with M-
D-, M-E-, M-N- and M-Q-N termini and is important for acetylation of actin and 
tropomyosin. NatC prefers M-L-, M-F-, M-I- and M-W. NatD has only two substrates, 
the histones H2A and H4, and recognizes a longer stretch in the substrate than the other 
NATs. NatE, although partly composed of the same subunits as NatA, acetylates a 
specific set of N termini with methionines followed by hydrophobic residues and has 
been implicated in sister chromatid cohesion and chromosome resolution. Recently, 
NatF was identified in higher eukaryotes only. It also acetylates M-L-, M-F-, M-I- and 
M-W- and M-K-N termini (Starheim et al, 2012). The biological roles of these NATs are 
still subject to intense research. In the context of post-translational N-terminal 
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acetylation, it is worth mentioning that most of the (few) studies on yeast and plant 
acetylomes identified substrate specificity for NatA, meaning an overrepresentation 
of  S-, A-, V- and T- N-termini predicted post-cleavage (Bienvenut et al, 2012; Helsens 
et al, 2011).  
In Plasmodium information on acetylation in general is still lacking and rather limited to 
lysine acetylation of histones and actin (Chung et al, 2009; Goyal et al, 2012; Miao et al, 
2013; Schmitz et al, 2005). The process of post-translational N-acetylation as described 
for PEXEL proteins after cleavage in the ER is highly interesting and the identification 
of the NAT that is responsible for this modification would mean considerable progress. 
Previous publications suggested some candidates, but so far without providing any 
further evidence (Boddey & Cowman, 2013; Chang et al, 2008; Osborne et al, 2010).  
 
Figure 11. Molecular functions of N-terminal acetylation (Starheim et al, 2012) 
(A) Chemical process of N-terminal acetylation catalysed by a NAT enzyme. (B) Examples of functional 
studies on the effects of this modification. Modified from Starheim et al (2012)
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 Aim of the study 1.5
The invasion of human erythrocytes by P. falciparum is accompanied by extensive 
parasite-induced modifications of the host cell, which contribute to parasite survival, 
cytoadhesion and host immune system evasion. The establishment of a protein export 
system to translocate hundreds of effector proteins into the terminally differentiated 
erythrocyte is a necessary prerequisite for this remodelling process. The majority of 
exported proteins are characterized by the PEXEL motif that is enzymatically processed 
in the parasite and proved to be essential for proper targeting beyond the parasitophorous 
vacuole (Hiller et al, 2004; Marti et al, 2004). It is of considerable interest to understand 
this bottleneck in the export mechanism as an attractive target for therapeutic 
interventions.  
The aim of the first part of this study was to dissect the function of each position of the 
PEXEL motif by conducting a mutagenesis screen on the model protein STEVOR
1-80 
(Przyborski et al, 2005). In detail, the capability of certain amino acids to functionally 
replace the wild-type counterparts in guiding proper processing and export of the mutant 
proteins was assessed. In continuation of previous work by P. Henrich (2008) positions 2 
to 4 of the pentameric export motif were subjected to various amino acid replacements 
followed by transfection of P. falciparum parasites. The export phenotypes of the mutant 
GFP-tagged STEVOR
1-80
 proteins were analysed by confocal fluorescence microscopy. 
Furthermore, some representative mutants were chosen for mass spectrometry analysis 
to determine their processing state with respect to cleavage and acetylation of the export 
motif. The repetition of certain replacements in a second PEXEL protein, KAHRP, 
should give information about the reproducibility of previous results.  
The second part of this study focussed on the process of N-terminal acetylation after 
cleavage of the PEXEL motif in the endoplasmic reticulum (Chang et al, 2008). Of 
particular interest was the identification of a putative N-acetyltransferase that could be 
responsible for this common modification among exported proteins. The expression and 
localization of the candidate enzyme in P. falciparum parasites was determined with 
fluorescent reporter tags, also in the endogenous genomic background. Furthermore, the 
functional role was investigated by attempted deletion of the respective gene as well as 
conditional downregulation of the enzyme on protein level. A better understanding of 
PEXEL-mediated protein export can hopefully be achieved through this study. 
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2 Materials and Methods 
Most of the methods mentioned in this chapter follow standard laboratory procedures for 
P. falciparum experiments and were already described in my diploma thesis (Risch, 
2009). For the sake of completeness, these parts are copied here, whereas newly 
introduced methods are marked with an asterisk*.  
 Materials 2.1
 Equipment 2.1.1
Analytical scales    Sartorius, Göttingen 
Autoclave     Tuttnauer Systec 2540, Wettenberg 
Camera, DC 120 Zoom digital  Kodak, New York 
Centrifuges 
J2-MC     Beckman, Krefeld 
RC5BPlus    Sorvall, Langenselbold 
Megafuge 2.0R   Heraeus Instruments, Hanau 
Megafuge 1.0R   Heraeus Instruments, Hanau 
L-60 Ultracentrifuge   Beckman, Krefeld 
Biofuge fresco   Heraeus Instruments, Hanau 
 Microcentrifuge MC13   Amicon Bioseparatia/ Millipore 
CCD Camera     Princeton Instruments, USA 
Computer-software 
Adobe Photoshop® 5.0  Adobe Systems Inc, USA 
Bioedit    http://www.mbio.ncsu.edu/BioEdit/bioedit 
CellQuest Pro    Becton Dickinson 
ClustalW    http://www.ebi.ac.uk/Tools/clustalw/ 
EndNote X6    ISI Research Soft, CA, USA 
Expasy Proteomics server  http://www.expasy.ch/tools/pi_tool.html 
FIJI image analysis   http://fiji.sc/Fiji 
InterProScan4    http://www.ebi.ac.uk/Tools/pfa/iprscan/ 
Kodak Digital Science 1D  Kodak, New York, USA 
MS Powerpoint 2010   Microsoft Corporation, CA USA 
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MS Word 2010   Microsoft Corporation, CA USA 
MS Excel 2010   Microsoft Corporation, CA USA   
Mozilla Firefox   Microsoft Communications Corp., USA 
Protein Data Bank   http://www.rcsb.org/pdb/home/home.do 
pDRAW32 software   AcaClone software 
PlasmoDB    http://plasmodb.org/plasmo/ 
PSIPRED    http://bioinf.cs.ucl.ac.uk/psipred/ 
Serial Cloner 2.6   http://serialbasics.free.fr/Serial_Cloner.html 
SigmaPlot 11.0; 12.0   Systat Software Inc. 
SMART    http://smart.embl-heidelberg.de/ 
Swiss-Model Server   http://swissmodel.expasy.org/ 
Zeiss Image Examiner  Zeiss, Jena 
DNA electrophoresis apparatus  Biorad, München 
Electroporator Gene Pulser® II  Biorad, München 
Film developer    Hyperprocessor Amersham Biosciences,  
      Freiburg 
Film exposition cassettes   Sigma, Taufkirchen 
Freezer -80ºC, UF85-300S   Heraeus GmbH, Hanau 
Freezers -20ºC    Liebherr, Biberach 
Fridges     Liebherr, Biberach 
Gas burner gasprofi 1 micro   WLD-TEC 
Heat block, Digi-block JR   Laboratory devices INC, USA 
Icemachine AF 30    Scotsman, Milano, Italy 
Incubator (P. falciparum)   Heraeus Instruments 
Incubator shaker Innova 4000/4300  New Brunswick Scientific Co. Inc. 
Liquid nitrogen tank    Air Liquide, Ludwigshafen 
MACS system    Miltenyi Biotec, Bergisch Gladbach 
Magnetic stirrer    Heidolph, Schwabach 
Microscopes: 
Confocal laser scanning microscope LSM 510 Zeiss, Jena 
Light optical microscope Axiolab  Zeiss, Jena 
Microwave oven    AEG, Nürnberg 
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GeneAmp PCR system 9700   AppliedBiosystems, CA USA 
pH-meter pH 537    WTW, Weilheim 
Pipetman Gilson P10; P20; P200; P1000 Abimed, Langenfeld 
Pipetus- akku     Hirschmann Labortechnik, Eberstadt 
pipetus® standard    Hirschmann Labortechnik, Eberstadt 
Power supply: Power Pac 300  Biorad, München 
Protein electrophoresis systems  Biorad, München 
Printer hp LaserJet 1300   Hewlett Packard, Heidelberg 
Quartz cuvettes    Hellma, Müllheim 
Rotors: SS-34; GS-3    DuPont Instruments, Bad Homburg 
      Beckman instruments, Palo Alto, CA, USA 
Semidry Blot System    Genmall Biotechnology Co.,Ltd 
Spectrophotometer UVIKON 923  Kontron Instruments, 
Sterile work bench Herasafe   Heraeus Instruments, Hanau 
Stop watch     Roth, Karlsruhe 
UV-lamp Typ N-6 L    Benda Laborgeräte und Ultraviolettstrahler 
UV-Transilluminator    Gibco BRL, Karlsruhe 
Vortex Genie 2    Roth, Karlsruhe 
Water bath Julabo 7A    Julabo, Seelbach 
 Disposables 2.1.2
Aluminium foil    Roth, Karlsruhe 
Cell culture plates    Greiner Bio-One, Kremsmünster 
Centrifugation tubes, Polypropylen-12/75 Greiner Bio-one, Kremsmünster 
Centrifugation tubes,     Greiner Bio-one, Kremsmünster 
Polystyren-6, 0/38 mm 
Clingfilm Saran    Dow Chemical Company, Schwalbach 
Coverslides     Roth, Karlsruhe 
Cryovials     Nalgene®, Wiesbaden 
Cuvettes     Sarstedt, Nümbrecht 
Electroporation cuvettes   Biorad, München 
Eppendorf tubes    Sarstedt, Nümbrecht 
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Falcon tubes (15 ml; 50 ml)   Corning incorporation, Bodenheim 
Film BioMax MR    Kodak, New York, USA 
Gloves      Hartmann, Heidenheim 
Immersion oil     Zeiss, Jena 25 
Kimwipes lite 200    Kimberly Clark 
MACS-columns CS    Miltenyi Biotec, Bergisch Gladbach 
Object slides     Marienfeld, Lauda-Königshofen 
Parafilm     American International CanTM, USA 
Plastic pipettes (1 ml; 2 ml; 5 ml;   Corning incorporation, Bodenheim 
10 ml: 25 ml) 
Pipette tips     Corning incorporation, Bodenheim 
PVDF membrane    Biorad, München 
Sterile filters (0,2 μm)   Millipore GmbH, Ashburn 
Sterile filtration devices   Corning incorporation, Bodenheim 
Thermo well PCR tubes   Corning incorporation, Bodenheim 
WhatmanTM 3MM paper   Firma Whatman Paper Company 
96-well plates, black, clear   Greiner Bio-One, Kremsmünster   
 Chemicals 2.1.3
The chemicals used in this study are from the firms Roth, Merck, Sigma, Serva, Thermo 
and Applichem and were ordered directly or through the Heidelberg Medical faculty.  
 Biological material 2.1.4
Enzymes and DNA/ Protein markers 
1 kb Plus DNA-ladder   Fermentas, St.Leon-Rot 
Page Ruler, prestained protein ladder+ Fermentas, St. Leon-Rot 
Restriction enzymes    New England BioLabs, Schwalbach 
DNA-polymerase EuroTaq   BioCat, Heidelberg 
DNA-polymerase Phusion   Finnzymes, Finland 
SAP      Promega, Mannheim 
T4-DNA-Ligase    Invitrogen, Karlsruhe 26 
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Kits 
High Pure Plasmid Isolation Kit  Roche, Mannheim 
Gel Extraction/PCR purification Kit  Qiagen, Hilden 
MaxiPrep Kit     Qiagen, Hilden 
DNeasy Blood&Tissue Kit   Qiagen, Hilden 
BM Chemiluminescence Blotting 
Substrate (POD)    Roche, Mannheim 
SuperScript II RT Kit    Invitrogen, Karlsruhe 
HisPurTM Cobalt Spin Columns  ThermoFisher Scientific, Ulm 
Rapid DNA ligation Kit   Fermentas, St. Leon-Roth 
 
Antibodies 
mouse α-GFP monoclonal   Roche, Mannheim 
rabbit α-mouse IgG POD   Dianova, Hamburg 
 
Parasite strains 
For this study, the 3D7 strain of P. falciparum parasites was used for transfection and 
genetic recombination techniques (Ponnudurai et al, 1981; Walliker et al, 1987). For the 
studies on DiCre-mediated excision a special 3D7 strain named 1G5 was kindly 
provided by M. Blackman. This strain is characterized by constitutive expression of the 
DiCre recombinase from the SERA 5 locus (Collins et al, 2013).  
 
Escherichia coli (E. coli) strains 
Since the genome of P. falciparum and hence the transfection vector is very rich in AT-
sequences, passage through bacteria can be difficult and unstable (Baca & Hol, 2000). 
The use of the special E. coli strain XL1-Blue improves transformation stability 
(Chahaun, 2002). Protein expression for purification purposes was carried out in BL21-
CodonPlus-RIL bacteria (Stratagene, California), which harbour extra copies for tRNA 
genes (argenineU-, leucineW-and isoleucineY-tRNA) for optimal expression of 
heterologous proteins of organisms with A/T-rich genetic sequences (Flick et al, 2004). 
These bacterial cells were kindly provided by Dr. B. Derrer. 
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Vectors 
The pARL1a+-vector was originally provided by T. W. Gilberger (Wrenger & Muller, 
2004) and is the standard episomal vector used in our laboratory for the transfection of 
P. falciparum. This vector harbours the 5’ UTR of PfCRT, which was removed in this 
study for single crossover recombination experiments. Furthermore, the plasmid encodes 
GFP, the ampicillin resistance marker and human DHFR (hDHFR) that confers 
resistance of the parasites to the positive selection marker WR99210 (Hastings & Sibley, 
2002). Alternatively, the positive selection marker cassette was exchanged with the 
blasticidin S deaminase gene from Aspergillus terreus, which confers resistance to 
blasticidin S (Mamoun et al, 1999). For double-knockout studies in the parasites, the 
pCC and pHTK vectors were used, which have the previously mentioned positive 
selection marker cassettes as well as negative selection marker genes that drive 
sensitivity to 5-fluorocytosine (5-FC) and ganciclovir, respectively (Duraisingh et al, 
2002; Maier et al, 2006). These plasmids were kindly provided by A. Maier (pCC) and 
N. Hertrich (pHTK). For the conditional gene excision strategy using the loxP/DiCre 
system, the pHH1-SERA5del3-preDiCre vector was kindly provided by M. Blackman 
(Collins et al, 2013). It harbours two loxP sites in the CAM and PbDT UTRs, a multiple 
cloning site to introduce homology regions of interest (by replacing the SERA 5 gene 
fragment) and the hDHFR positive selection marker cassette. The vectors for the 
destabilization domain (DD) system were kindly provided by M. Azevedo (DD24 tag) as 
well as M. Ganther (DD29 tag) (de Azevedo et al, 2012). For conditional 
downregulation of the putative transferase (PfNAT), the DD24 domain (including an HA 
tag) was cloned into the previously generated pARL-PfNAT-GFP recombination vector. 
For protein expression the pET28a+ expression vector was used (Novagen), which was 
kindly provided by Dr. B. Derrer. Vector maps see Appendix. 
 
Oligonucleotides + Polynucleotides 
Primers were obtained from Thermo Scientific (Ulm). Sequencing was carried out by 
GATC (Konstanz). Synthetic sequences of the putative transferase (PfNAT) were 
generated by GeneArt® at Life technologies (Darmstadt). 
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General primers 
pARL-80 fwd 5’ CTATAATATCCGTTAATAATAAATACACGCAG 3’  
pARL +70 rev 5' CATACACATTTTTACAGTTATA 3' 
GFP +80 rev 5’ CAGAAAATTTGTGCCCATTAAC 3’ 
M13 fwd 5’ GTAAAACGACGGCCAG 3’ 
M13 rev  5’ CAGGAAACAGCTATGAC 3’ 
HA tag +26 rev  5' GCATAGTCAGGAACATCGTAAGGGTA 3' 
3xHA_KpnI for  5' TGTGGTACCTACCCGTACGACGTCCCGG 3' 
CAD AvrII for 5' TGATAGCCTAGGGGAGTGCAGGTGGAAACC 3' 
pTEX150 -61 for 5' CACAGGAAACAGCTATGAC 3' 
 
STEVOR
1-80
 and KAHRP
1-69
 mutagenesis 
stev80AvrIIrev 5' TGATAGCCTAGGTTTCTTTATTGCGTCTTCGTTC 3' 
stevXhoI for 5' TGTTAGCTCGAGATGAAGATGTATAACCTTAAAATGTT 
  ATTG 3' 
stevL49D for 5' CGATAAAATCAAGAGATTTAGCACAAACCC 3' 
stevL49D rev 5' GGGTTTGTGCTAAATCTCTTGATTTTATCG 3' 
stevL49E for 5' CGATAAAATCAAGAGAATTAGCACAAACCC 3' 
stevL49E rev 5' GGGTTTGTGCTAATTCTCTTGATTTTATCG 3' 
stevL49H for 5' CGATAAAATCAAGACATTTAGCACAAACCC 3' 
stevL49H rev  5' GGGTTTGTGCTAAATGTCTTGATTTTATCG 3' 
stevL49M for 5' CGATAAAATCAAGAATGTTAGCACAAACCC 3' 
stevL49M rev 5' GGGTTTGTGCTAACATTCTTGATTTTATCG 3' 
stevL49Q for 5' CGATAAAATCAAGACAATTAGCACAAACCC 3' 
stevL49Q rev 5' GGGTTTGTGCTAATTGTCTTGATTTTATCG 3' 
stevL49R for 5' CGATAAAATCAAGAAGATTAGCACAAACCC 3' 
stevL49R rev 5' GGGTTTGTGCTAATCTTCTTGATTTTATCG 3' 
stevL49W for 5' CGATAAAATCAAGATGGTTAGCACAAACCC 3' 
stevL49W rev 5' GGGTTTGTGCTAACCATCTTGATTTTATCG 3' 
stevL49Y for 5' CGATAAAATCAAGATATTTAGCACAAACCC 3' 
stevL49Y rev 5' GGGTTTGTGCTAAATATCTTGATTTTATCG 3' 
stevL50D for 5' CGATAAAATCAAGACTCGATGCACAAACCC 3' 
stevL50D rev 5' GGGTTTGTGCATCGAGTCTTGATTTTATCG 3' 
stevL50E for 5' CGATAAAATCAAGACTCGAAGCACAAACCC 3' 
stevL50E rev 5' GGGTTTGTGCTTCGAGTCTTGATTTTATCG 3' 
stevL50H for 5' CGATAAAATCAAGACTCCATGCACAAACCC 3' 
stevL50H rev 5' GGGTTTGTGCATGGAGTCTTGATTTTATCG 3' 
stevL50M for 5' CGATAAAATCAAGACTCATGGCACAAACCC 3' 
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stevL50M rev 5' GGGTTTGTGCCATGAGTCTTGATTTTATCG 3' 
stevL50Q for 5' CGATAAAATCAAGACTCCAAGCACAAACCC 3' 
stevL50Q rev 5' GGGTTTGTGCTTGGAGTCTTGATTTTATCG 3' 
stevL50R for 5' CGATAAAATCAAGACTCAGAGCACAAACCC 3' 
stevL50R rev 5' GGGTTTGTGCTCTGAGTCTTGATTTTATCG 3' 
stevL50W for 5' CGATAAAATCAAGACTCTGGGCACAAACCC 3' 
stevL50W rev 5' GGGTTTGTGCCCAGAGTCTTGATTTTATCG 3' 
stevL50Y for 5' CGATAAAATCAAGACTCTATGCACAAACCC 3' 
stevL50Y rev 5' GGGTTTGTGCATAGAGTCTTGATTTTATCG 3' 
stevA51D for 5' ATCAAGACTCTTAGATCAAACCCAAATCC 3' 
stevA51D rev 5' GGATTTGGGTTTGATCTAAGAGTCTTGAT 3' 
stevA51E for 5' ATCAAGACTCTTAGAACAAACCCAAATCC 3' 
stevA51E rev 5' GGATTTGGGTTTGTTCTAAGAGTCTTGAT 3' 
stevA51H for 5' ATCAAGACTCTTACATCAAACCCAAATCC 3' 
stevA51H rev 5' GGATTTGGGTTTGATGTAAGAGTCTTGAT 3' 
stevA51M for 5' ATCAAGACTCTTAATGCAAACCCAAATCC 3' 
stevA51Mrev 5' GGATTTGGGTTTGCATTAAGAGTCTTGAT 3' 
stevA51Q for 5' ATCAAGACTCTTACAACAAACCCAAATCC 3' 
stevA51Q rev 5' GGATTTGGGTTTGTTGTAAGAGTCTTGAT 3' 
stevA51R for 5' ATCAAGACTCTTAAGACAAACCCAAATCC 3' 
stevA51R rev 5' GGATTTGGGTTTGTCTTAAGAGTCTTGAT 3' 
stevA51T for 5' ATCAAGACTCTTAACACAAACCCAAATCC 3' 
stevA51T rev 5' GGATTTGGGTTTGTGTTAAGAGTCTTGAT 3' 
stevA51W for 5' ATCAAGACTCTTATGGCAAACCCAAATCC 3' 
stevA51W rev 5' GGATTTGGGTTTGCCATAAGAGTCTTGAT 3' 
stevA51Y for 5' ATCAAGACTCTTATATCAAACCCAAATCC 3' 
stevA51Y rev 5' GGATTTGGGTTTGATATAAGAGTCTTGAT 3' 
stevQ52D for 5' ATCAAGACTCTTAGCAGATACCCAAATCC 3' 
stevQ52D rev 5' GGATTTGGGTATCTGCTAAGAGTCTTGAT 3' 
stevQ52E for 5' ATCAAGACTCTTAGCAGAAACCCAAATCC 3' 
stevQ52E rev 5' GGATTTGGGTTTCTGCTAAGAGTCTTGAT 3' 
stevQ52H for 5' ATCAAGACTCTTAGCACATACCCAAATCC 3' 
stevQ52H rev 5' GGATTTGGGTATGTGCTAAGAGTCTTGAT 3' 
stevQ52K for 5' ATCAAGACTCTTAGCAAAGACCCAAATCC 3' 
stevQ52Krev 5' GGATTTGGGTCTTTGCTAAGAGTCTTGAT 3' 
stevQ52M for 5' ATCAAGACTCTTAGCAATGACCCAAATCC 3' 
stevQ52Mrev 5' GGATTTGGGTCATTGCTAAGAGTCTTGAT 3' 
stevQ52N for 5' ATCAAGACTCTTAGCAAATACCCAAATCC 3' 
stevQ52N rev 5' GGATTTGGGTATTTGCTAAGAGTCTTGAT 3' 
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stevQ52R for 5' ATCAAGACTCTTAGCAAGAACCCAAATCC 3' 
stevQ52R rev 5' GGATTTGGGTTCTTGCTAAGAGTCTTGAT 3' 
stevQ52S for 5' ATCAAGACTCTTAGCATCAACCCAAATCC 3' 
stevQ52Srev 5' GGATTTGGGTTGATGCTAAGAGTCTTGAT 3' 
stevQ52W for 5' ATCAAGACTCTTAGCATGGACCCAAATCC 3' 
stevQ52W rev 5' GGATTTGGGTCCATGCTAAGAGTCTTGAT 3' 
stevQ52Y for 5' ATCAAGACTCTTAGCATATACCCAAATCC 3' 
stevQ52Y rev 5' GGATTTGGGTATATGCTAAGAGTCTTGAT 3' 
KAHRP XhoI for 5' TGTTAGCTCGAGATGAAAAGTTTTAAGAACAAAAATACTTT 
 GAGG 3' 
KAHRP69 AvrII rev 5' TGATAGCCTAGGATGGTGATGGTGGTGATGGTGTTCATG 3' 
KAHRPA57T rev 5' TGATAGCCTAGGATGGTGATGGTGGTGATGGTGTTCATGTT 
 GCTTTTGTGTTAAAGTTCTC 3' 
KAHRPA57D rev 5' TGATAGCCTAGGATGGTGATGGTGGTGATGGTGTTCATGTT 
 GCTTTTGATCTAAAGTTCTC 3' 
KAHRPA57R rev 5' TGATAGCCTAGGATGGTGATGGTGGTGATGGTGTTCATGTT 
 GCTTTTGTCTTAAAGTTCTC 3' 
KAHRPA57S rev 5' TGATAGCCTAGGATGGTGATGGTGGTGATGGTGTTCATGTT 
 GCTTTTGAGATAAAGTTCTC 3' 
KAHRPA57V rev 5' TGATAGCCTAGGATGGTGATGGTGGTGATGGTGTTCATGTT 
 GCTTTTGAACTAAAGTTCTC 3' 
 
Characterization of PfNAT (PF14_0350)  
PF14_0350 XhoI for 5' TGTTAGCTCGAGATGAATATATTTAAGCAGAAAG 3' 
PF14_0350 AvrII rev 5' TGATAGCCTAGGATCCAAGATATTATTTGTATAGC 3' 
PF14_0350 -470bp for 5' CCTTATTATATATTTTTATATATCCTC 3' 
PF14_0350_+122bp rev 5' GTATATACCTAAATATTAAAAATGTATG 3' 
PF14_0350 BamHI rev 5' CGCGGATCCATCCAAGATATTATTTGTATAGC 3' 
PF14_0350_aa120_NheI for 5' CTAGCTAGCAATTTATATAAGAGTTACATTAAC 3' 
PF14_0350_aa120_AvrII rev 5' TGATAGCCTAGGATTTTCCAAATCTGGGCAATC 3' 
PF14_0350_aa120_BamHI rev 5' CGCGGATCCATTTTCCAAATCTGGGCAATC 3' 
PF14_0350_MP120 for 5' GATTTGGAAAATTTATATAAGAGTTACATTAAC 3' 
PF14_0350_MP120 rev 5' GTAACTCTTATATAAATTTTCCAAATCTGGGCAATC 3' 
PF14_0350_aa380_NheI for 5' CTAGCTAGCTTTAATATAAGTGAAATATCA 3' 
PF14_0350_aa380_XhoI for 5' TGTTAGCTCGAGTTTAATATAAGTGAAATATCAAATAG 3' 
PF14_0350_MP400 for 5' CATCAGGATTTAATGAAATAAG 3' 
PF14_0350_MP400 rev 5' CTTATTTCATTAAATCCTGATG 3' 
PF14_0350_aa530_Avr II rev 5' TGATAGCCTAGGAAAATCATCTTTATTAAGTATTTTTG 3' 
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PF14_0350_aa530_XhoI rev 5' TGTTAGCTCGAGAAAATCATCTTTATTAAGTATTTTTGAC 3' 
PF14_0350_bp1111_NotI for 5' TTGGCGGCCGCGAAAGATACATCATCTACACAGAATGTG 3' 
PF14_0350_bp1111_XhoI for 5'TGTTAGCTCGAGGAAAGATACATCATCTACACAGAATGTG  
PF14_0350_bp1303 rev 5' CTATACCTACACATCCTAC 3' 
PF14_0350_bp1304 for 5' TACCGTTTAAAGGTGACAATAC 3' 
PF14_0350_bp357 rev 5' TTCCAAATCTGGGCAATCTTTTC 3' 
PF14_0350_bp358 for 5' AATTTATATAAGAGTTACATTAAC 3' 
PF14_0350_locus 5’ for 5' GTTATTATTTATTCGTGATCTAAACAAATAG 3' 
PF14_0350_locus 5’ rev 5' ATTGATGATACTGTGTAAATAATGATTAC 3' 
FLAG (-) AvrII+KpnI 5' CCTACTTGTCATCGTCGTCCTTGTAATCC 3' 
FLAG (-) AvrII+KpnI w/o stop 5' CCTTGTCATCGTCGTCCTTGTAATCC 3' 
FLAG (+) AvrII+KpnI 5' CTAGGGATTACAAGGACGACGATGACAAGTAGGGTAC 3' 
FLAG (+) AvrII+KpnI w/o stop 5' CTAGGGATTACAAGGACGACGATGACAAGGGTAC 3' 
 
Colocalization with other ER proteins 
mCherry BamHI for 5' CGCGGATCCATGGTGAGCAAGGGCGAG 3' 
mcherry KpnI XmaI rev (no stop) 5' CGCCCGGGTACCTTTCTTGTACAGCTCGTCCATG 3' 
PF10_0360 XhoI for 5' TGTTAGCTCGAGATGTTCAATCGTTTATTTG 3' 
PF10_0360 AvrII rev 5' TGATAGCCTAGGAAATTCTTTTCCAATATATTTCG 3' 
Plasm.V_Xho I for 5' TGTTAGCTCGAGATGAATAATTATTTTTTAAGGAAAG 3' 
Plasm. V_Avr II rev 5' TGATAGCCTAGGTGTTGATTCCTGTATGGGAG 3' 
 
Active-site mutagenesis 
PF14_0350_GtoA1381_for  5' GAATGAGAATTGCTAGCCGATTATTAAC 3' 
PF14_0350_GtoA1381_ rev  5' GTTAATAATCGGCTAGCAATTCTCATTC 3' 
PF14_0350_GtoA1500_ for  5' GTTAAGCAAAATGCTTTTAATTTATCTC 3' 
PF14_0350_GtoA1500_ rev  5' GAGATAAATTAAAAGCATTTTGCTTAAC 3' 
PF14_0350_YtoA1480_ for 5' CTGATAGCTTAGCTTTCGTTAAGC 3' 
PF14_0350_YtoA1480_ rev 5' GCTTAACGAAAGCTAAGCTATCAG 3' 
PF14_0350_RtoM1365_ for  5' GTAAAAAAAGATAATATGAGAATGAGAATTG 3' 
PF14_0350_RtoM1365_ rev  5' CAATTCTCATTCTCATATTATCTTTTTTTAC 3' 
PF14_0350_TandN1460_ for 5' GAATTAAAAGTTTTTGTTAACAATTTACTTACTGATAGC 3' 
PF14_0350_TandN1460_ rev 5' GCTATCAGTAAGTAAATTGTTAACAAAAACTTTTAATTC 3' 
 
Knockout of PfNAT via pCC and pHTK system 
PF14_Flank 5' SacII for 5' TGACCGCGGGAAGATTTTTCAATTGTTGATGGATG 3' 
PF14_Flank 5'SpeI rev  5' TGTTAGACTAGTGCTTAAATATATTCATCCTTCCCTTCTC 3' 
PF14_Flank 3' NcoI for 5' TGTTAGCCATGGCTTTGCTTCTACAGAAATACAGAGC 3' 
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PF14_Flank 3' AvrII rev 5' TAGTCCTAGGGATATACATGAAGAAACACACCCTC 3' 
PF14_InGene 5' SacII for 5' TGACCGCGGGATTAATATATTTAAGCAGAAAGAGAATAC 3' 
PF14_InGene 5' SpeI rev 5' TGATGACTAGTCATCCTTCCACGTTAATGTAACTC 3' 
PF14_InGene 3' NcoI for 5' TGATACCATGGCTCAAATTGTTAGGAGAGGTCTAATG 3' 
PF14_InGene 3' AvrII rev 5' TAGTCCTAGGTCAATCCAAGATATTATTTGTATAGCTC 3' 
pcc4_BSDcass_for 5' GCATAAGCCTTTGTCTCAAG 3' 
pcc4_BSDcass_rev 5' CTTAGCCCTCCCACACAT 3' 
pcc4_CDcass_for 5' GGTTAAACACAGTAGTATCTG 3' 
pcc4_CDcass_rev 5' CTACTCCGATAGAATCATCAG 3' 
pHTK MCS 5’ for 5' CTATATACTATGGAATACTAAATATATATCCAATGG 3' 
pHTK MCS 5’ rev 5' CTCAGAGATTGCATGCAAGC 3' 
pHTK MCS 3’ for 5' CTAATCATGTAAATCTTAAATTTTTC 3' 
pHTK MCS 3’ rev 5' GTGTGAAATACCGCACAGATG 3' 
pHTK_hDHFRcass_for 5' CATGGTTCGCTAAACTGCATC 3' 
pHTK_hDHFRcass_rev 5' CCTTTCTCCTCCTGGACATC 3' 
pHTK_TKcass_for 5' CTATTTACATGCATGTGCATGC 3' 
pHTK_TKcass_rev 5' CAATACGGTGCGGTATCTGC 3' 
 
Knockout of PfNAT via loxP/DiCre system 
PF14_0350full_synth_XhoI for 5' TGTTAGCTCGAGATGAACATCTTCAAGCAAAAAG 3' 
PF14_0350full_synth_AvrII rev 5' TGATAGCCTAGGATCCAAGATATTGTTGGTGTAG 3' 
PF14_C-term_chim_SpeI for 5' CTAGACTAGTAGGAAAATTTCCGGAAGCG 3' 
PF14_C-term_chim_loxP_HindIII rev 5’ CCCAAGCTTTAATAACTTCGTATAATGTATGCTATACG 
  AAGTTATTTTATTTTTTTTTTCGTTAGAAC 3'  
PF14_C-term_synth_no Hind_for 5' TTGTTGTTCAACATCTCCGAAATC 3' 
PF14_C-term_synth + 41 rev 5' CAT GAA GTG TCT GTT GGA G 3' 
PF14_C-term_synth_XhoI rev 5' GGTACCCTCGAGATCCAAGATGTTG 3' 
PF14_5’UTR_chim_SpeI for 5' TGATGACTAGTGAAGATTTTTCAATTGTTGATGGATG 3' 
PF14_5’UTR_chim_HindIII rev 5'CCCAAGCTTTTAATTTATATTTTTTTATTTTTTATTTAATAC 3' 
PF14_1st intron_HindIII rev 5' CAAGCTTTATTATAATATATATATGTTTTCCATAAG 3' 
PF14_0350_fullsynth+120 rev 5' GTCTCTTTCTTCCAATTGTCTG 3' 
PF14_0350_fullsynth+167 rev  5' TCAATGAGTTGAAGTGGTCG 3' 
DiCre_Cre60 for 5' CCAGCAGCCTCACCATGGCC 3' 
DiCre_Cre60 rev 5' CTGCCTCGCCCTTCTGACTCC 3' 
CAM5’_BamHI for 5' CGCGGATCCTGATATATTTCTATTAGG 3' 
CAM5’_SpeI rev 5' TGATGACTAGTAACCATTTTGTAAAAAAAATTAAAATA 3' 
PbDT3’UTR_AvrII for 5' TAGTCCTAGGGTCGAGGGATATGGCAGC 3' 
PbDT3’UTR_NotI rev 5' TTGGCGGCCGCCTACCCTG 3' 
MATERIALS AND METHODS 
42 
Knockdown of PfNAT via DD system 
DD24_KpnI for 5' CGGGGTACCATGGGAGTGCAGGTGGAAACC 3' 
DD24_BspEI rev 5' TGTTAGTCCGGATTATTCCAGTTCTAGAAGCTCCACATC 3' 
DD +22 rev 5' GGTTTCCACCTGCACTCC 3' 
pCRK4-DD24 rev 5' TTGGGGAAGGTGCGCCCG 3' 
PF14_0350_MluI rev 5' CGGCACGCGTATCCAAGATATTATTTGTATAGC 3' 
PF14_0350_XhoI rev   5' TGTTAGCTCGAGATCCAAGATATTATTTGTATAGC 3' 
 Buffers, media and solutions 2.1.5
Albumax II     5% (w/v) Albumax II 
      in RPMI 25 mM HEPES L-Glutamine  
      (Gibco), filter sterilize 
ampicillin stock, 1000x   100 mg/ml in ddH2O 
AP21998 stock, 1000x   1 mM in absolute ethanol 
aprotinin stock, 200x    10 mg/ml in ddH2O 
APS      10% (w/v) APS in ddH2O 
Bacteria lysis buffer    50 mM Tris pH 8 
      2 mM EDTA 
      100 µg/ml lysozyme 
      0.1% TritonX-100 
Cell culture media 
 Non-transfectants   10% human serum 
      0.2 μg/ml Gentamycin 
      0.2 mM Hypoxanthine 
      in RPMI 25 mM HEPES L-Glutamine  
      (Gibco) 
 Transfectants    5% human serum 
      5% Albumax II 
      0.2 μg/ml Gentamycin 
      0.2 mM Hypoxanthine 
      in RPMI 25 mM HEPES L-Glutamine 
Coomassie Destaining Solution  20% methanol 
      7,5% acetic acid 
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Coomassie Staining Solution   5% methanol 
      10% acetic acid 
      0.05% Coomassie Brilliant Blue R-250 
Cytomix     120 mM KCl 
      0.15 mM CaCl2 
      10 mM K2HPO4/ KH2PO4, pH: 7.6 
      25 mM HEPES/2 mM EGTA pH 7.6 
      5 mM MgCl2 in ddH2O 
      adjust to pH 7.6 with KOH 
      filter sterilize 
DNA loading buffer    60% glycerol 
      60mM EDTA 
      0.25% Bromphenol Blue 
Freezing Solution    6.2 M glycerol 
      0.14 M Na-lactate 
      0.5 mM KCL 
      add ddH2O, adjust to pH 7.2 with  
      0.5 M NAHCO3, pH 9, filter sterilize 
Gelatin Solution    0.5% (w/v) gelatin 
      in HEPES-buffered RPMI 1640 
      filter sterilize 
IC50 lysis buffer    20mM Tris base (2.423g) in 1L  
      adjust pH to 7.4 with concentrated HCl  
      5mM EDTA (10ml 0.5M EDTA)  
      0.008% w/v saponin (80mg saponin)  
      0.08% w/v Triton X-100 (0.8ml)  
      mix, vacuum filter, store at RT  
      for assay analysis: mix 10ml of lysis buffer  
      with 1.2 μl SYBR green (10,000x final) 
LB agar     10 g tryptone 
      5g yeast extract 
      5g NaCl 
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      15g agar 
      ad 1l  ddH2O 
leupeptin stock, 250x    5 mg/ml in ddH2O 
MACS buffer     1x PBS 
      2 mM EDTA 
      0.5% BSA 
PBST      1xPBS 
      0.1% Tween 20 
PHEM buffer 0.4 M    240mM PIPES 
      100mM HEPES 
      8mM MgCl2 
      40mM EGTA 
      pH to 6.9 
PIPES Buffer 0.5 M    151 g/ l PIPES dissolve in 1M NaOH 
PMSF stock, 100x    100 mM in isopropanol 
Protease inhibitor mix (1x)   0.01 mg/ml Pepstatin A  
      0.05 mg/ml aprotinin 
      0.02 mg/ml leupeptin 
      1 mM PMSF (add before use!) 
Ringer solution    122.5 mM NaCl 
      5.4 mM KCl 
      1.2 mM CaCl2 
      0.8 mM MgCl2 
      11 mM D-Glucose 
      10 mM HEPES 
      1 mM NaH2PO4 in ddH2O 
      adjust pH: 7.4 
RNA running buffer (20x)   41.86 g MOPS 
      6.8 g NaOAc 
      3.8 g EDTA 
      ad 500 ml ddH2O 
SDS loading buffer, 6x   0.35 M TrisCl (pH 6.8) 
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      36% glycerol 
      10.28% SDS 
      5% β-mercaptoethanol 
      0.012% bromophenol blue 
SDS-PAGE running buffer   25 mM Tris 
      250 mM glycine 
      0.1% SDS 
SDS-PAGE transfer buffer   5 mM Tris 
      4 mM glycine 
      0.03% SDS 
Sorbitol Solution    5% (w/v) D-sorbitol in ddH2O 
      filter sterilize 
Super Broth     35 g tryptone 
      30 g yeast extract 
      5 g NaCl 
      ad 1l ddH2O 
SOB medium     20 g tryptone 
      5 g yeast extract 
      0.5 g NaCl 
      5 g MgSO4 x 7 H2O 
      ad 1l ddH2O, autoclave 
SOC medium:     SOB + 20 mM D-Glucose, sterile, freeze 
1xTAE     4 mM Tris-acetate 
      1 mM EDTA (pH 8.0) 
TB buffer     10 mM PIPES buffer 
       
      15 mM CaCl2 
      250 mM KCL 
      dissolve in H2O, adjust pH with KOH to 6.7, 
      add 55 mM MnCl2, filter-sterilize 
Thawing solution I    12% NaCl autoclave 
Thawing solution II    1.6% NaCl autoclave 
MATERIALS AND METHODS 
46 
Thawing solution III    0.9% NaCl / 0.2% glucose 
      filter sterilize 
WR99210     20μM in RPMI 25 mM HEPES L-Glutamine 
WR99210 stock    10 mM in 20% DMSO (v/v) 
 Cell culture 2.2
 Culture of P. falciparum 2.2.1
Intraerythrocytic stages of P. falciparum parasites were grown continuously in vitro as 
described previously (Trager & Jensen, 1976, 2005). All experiments were carried out 
with the 3D7 strain (Ponnudurai et al, 1981; Walliker et al, 1987). Culture conditions 
consisted of an atmosphere of 3% CO2, 5% O2, 92% N2 and 95% humidity at 37°C. 
Parasites were grown in 10 cm or 25 cm diameter petri dishes containing a final volume 
of 14 ml or 35 ml, respectively, of HEPES-buffered RPMI 1640 medium supplemented 
with 5-10% heat-inactivated A human serum, optionally 5% albumax II, 200 μM 
hypoxanthine, 0.2 μg/ml gentamycin as well as 3-4% group A erythrocytes. Parasitaemia 
was determined by Giemsa-stained blood smears and kept at 1-5%. Every 1-3 days the 
medium was exchanged and as soon as parasitaemia reached 5-10%, the parasite culture 
was split in order to avoid toxification of the media by parasitic metabolites. 
 Freezing of parasites 2.2.2
Successful freezing of P. falciparum requires ring stage parasites, which survive the 
freezing and thawing procedure best. The cells were resuspended in a volume of 14 ml 
of cell culture media and centrifuged (1900 rpm for 2 min, RT). The supernatant was 
discarded and 1/3 of the pellet volume of freezing solution was slowly added to the 
pellet (pellet in 14 ml culture plate ~0.5 ml). After 5 min incubation at RT, another 4/3 
of pellet volume was added. The mix was distributed into cryovials, incubated for 5 min 
at RT and frozen. After short-term storage in a -80°C freezer long term storage was 
maintained in liquid nitrogen tanks. 
 Thawing of parasites 2.2.3
Frozen parasites in cryovials were removed from liquid nitrogen tanks and warmed up to 
37°C. 200 μl of thawing solution I (12% NaCl) was added drop wise followed by 
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transfer to a 15 ml falcon tube. 9 ml of thawing solution II (1.6% NaCl) was added 
dropwise with frequent shaking. The solution was centrifuged (1900 rpm for 2min, RT) 
and the supernatant removed. Finally, 7 ml of thawing solution III (0.6% NaCl, 0.9% 
glucose) was pipetted drop wise. After further centrifugation the pellet was resuspended 
in cell culture media and transferred to a prepared cell culture dish (14 ml) containing 
0.5 ml of blood. From two days after onwards, media was exchanged daily and a 
selection marker (WR99210, 5 nM) was added optionally. 
 Determining parasitaemia 2.2.4
In order to determine parasitaemia and developmental stages, thin blood smears of 
around 50 μl of concentrated culture were air-dried on microscope slides, fixed in 100% 
methanol for 30sec, dried and stained in Giemsa solution for 10-20 min (Fleischer, 
2004). Afterwards, the slides were washed with water and examined on a light 
microscope under oil immersion using a 100x objective. Parasitaemia, defined as the 
percentage of parasite-infected red blood cells, was determined by counting infected and 
uninfected cells and calculated with the following formula: 
(number of infected erythrocytes/total number of erythrocytes) x 100 = % parasitaemia 
 Parasite synchronization  2.2.5
For the purpose of synchronizing parasite cultures, different techniques can be applied 
according to further experimental applications. One of the most common techniques is 
sorbitol lysis (Lambros & Vanderberg, 1979), which osmotically destroys the 
tubovesicular network of late stage trophozoites, an induced transport system, which is 
absent in ring stages. Cell culture media was removed from a mixed stage plate and 10 
ml of prewarmed, sterile 5% sorbitol was added. After resuspension and transfer to a 15 
ml falcon tube, the parasites were incubated for 10 min at 37°C, centrifuged (1900 rpm 
for 2 min, RT) and after an optional washing step in RPMI medium transferred to a new 
petri dish containing the appropriate amount of new RPMI medium as well as 3-4% 
haematocrit. 
 Magnetic cell sorting (MACS column) 2.2.6
The enrichment of late stage parasites (trophzoites and schizonts) for consecutive 
experiments can be achieved by magnetic cell sorting (Ribaut et al, 2008; Uhlemann, 
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2000), which is based on the paramagnetic properties of the hemozoin crystal in the 
parasite food vacuole, a product of parasitic haem metabolism. Hemozoin-containing 
parasites are retained in the metal wool of the column as long as magnetic force is 
applied, whereas red blood cells (with ring stage parasites) are washed away. After 
equilibration of the column with MACS buffer the parasite culture was applied gradually 
onto the magnet-surrounded column and liquid outflow was reduced by the stopcock to 
maximal 1 drop per second. MACS buffer was added until the outflow was clear and 
finally the retained cells were eluted by the removal of the column from the magnet 
apparatus and application of 12-15 ml of MACS buffer at full outflow speed. The eluate 
was collected in a falcon tube and centrifuged (1900 rpm for 2 min, RT) before used in 
further experiments. 
 Limiting dilution assay* 2.2.7
Clonal parasite populations are retrieved by limiting dilution of a culture in 96-well 
plates with an initial inoculum of 0.25 - 0.5 parasites/well. Individual clones in single 
wells can be detected by visual, microscopic or enzymatic detection methods after 2-5 
weeks and can be used for further studies (Butterworth et al, 2011; Rosario, 1981). For 
the assay the parasitaemia of the starting P. falciparum culture in 10 ml of medium with 
2% haematocrit of total RBCs (200 µl, infected and uninfected) was carefully 
determined as a prerequisite for successful dilution of the parasites (clonal populations 
are impossible if more than one parasite occupies one well or all wells are positive). The 
total number of parasites in this starting culture was calculated from the parasitaemia, 
the haematocrit and the information that 1 ml of a suspension at 50% haematocrit 
usually harbours roughly 5x10
9
 RBCs (Bunn, 2011). A calculation example for 10 ml 
starting culture with 2% haematocrit and 3% parasitaemia is given (RBC = iRBC = 
parasite): 
1. 2% haematocrit x 10 ml = 50% haematocrit x Y ml 
 Y = 2% x 10 ml /50% = 0.4 ml (at 50%) 
2. 5x10
9
 RBCs/ 1ml = Y RBCs/ 0.4 ml 
 Y = 2 x 10
9
 RBCs (in 10 ml of 2% haematocrit or 0.4 ml of 50%) 
3. 2 x 10
9
 iRBCs / 100% = Y iRBCs / 3% 
 Y = 6 x 10
7
 iRBCs in 10 ml = 6 x 10
6
 iRBCs (=parasites) in 1ml 
MATERIALS AND METHODS 
49 
With this information in mind a serial dilution was conducted from 5 x 10
6
 parasites per 
ml to 5 x 10
1
 parasites per ml using 1:10 dilutions in a final volume of 10 ml. The 
samples were repeatedly inverted to ensure proper mixing. In the previous example the 
initial dilution sample (5 x 10
6 
parasites / ml) is calculated as following: 
4. 10 ml x 5 x 10
6
 / 6 x 10
6
 = Y = 8.33 ml of iRBCs from starting culture + 1.67 ml 
 of medium 
From the second last dilution (50 parasites per ml) two final dilutions of 5 parasites per 
ml and 2.5 parasites per ml were prepared in a final volume of 15 ml medium (1.5 ml 
and 0.75 ml of pre-dilution) plus 300 µl uninfected fresh RBCs (2% haematocrit). 100 µl 
of these suspensions were aliquoted into 96-well plates and incubated under the 
appropriate culture conditions. To control for the presence of parasites 5 ml of the final 
dilutions were transferred to small culture plates. For visual detection of positive wells it 
was important to use 96-well plates with conical (V-shaped) bottoms. Medium without 
selection marker was exchanged every second to fourth day until parasite appearance or 
for 2-5 weeks. The haematocrit was increased by 1% each week. The control plates 
usually were the first to become positive after 2 weeks followed by increasing numbers 
of positive wells in the 96-well plates after 2-3 weeks. A dark colour of the blood as well 
as a cloudy medium was indicative of parasitized wells and confirmed by microscopic 
analysis. Subsequently, the content of parasitized wells was transferred to small culture 
plates to increase parasite numbers for freeze-downs and further investigations. If more 
than 75% of the wells became positive, the experiment was repeated to ensure clonal 
populations. 
 Determination of drug IC50 value* 2.2.8
In order to use the appropriate concentrations of negative selections markers (5-
fluorouracil and ganciclovir) for genetic recombination methods the 50% inhibitory 
concentration was determined in P. falciparum 3D7 intraerythrocytic cultures using a 
standard SYBR green I-based fluorescence assay (Johnson et al, 2007; Smilkstein et al, 
2004). Parasite cultures at mixed stages of 0.5% parasitaemia with 3% haematocrit were 
prepared (~6 ml/ 96-well plate) for the assay and 50 µl used per well. Furthermore, drug 
solutions were prepared at 6 times the highest concentration aimed for the assay. A range 
of drug concentrations was chosen based on literature (or tested in preceding IC50 
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measurements) to cover parasite viability from 0-100% with sufficient amount of data 
points in the curve to determine the IC50 concentration. The pipetting scheme included 
appropriate dilution steps of the drugs (e.g. 1:2, 1:3) from the top row down as well as 
uninfected RBCs (0% growth) and untreated iRBCs (= 100% growth) as controls. Outer 
rows were omitted due to extensive evaporation. Each concentration was tested in 
duplicates and the assays were repeated 2-3 times. The plate scheme looked like this: 
X X X Drug1 Drug1 Drug2 Drug2 Drug3 Drug3 Drug4 Drug4 X 
X RBC iRBC Highest concentrations      X 
X RBC iRBC         X 
X RBC iRBC         X 
X RBC iRBC  Dilutions       X 
X RBC iRBC         X 
X RBC iRBC         X 
X X X X X X X X X X X X 
 
50 µl of complete medium was pipetted in each well plus 25 µl of the drug solution in 
the wells of the top row (in case of 1:3 dilution steps). This mix was resuspended well 
and 25 µl were transferred to the row below and so on. After diluting the last row, the 
final 25 µl were discarded. 50 µl of prepared parasites (see above) were added to each 
well to have a total volume of 100 µl with 1.5% final haematocrit. The plate was 
returned to the incubator for 72 h, and then frozen at -80°C for at least 2 h or until 
further use. On the day of measurement, the plates were thawed for at least 1 h and 
100 µl of lysis buffer plus SYBR green I (1.2 µl SYBR green/ 10ml lysis buffer) was 
added per well while avoiding exposure to bright light. The plate was shaken briefly to 
mix the suspension and incubated in the dark for 1 h at RT. Afterwards, fluorescence 
was measured in the FLUOstar OPTIMA microtiter plate fluorescence reader (BMG 
Labtech) using the provided manufacturer’s software at 520 nm of emission after 
excitation at 485 nm and specific program settings (gain 1380, 10 flashes/well, top 
optic). Afterwards, the mean fluorescence signal was calculated for the controls (RBCs, 
iRBCs) as well as the duplicates for each drug concentration. The value of uninfected 
RBCs was deducted as background from all iRBC measurements; the value for untreated 
iRBCs was set as 100% growth. The growth inhibition by the different drug 
concentrations was plotted in SigmaPlot (Version 11.0 or 12.0) and the IC50 and IC90 
values were deducted from the fitted curves (Hill function, three parameters). 
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 Transfection of P. falciparum 2.3
The transfection of P. falciparum followed two standard protocols, which include the 
introduction of plasmid DNA by electroporation of a 1-2% ring stage parasite culture or 
of uninfected erythrocytes prior to parasite invasion (Chahaun, 2002; Hasenkamp et al, 
2013; Wu et al, 1995). Both methods have proven useful with the advantage of the latter 
one to be gentler to the parasites because they are not exposed to the trauma of 
electroporation. 
 Preparation 2.3.1
Parasites 
Parasites were synchronized with sorbitol a few days before transfection in order to 
guarantee a parasitaemia of 2-3% of late schizont or 1-2% early ring stages at the day of 
transfection depending on the protocols used. Prior to transfection the parasite culture 
was resuspended, centrifuged (1900 rpm for 2 min, RT) and the supernatant was 
removed. In case the parasitaemia was too high, a dilution in blood yielded the 
appropriate ratio.  
 
Transfection vectors 
After isolation of the transfection plasmids by a Plasmid Maxi Kit, the concentration and 
quality was estimated by spectrophotometry and agarose gel electrophoresis, 
respectively. A volume equal to 100-120 μg of DNA was used for transfection. After 
addition of ddH2O to a final volume of 180 μl, 20 μl of 3 M sodium acetate (pH 5.2) and 
2.5 vol of ice-cold absolute ethanol were used for precipitation of the plasmid DNA. 
Short vortexing and incubation at -20°C for 1 h resulted in the visible condensation of 
DNA. After centrifugation (13 000 rpm for 30 min, 4°C), the pellet was desalted with 
500 μl of 70% ethanol. Finally, after further centrifugation (13 000 rpm for 15 min, 
4°C), the pellet was air-dried and resuspended in 30 μl of sterile TE-buffer and stored at 
-20°C ON. Prior to transfection, the DNA was supplemented with 370 μl of sterile 
cytomix. 
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 Electroporation of infected red blood cells 2.3.2
A fresh culture dish with 14 ml medium and 0.4 ml of fresh erythrocytes was prepared in 
advance shortly before the transfection procedure. 200 μl of 1-2% ring stage-infected 
erythrocytes were combined with 400 μl of DNA/cytomix, immediately transferred to an 
electroporation cuvette (2 mm) and electroporated in the gene pulser (Biorad) with 0.31 
kV and 0.950 μF at the highest capacity setting. Quickly afterwards the sample was 
pipetted into the prepared culture plate and incubated immediately in the appropriate 
atmosphere. 
 Electroporation of uninfected red blood cells* 2.3.3
1 ml of fresh uninfected RBCs was mixed with 6 ml of cytomix, centrifuged (1900 rpm 
for 2 min, RT) and the supernatant was removed. This washing step was repeated once 
more, before 400 µl of packed cell pellet was mixed with 400 µl of prepared 
DNA/cytomix and transferred to two pre-chilled electroporation cuvettes (2 mm). These 
cuvettes were cooled on ice for 5 min, then electroporated in the gene pulser (Biorad) 
with a voltage of 0.31 kV and a capacitance of 950 µF at high capacity setting. The time 
constant should be between 8-12 msec. The samples were returned on ice for 5 min, then 
transferred to 15 ml falcon tubes by rinsing the cuvette with 2x2 ml of complete 
medium. After centrifugation (1900 rpm for 2 min, RT) the supernatant was discarded 
and the pellet of DNA loaded RBCs was resuspended in a 14 ml culture dish including 
14 ml of medium and 100 µl of 2-3% (or less) schizont-infected RBCs for a final 
parasitaemia of around 0.5%. The culture was returned to the incubator and medium was 
exchanged daily. The transfection procedure was repeated with these parasites and new 
DNA 48 hours later to increase the chance to invade loaded RBCs. Subsequently, 
parasites were split to 2-3% and subjected to drug selection. 
 Selection procedure 2.3.4
48 hours after transfection, the medium was exchanged and the positive selection 
markers WR99210 or Blasticidin S were added to a final concentration of 5 nM and 9 
mM, respectively (Hastings & Sibley, 2002; Mamoun et al, 1999). Starting from the 
third day of transfection medium (14 ml) and selection marker were exchanged daily for 
one week, during which the parasites disappeared from the blood smears. This was 
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followed by splitting the culture in half using fresh erythrocytes in the second week and 
a three weeks period of providing fresh medium and marker twice a week until the 
parasites appeared again in the blood smear. 200 μl of fresh erythrocytes were added 
every second week. The selection period usually lasted 21-30 days. 
 Microbiological methods 2.4
 Preparation of chemocompetent E.coli* 2.4.1
For preparation of chemocompetent XL-1 Blue E. coli cells, 10 ml of Luria Broth 
medium was inoculated with a single bacterial colony and incubated at 37°C under 
shaking conditions (220 rpm) overnight. The next day, 250 ml of SOB medium was 
inoculated with this preculture to a final OD600 of 0.1/ml and shaken again for ~2 h at 
37°C until 0.6 OD/ml. At that point the flask was cooled on ice for 10 min, followed by 
centrifugation (6000 rpm for 25 min, 4°C). All consecutive steps are carried out on ice 
with pre-chilled solutions. The pellet was resuspended in 80 ml of ice-cold TB buffer 
and incubated on ice for 10 min. After centrifugation (6000 rpm for 10 min, 4°C) and 
removal of the supernatant the pellet was resuspended in 20 ml of TB buffer. 1.4 ml of 
DMSO was carefully added to this suspension under agitation followed by 10 min of 
incubation on ice. Finally, the competent cells were aliquoted into 1.5 ml Eppendorf 
tubes (100 µl each) that were pre-chilled using dry-ice plus ethanol. The bacteria were 
stored at -80 °C until further use.  
 Transformation and culture of E. coli* 2.4.2
Plasmid DNA was introduced into chemocompetent XL-1 Blue E. coli bacteria by heat 
shock (Chan et al, 2013). For this purpose, 50 μl of frozen bacterial cells were thawed on 
ice and mixed with 1-10 μl of DNA. After incubation on ice for 15-30 min the cells were 
incubated in the 42°C water bath for 45 sec followed by 2 min cooling on ice. Then the 
transformed bacteria were supplemented with 1 ml of prewarmed SOC medium and 
incubated for 1h at 37°C under shaking conditions (220 rpm). Finally, the bacterial 
suspension was pelleted or directly plated (100 µl) onto selective LB agar plates and 
incubated overnight at 37°C. 
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 Selection and storage 2.4.3
Positive clones were grown on selective LB agar plates containing the appropriate 
antibiotic (ampicillin: 100 μg/ml, kanamycin: 50 μg/ml) and further investigated using 
colony PCRs. The plasmids were either stored at -20°C after isolation (High Pure 
Plasmid Isolation kit) or as transformed colonies on LB agar plates at 4°C. Furthermore, 
glycerol stocks of transformed bacteria (25% glycerol) were produced and stored at -
80°C. For further use, a small pipette tip was quickly scratched over the surface of the 
frozen stocks and used for inoculation. 
 Molecularbiological methods 2.5
 Nucleic acids 2.5.1
2.5.1.1 Electrophoresis of DNA and RNA 
DNA and RNA can be separated according to fragment size using agarose gel 
electrophoresis. For DNA electrophoresis, 1.0%-1.5% agarose gels were prepared by 
weighing in the agarose, dilution in 1xTAE buffer, boiling until dissolution and cooling. 
Ethidium bromide was added to the dissolved agarose to a final concentration of 1 μg/ml 
short before pouring. It intercalates with DNA allowing visualization by ultra violet 
(UV) irradiation. After polymerization, the gels were loaded with appropriate amounts of 
DNA sample diluted in DNA loading buffer (1:5, v/v) and separated together with a 
convenient DNA size standard. Electrophoresis was conducted at a constant voltage in 
1xTAE (30 ml gels maximum 90 V, 150 ml gels maximum 140 V). The gels were 
photographed using the Electrophoresis Documentation and Analysis System 120 
(Kodak). 
For the control of isolated RNA, 0.28 g LE-agarose, 2 ml of 20x RNA running buffer 
and 30 ml of ddH2O were heated, supplemented with 0.5 μl ethidium bromide and 7.9 ml 
formaldehyde and poured into a ribonuclease (RNAse) free gel chamber. RNA loading 
buffer was added to the samples (1:1) and electrophoresis was performed at 60 mV for 
45-60 min. 
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2.5.1.2 DNA extraction from agarose gels 
DNA ranging from 70 bp to 10 kb was extracted using the QIAquick gel extraction kit 
protocol (Qiagen), which uses binding of DNA to a silica membrane in high salt 
conditions, whereas contaminants pass through. Briefly, the DNA fragment was excised 
under a weak UV lamp, weighed and 3 volumes of QG buffer were added to 1 volume of 
gel (mg = ml). The mix was incubated at 50°C for 10 min, supplemented with 1 volume 
of isopropanol, applied to the provided column and centrifuged (13 000 rpm for 1 min, 
RT). After the absorption of DNA in high salt-content conditions and a washing step, 
elution was performed with low-salt buffer (10 mM Tris-Cl, pH 8.5). DNA 
concentration and quality were analysed using a spectrophotometer and agarose gel 
electrophoresis, respectively.  
2.5.1.3 Photometric determination of DNA/RNA concentration 
DNA concentration was measured by spectrophotometry using the UVIKON 923 
photometer (Kontron instruments). The absorbance (OD) at 260 nm was analysed for 
DNA and RNA, where an OD260 of 1 equals 50 μg/ml dsDNA and 40 μg/ml ssRNA. 
Dilutions were included using the following formula: 
OD260 x 50 (dsDNA) x dilution factor / 1000 = X μg/μl 
OD260 x 40 (ssRNA) x dilution factor / 1000 = X μg/μl 
2.5.1.4 Enzymatic digestion of DNA 
Restriction endonucleases were used to digest insert and vector DNA for subsequent 
cloning as well as to control the appropriate fragment sizes of plasmid inserts, e.g. prior 
to sequencing. Buffers were chosen according to the manufacturer’s recommendations. 
Restriction temperature ranged from RT to 37°C and duration from 1 h to ON. 
Depending on the respective purpose, different reaction mixes were prepared as follows: 
 
 control digest of 
mini/maxi prep (15 μl) 
restriction digest of 
vector DNA (20 μl) 
restriction digest of 
insert DNA (20 μl) 
DNA 1-5 μl (1.5 μg) ~5 μl (10 μg) 12 μl 
Enzyme 1 0.4 μl 0.8 μl 0.8 μl 
Enzyme 2 0.4 μl 0.8 μl 0.8 μl 
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Buffer 10x 1,5 μl 2 μl 2 μl 
BSA 10x 1.5 μl 2 μl 2 μl 
ddH2O  ad 15 μl ad 20 μl ad 20 μl 
incubation time 1.5 h min.2 h min.2 h 
temperature 37°C 37°C 37°C 
2.5.1.5 Dephosphorylation of DNA with alkaline phosphatase 
Shrimp alkaline phosphatase (SAP) from Pandalus borealis catalyses the 
dephosphorylation of 5’ phosphates from DNA in order to prevent religation of plasmid 
vectors (Sambrook, 2001). Appropriate ligation is only possible with the insert, which 
still has intact phosphate groups. SAP is completely and irreversibly inactivated by heat. 
After restriction digest, 2 μl of SAP buffer 10x and 1 μl of SAP enzyme (Promega) were 
added to 20 μl of vector digest mix (DNA conc. ~10 μg), incubated for 30 min at 37°C 
and heat-inactivated for 15 min at 65°C. The sample was subsequently gel extracted.  
2.5.1.6 Ligation 
T4 DNA ligase was used for ligation, which is isolated from bacteriophage T4 and 
catalyses the formation of a phosphodiester bond between juxtaposed 5'-phosphate and 
3'-hydroxyl termini in duplex DNA or RNA with blunt or cohesive ends. The restricted 
fragments were purified by gel extraction or direct purification protocols. The molar 
ratio of vector to insert was kept at about 1:3. In 10 μl final volume, 2 μl of Ligase buffer 
(10x) and 1 μl of T4 Ligase (Invitrogen) were added to the vector:insert mix, followed 
by 1.5 h incubation at RT or ON at 15°C.  
2.5.1.7 Polymerase chain reaction (PCR) 
Polymerase chain reaction (Mullis et al, 1986; Saiki et al, 1985) was used for 
amplification of genes, targeted mutagenesis and colony screening of bacteria. Different 
PCR methods were applied. 
 
Colony PCR 
The following PCR reaction mix was prepared on ice and 1 colony per tube was picked 
with a pipette tip and added. 
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25 μl reaction mix     PCR program 
Primer for (50 μM)  0.25 μl   94 °C  7’ 
Primer rev (50 μM)  0.25 μl   94 °C  45” 
MgCl2 (50 mM)  1.25 μl   50 °C  45”  30x 
dNTPs (2 mM)  2.5 μl   68 °C  1’10” 
Euro Taq buffer 10x  2.5 μl   68 °C  10’ 
ddH2O    18 μl   4 °C  pause 
Euro Taq polymerase  0.25 μl 
 
Megaprimer synthesis PCR (site-directed mutagenesis I) 
For site-directed mutagenesis (Barik, 1997, 2002; Ling & Robinson, 1997) two PCR 
reactions were prepared, each containing one external primer annealing close to each end 
of the gene of interest as well as one internal primer that introduced the desired 
mutation, e.g. alanine replacements. The products of the 2 PCRs were two megaprimers 
that overlapped in the area of mutation and were used as templates in the subsequent 
overlap extension PCR (see below). 
50 μl reaction mix     PCR program 
Primer for (50 μM)  0.5 μl   98 °C  1’ 
Primer rev (50 μM)  0.5 μl   98 °C  30” 
MgCl2 (50 mM)  0.2 μl   61 °C  30”  25x 
DNA template  1 μl   72 °C  25” 
dNTPs (2 mM)  5 μl   72 °C  10’ 
Phusion buffer HF 5x  10 μl   4 °C  pause 
Phusion polymerase  0.5 μl    
ddH2O    32.5 μl  
 
Overlap extension PCR (site-directed mutagenesis II) 
The megaprimers were extracted and subjected to a second PCR called overlap extension 
PCR (Ho et al, 1989). Additionally, this PCR also contained external primers for further 
amplification but, importantly, was lacking the template DNA. 
50 μl reaction mix     PCR program 
Primer for (25 μM)  1 μl   98 °C  1’ 
Primer rev (25 μM)  1 μl   98 °C  30” 
(MgCl2 (50 mM)  0.2 μl   60 °C  1’30”  20x 
Megaprimer X  1.5 μl   72 °C  20” 
Megaprimer Y  1.5 μl   95 °C  30” 
dNTPs (2 mM)  5 μl   50 °C  50”  20x 
Phusion buffer HF 5x  10 μl   72 °C  30” 
Phusion polymerase  0.5 μl   72 °C  10’ 
ddH2O    29.5 μl   4 °C  pause 
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PCR on genomic DNA of P. falciparum* 
For cloning as well as to control for genetic recombination, gDNA was extracted from P. 
falciparum parasites using the DNeasy Blood&Tissue (Qiagen) kit as described in 
section 2.5.1.10. The elution volume was usually 2x 100 µl, of which 0.5 µl-2 µl were 
used for PCR amplification, depending on the concentration of the gDNA. The reaction 
mix was identical to the one for colony PCR and the program consisted of the following: 
94 °C  2-4’ 
92 °C  30” 
54 °C  35”  35x 
62 °C  1’10” 
62 °C  10’ 
4 °C  pause 
2.5.1.8 Plasmid isolation from bacteria  
Small scale (mini) plasmid isolation from bacteria was achieved using High Pure 
Plasmid Isolation kit (Roche), which is based on alkaline lysis and specific adsorption of 
released DNA onto glass fibre columns. According to the standard protocol, an 
overnight bacteria culture was centrifuged (3800 rpm for 7 min, RT) and the pellet was 
treated with suspension and lysis buffer and incubated for 5 min, RT. After addition of 
chilled DNA binding buffer and incubation for 5 min on ice, the suspension was 
centrifuged (13 000 rpm for 10 min, 4°C). The supernatant was pipetted onto the column 
and centrifuged (13 000 rpm for 1 min, RT). After two washing steps the DNA was 
eluted with 30 μl of elution buffer and stored at -20°C. 
Large-scale (maxi) plasmid isolation was performed using the Plasmid Maxi Kit 
(Qiagen) according to the manufacturer’s protocol. Briefly, 400 ml bacteria suspension 
containing the appropriate amount of antibiotic was grown overnight. The cells were 
harvested by centrifugation (5000 rpm for 15 min, 4°C) and sequentially mixed and 
incubated with resuspension, lysis and neutralization buffers. Precipitation of genomic 
DNA, proteins and cell debris was carried out on ice. The supernatant containing the 
plasmid DNA was separated from debris by centrifugation (13 000 rpm for 30 min, 4°C) 
and loaded onto an equilibrated tip. After several washing steps, DNA was eluted, 
precipitated with isopropanol and centrifuged (11 000 rpm for 30 min, 4°C). The DNA 
pellet was air-dried and resuspended in 10 mM Tris-HCl buffer, pH 8.5. 
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2.5.1.9 Sequencing of DNA 
After mini or maxi isolations and control digests, plasmids were sent to GATC 
(Konstanz) for sequencing at a recommended concentration of 30-100 ng/μl in a total 
volume of 30 μl. Appropriate primers were sent in 10 pmol/μl. The sequencing order 
was purchased online and the sequencing results were downloaded in .abi format and 
analysed using BioEdit (Hall, 1999) and ClustalW (Larkin et al, 2007). 
2.5.1.10 Isolation of genomic DNA from P. falciparum* 
For maximum yield of genomic DNA (gDNA) from P. falciparum intraerythrocytic 
cultures it is recommended to use 1-2 big (35 ml) culture plates with parasites of 
trophozoite to schizont stage at a parasitaemia of 5%. Parasitized cultures were 
centrifuged (1900 rpm for 2 min, RT) and the pellets resuspended in 10 ml of 1x 
PBS/0.1% saponin. After inversion and incubation on ice for 3-5 min the lysate was 
centrifuged (4000 rpm for 10 min, 4°C or RT) and the pellet washed with 1 ml of 1x 
PBS. The supernatant was discarded and the parasite pellet was either frozen or directly 
used for gDNA extraction using the DNeasy Blood & Tissue Kit (Quiagen). Briefly, 
parasites were treated with lysis buffer and proteinase K followed by addition of 100% 
ethanol to adjust buffer conditions. Separation of DNA from contaminants is achieved 
through specific binding to silica-based membranes in the presence of high 
concentrations of chaotropic salt. After centrifugation (8000 rpm for 1 min, RT) and two 
washing steps the clean DNA is eluted in elution buffer or water and stored at -20°C.  
2.5.1.11 Isolation of total RNA from P. falciparum 
In order to prepare messenger RNA (mRNA) for complementary DNA (cDNA) 
synthesis, total parasite RNA was extracted with TRIzol® reagent (Invitrogen) following 
the manufacturer’s protocol. Parasites were used that were repeatedly subjected to 
gelatine flotation in order to ensure a knob-forming phenotype. After the removal of 
medium from 6 big plates with 5-7% parasitaemia, the erythrocytes were resuspended in 
1xPBS, transferred into 50 ml falcon tubes and centrifuged (2000 rpm for 2 min, 4°C, 
from 800 rpm downwards without break). After an additional washing step in PBS, the 
parasites were lysed in PBS/0.2% freshly prepared prewarmed saponin (ratio 1:1, e.g. 25 
ml each) and centrifuged (3800 rpm for 8 min, 4°C, with break). After removal of the 
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supernatant, 5 x the parasite pellet volume of prewarmed TRIzol was added. The mix 
was shortly vortexed and stored at -80°C ON in a 50 ml Falcon tube.  
One day after, the RNA pellet was heated to 30°C for 5 min. All subsequent steps were 
carried out under sterile conditions using sterile material in order to prevent RNAse 
contamination. 0.2 ml chloroform was added per 0.75 ml of TRIzol and samples were 
vigorously shaken for 15 sec and incubated at 30°C for 10 min. Following centrifugation 
(12 000 x g for 10 min, 2-8°C), the suspension separates into a lower red phenol-
chloroform phase, an interphase and an upper aqueous phase, which contains the RNA. 
This upper phase was transferred carefully into a clean tube and RNA was precipitated 
using 0.5 ml of isopropanol per 0.75 ml of TRIzol initially used. The samples were 
incubated at 30°C for 10 min and centrifuged (12 000x g for 10 min, 4°C). The gel-like 
RNA pellet was washed once with 75% ethanol, vortexed shortly and centrifuged (7500x 
g for 5 min, 4°C). The RNA pellet was air-dried briefly and dissolved in the appropriate 
volume of RNAse free water (50 – 300 μl) followed by heating up to 55°C for 10 min. 
RNA quality was analysed on an RNA gel and quantified by spectrophotometry, before 
being processed further in cDNA synthesis. 
2.5.1.12 cDNA synthesis by reverse transcription 
For reverse transcription the SuperScript First-Strand Synthesis System for RT-PCR 
(Invitrogen) was used. The protocol followed strictly manufacturer’s recommendations 
and was carried out with 5 μg total RNA. Briefly, first strand cDNA synthesis was 
primed with oligo(dT) primers, which specifically hybridized to polyA tails of mRNA. 
Reverse transcriptase (RT) bound these primers and synthesized first-strand cDNA 
transcripts. RNAse H removes RNA from the cDNA:RNA hybrids. After synthesis the 
target cDNA was directly amplified in a conventional PCR using gene specific primers 
to yield the DNA of interest. 
 Proteins 2.5.2
2.5.2.1 Preparation of parasite protein extracts* 
Total proteins were extracted from P. falciparum transfectant parasites and used for 
antibody detection of different GFP-tagged fusion proteins in western blots. Briefly, 
parasites were purified using the magnetic column and pelleted by centrifugation (1900 
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rpm for 2 min, RT). The pellet was washed once with 1xPBS and then resuspended in 
10x the pellet volume of lysis buffer containing 1xPBS, 0.07% saponin and protease 
inhibitors (leupeptin, aprotinin, PMSF, pepstatin A). Alternatively, membrane proteins 
were extracted by simple lysis with 10x the pellet volume of H20 (plus protease 
inhibitors). After incubation at 37°C for 1-3 min, the sample was centrifuged (13 000 
rpm for 1 min, 4°C) and separated into supernatant and pellet. The supernatant was 
supplied with an equal volume of SDS loading buffer, while the pellet was washed once 
in cold 1xPBS plus protease inhibitors. The supernatant of the washing step was 
discarded and the volume of the pellet sample was adjusted with PBS and loading buffer 
to the same as the supernatant. Samples were stored at -20° until further use. 
2.5.2.2 Differential lysis assay* 
This method is used to roughly define the localization and orientation of proteins in the 
different cellular compartments such as the RBC cytoplasm, the parasitophorous vacuole 
(PV) and the parasite cytoplasm. Mainly, distinction can be achieved by the accessibility 
of different compounds to these compartments and the proteins residing within 
(Blumenthal & Habig, 1984; Saridaki et al, 2009; Spielmann et al, 2006). Treatment of 
infected erythrocytes with tetanolysin specifically destroys the erythrocyte plasma 
membrane due to its cholesterol content, whereas the PVM is unaffected. Additional 
lysis with saponin further breaks the MC and PVM membranes but leaves the parasite 
plasma membrane (PPM) intact. Infected erythrocytes of 5% parasitaemia, rich in 
trophozoites, were isolated using the MACS column and washed in 1xPBS. In parallel, a 
1:200 dilution of tetanolysin (stock: 1 mg/ml, 500 U/ml) was activated with 10 mM 
dithiothreitol (DTT) for 15 min at RT. The pellet was resuspended in a suitable volume 
of buffer (80-400 µl, dependant on pellet size) containing 1xPBS, activated tetanolysin 
(4 µl/ 100 µl buffer) as well as protease inhibitors (leupeptin, aprotinin, PMSF). This 
suspension was incubated on ice for 10 min, then at 37°C for 3 min. After centrifugation 
(13 000 rpm for 1 min, 4°C) the supernatant was removed and supplemented with equal 
amounts of SDS loading buffer (= Tet, SN). The pellet was washed once with 1xPBS 
followed by addition of lysis buffer (same volume as before) containing 1xPBS, 0.07% 
saponin and protease inhibitors. After incubation at 37°C for 1 min, the sample was 
centrifuged (13 000 rpm for 1 min, 4°C) and the supernatant supplemented with equal 
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amounts of SDS loading buffer (= Tet+Sap, SN). The pellet, corresponding to the 
parasite fraction, was washed once with cold 1xPBS and centrifuged as before. After 
removal of the supernatant, the volume of the pellet sample was adjusted to the 
supernatant samples with PBS and protein loading buffer for rough comparison of 
protein amounts (= Tet+Sap, P). Samples were stored at -20 °C. 
2.5.2.3 Western blot analysis 
Western blot analysis followed the differential lysis assay and consisted of SDS 
polyacrylamide gel electrophoresis (PAGE) (Laemmli, 1970), semi-dry transfer, 
antibody labelling (Burnette, 1981) and chemoluminescence detection (Thorpe & 
Kricka, 1986). 
 
SDS-PAGE 
10% SDS gels were prepared as following and polymerized for 1 h - ON: 
10% separating gel stacking gel 
H2O 4 ml 3.4 ml 
Acrylamide/bis 29:1 3.3 ml 0.83 ml 
Tris lower pH 8.8 2.5 ml - 
Tris upper pH 6.8 - 0.63 ml 
SDS 10% 100 μl 50 μl 
APS 10% 100 μl 50 μl 
TEMED 5 μl 6 μl 
 
Pellet samples were optionally subjected to sonication or pipetted repeatedly and 
denatured at 75°C for 3 min prior to loading. The gels ran in 1x SDS running buffer at 
200 V and 60 mA until the loading buffer front reached the end of the gel. 
 
Semi-dry transfer and antibody labelling 
During semi-dry transfer the proteins were transferred from the SDS-gel onto a 
polyvinylidene difluoride (PVDF) membrane, which was subsequently subjected to 
antibody labelling. Briefly, the gel was placed onto a methanol/SDS transfer buffer-
equilibrated PVDF membrane, which was further surrounded by 3 layers of wetted 
Whatman papers. The transfer was conducted at 15 V and 230 mA for 1 h. Subsequently, 
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the membrane was blocked in 5% skim milk/PBS for 1 h at RT or ON at 4°C. After 
blocking, the primary antibody (dilution in 1% BSA/PBS) was applied for 1 h at RT, 
followed by 3 washing steps in PBST (PBS, 0.1% Tween 20). Blocking in 5% skim 
milk/PBS for 30 min at RT was followed by incubation with the secondary antibody 
(dilution in 1% BSA/PBS) for 30 min at RT, 3 washes in PBST and, finally, the addition 
of chemoluminescence chemicals. The membranes were immediately wrapped into ceran 
foil and detection was achieved by x-ray film exposure and development. 
2.5.2.4 Protein expression and purification* 
For the purpose of establishing an in vitro acetylation assay as well as generating 
antibodies against the putative transferase, that was central to this study (PfNAT), two 
fragments of the protein comprising amino acids 146-527 (excluding N-terminal 
transmembrane domains and C-terminal putative ER retention signals, full length: 544 
aa) and 380-527 were cloned into the pET28a+ expression vector and subsequently 
purified from transformed E. coli RIL cells using His-tag based affinity purification 
columns (HisPur Cobalt spin columns, Thermo Scientific). Native purification 
conditions were initially used to retrieve functional protein for the enzymatic assay. 
However, due to deposition in bacterial inclusion bodies the yield of soluble protein was 
very low and contaminated with additional proteins. Therefore, subsequent extractions 
for antibody production were carried out under denaturing conditions (Gopal & Kumar, 
2013). 
 
Optimization of protein expression 
In a first step, the best expression conditions for the protein fragments in E. coli RIL and 
RIPL cells were tested using different temperatures, growth periods and concentrations 
of the inducer isopropyl β-D-1-thiogalactopyranoside (IPTG). Soluble proteins were 
separated from insoluble material and both fractions were compared using SDS-PAGE 
(15% gel) followed by staining with Coomassie-Blue.  
Briefly, an overnight culture of transformed RIL bacteria was grown in the presence of 
the selective antibiotics chloramphenicol (34 µg/ml) and kanamycin (50 µg/ml) and 
diluted on the next day in LB medium to an OD600 of 0.2 OD/ml. After 30 min of 
incubation at 37°C (OD600 ~0.5/ml), selective antibiotics and IPTG (0.1 mM, 0.4 mM, 1 
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mM) were added and the cultures were grown at different temperatures (18°C, 30°C, 
37°C) for various durations (2 h, 4 h, 6 h, ON). The suspension was then centrifuged 
(4000 rpm for 5 min, RT) and the pellet was washed once with H20. Cells were lysed 
with lysis buffer containing lysozyme (100 µg/ml) and Triton X-100 (0.1%), treated with 
protease inhibitors (aprotinin, leupeptin, PMSF), sonicated and centrifuged (13 000 rpm, 
for 5 min, 4°C). Supernatant and pellet were separated, adjusted for the same volume 
and equally supplemented with protein loading buffer for SDS-PAGE.  
 
Protein purification  
Small-scale and large-scale protein purification under native and denaturing conditions 
was conducted using the HisPur Cobalt spin columns (Thermo Scientific). Small 
aliquots were taken at several steps for SDS-PAGE to control for the presence of the 
proteins of interest. An overnight starter culture of transformed RIL bacteria was set up 
at 37°C in LB medium plus chloramphenicol and kanamycin as selective antibiotics. On 
the next day, the culture was diluted in a larger volume (100-800 ml) and incubated at 
37°C under shaking conditions to 0.5 OD600/ml for induction with 0.1 mM IPTG (plus 
addition of antibiotics). After 2-4 h the suspension was pelleted (4000 rpm for 10 min, 
RT) and the pellet was washed with H20 and weighed. 1 ml of lysis buffer (column 
equilibration buffer plus lysozyme, TritonX-100 and protease inhibitors) was added per 
0.1 mg of pellet weight. After 15 min rotation on a wheel (RT or 4°C, depending on 
protocol), the samples were sonicated and centrifuged (13 000 rpm for 15 min, 4°C). The 
supernatant was retrieved for purification under native or denaturing conditions on the 
HisPur™ Cobalt Spin Column (Thermo Scientific) according to the manufacturer’s 
protocol. Alterations were made in the imidazole concentrations of washing (10 mM, 50 
mM) and elution (100 mM – 500 mM) buffers and number of washing steps to increase 
the purity of the eluate. The fractionated samples were stored at -80°C. 
 Confocal fluorescence microscopy* 2.6
The localization of endogenous GFP/mCherry-tagged proteins within the parasites and 
RBCs of mutant transfectant lines was analysed by confocal laser scanning microscopy. 
Infected erythrocytes were enriched using the MACS column and washed twice in pre-
warmed Ringer solution, before being added to a perfusion chamber containing Ringer 
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solution. Optionally, parasite DNA was stained with Hoechst 33342 (15 nM) that was 
added to the Ringer solution. After settling onto the cover slips, the parasites were 
mounted onto the LSM 510 laser-scanning microscope (Zeiss, Jena) and viewed with a 
63x or 100x magnification objective (Plan-Apochromat 63x/100x, 1.4 Oil; C-
Apochromat 63x/100x, 1.2 H2O immersion) in bright field (DIC), wide-field 
fluorescence (HBO-lamp) and confocal fluorescence. GFP fusion proteins were excited 
using a 488 nm Argon ion laser and emission was detected through a 505-550 nm band 
pass filter. For excitation of the Hoechst 33342 dye the UV-Laser was used (364 nm) 
and emission was detected with a 385-470 nm band pass filter. Fluorescence of 
mCherry-tagged fusion proteins was excited using a 543 nm Helium-Neon laser and 
emission was detected through a 560 nm low pass filter. Images were collected using the 
LSM Imaging software (Zeiss, Jena) and further processed using FIJI (Schindelin et al, 
2012). In the subsequent ‘Results’ section, nuclear staining with Hoechst is always 
represented by the blue channel, GFP fluorescence is depicted in the green channel, 
mCherry in the red channel, DIC imaging is in the bright field channel and a fourth 
image represents the overlay of the former channels. For quantitative image analysis, 
settings were optimized to prevent extensive bleaching and saturation of pixels in the 
brightest intensities. Raw images were used for quantification purposes, while 
qualitative images were carefully processed concerning brightness, contrast, signal 
amplification and background reduction using the FIJI image analysis software.  
 Flow cytometry* 2.7
The quantification of fluorescence in live P. falciparum parasites expressing a regulable 
GFP-tagged version of the candidate protein in this study (PfNAT) was achieved 
through flow cytometric analysis using a FACScalibur (Becton Dickinson) as previously 
described (Staalsoe et al, 1999). Briefly, iRBCs of a 5 ml culture plate were magnet-
purified on the MACS column with minimum exposure to light, pelleted (1900 rpm for 2 
min, RT), washed twice in Ringer solution, resuspended in 100 µl of Ringer solution and 
incubated in the 37°C water bath. For direct FACS analysis, 40 µl of this suspension was 
added to 400 µl of 1xPBS and transferred into suitable vials. In parallel, DNA staining 
with EtBr (1 µg/ ml) was carried out in 60 µl 1xPBS plus 40 µl parasite suspension at 
37°C for 10 min. After incubation, the 100 µl of sample were added to 300 µl of 1xPBS 
MATERIALS AND METHODS 
66 
and transferred to suitable vials. Fluorescence was collected in the GFP channel (FL1-H) 
of the FACScalibur, whereas EtBr staining was collected in the respective channel (FL2-
H). 50 000 cells were counted per measurements and plotted in histograms using the 
CellQuest Pro analysis software 6.0.4 (Becton Dickinson). A region of interest excluding 
background fluorescence was determined (M2) and information such as the geometric 
mean and gated events was collected for this selected area. The remaining 20 µl of 
parasite samples were centrifuged and smeared on a glass slide for Giemsa-staining and 
microscopic observation of developmental stage and parasitaemia. 
 Mass spectrometry* 2.8
P. falciparum parasites expressing different GFP-tagged mutant STEVOR
1-80
 and 
KAHRP
1-69
 proteins were analysed for N-terminal cleavage and acetylation of the 
PEXEL motif. This part was conducted in collaboration with the group of Dr. Christine 
Schaeffer-Reiss at the Laboratoire de Spectrométrie de Masse BioOrganique in 
Strasbourg. The methods are provided in their final reports and copied for the sake of 
completeness. Prior to mass spectrometric analysis, sample preparation included large-
scale purification of mutant transgenic parasites using the MACS column, saponin lysis 
of these iRBCs and affinity-purification of the GFP-tagged fusion proteins from pellet 
and saponin fractions using anti-GFP antibody-coupled agarose beads (carried out by Dr. 
C. Sanchez and S. Prior).  
 Sample preparation for loading buffer elutions 2.8.1
Gel electrophoresis 
Samples were loaded on a 15% SDS polyacrylamide gel for electrophoresis. After 
migration the gels were stained using colloidal blue during 4 days. All the major bands 
were then excised from the gel and put into a costar 96 well plate. Destaining, reduction, 
alkylation and dehydration were then performed using an automated system (MassPREP, 
Waters, Manchester, UK). The gel slices were washed twice with 50 µL of 25 mM 
ammonium hydrogen carbonate (NH4HCO3) and 50 µL of acetonitrile. The cysteine 
residues were reduced by 50 µl of 5 mM TBP at 57°C and alkylated by 50 µl of 55 mM 
iodoacetamide. Finally a dehydration step with acetonitrile was performed. 
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In-gel labelling reaction 
The N-termini of the proteins are then labelled using N-tris (2,4,6-trimethoxy-phenyl) 
phosphonium acetyl succinimide (TMPP), which, apart from improving the ionization 
and fragmentation pattern of a sample, can only bind to unmodified N-termini (Bland et 
al, 2014). 100 µg of TMPP in 80/20 water/acetonitrile (2 µL) are added to each gel 
bands before adding 50 µL of the reaction buffer, which consisted of 50 mM Tris-HCl  
pH = 8.20. The reaction is done over 1 hour under agitation and then 2 µL of 50 % 
hydroxylamine were added to quench the reaction (30 min with agitation). The gel slices 
are then transferred to a new plate and 4 cycles of washing and dehydration are 
performed using the Massprep automated system. 
 
Digestion 
The proteins were then cleaved in gel with 62.5 ng of modified porcine trypsin 
(Promega, Madison, WI, USA) in 50 µL of 25 mM hydrogen carbonate at 37°C 
overnight. The tryptic peptides were then extracted twice using 30µL of a CH3CN/H2O 
60/40 + 1% HCOOH solution for the first extraction and 10µL 100% CH3CN for the 
second one. The extracts corresponding to the same bands were pooled and then the 
volumes were reduced by speed vacuuming to eliminate acetonitrile and concentrate the 
peptides. The samples were then ready to be analysed by LC-MS/MS. 
 LC-MS/MS analysis 2.8.2
Samples were analysed using an ultra-performance liquid chromatography system 
(NanoAcquity, Waters, Milford MA, USA) coupled to a high resolution 
nanoElectrospray-Quadrupole-Time of Flight type mass spectrometer (Maxis, Bruker 
Daltonics, Bremen, Germany). The samples were trapped on a 20 х 0.18 mm, 5 µm 
Symmetry C18 precolumn (Waters), and the peptides were separated on a ACQUITY 
UPLC® BEH130 C18 column (Waters), 75 µm x 250 mm, 1.7 µm particle size. The 
solvent system consisted of 0.1% formic acid in water (solvent A) and 0.1% formic acid 
in acetonitrile (solvent B). Trapping was performed during 1 min at 15 µL/min with 99% 
of solvent A and 1% of solvent B. Elution was performed at a flow rate of 450 nL/min, 
using 6-43.5% gradient (solvent B) over 35 min at 45°C followed by 90% (solvent B) 
over 1 min before the reconditioning of the column at 99% of solvent A over 6 min. 
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The Maxis equipped with a nanosprayer was operated in the positive ion mode. Mass 
calibration of the TOF was achieved prior to analysis from m/z 50 to 2200 using 
Tunemix (Agilent technologies, Waldbronn, Germany).  Online correction of this 
calibration was performed using two Tunemix ions (m/z 299.2945 and 922.0098) as 
recalibration masses. The capillary voltage was set to 4500 V and the end plate offset to 
-500 V. For tandem MS experiment, the system was operated with automatic switching 
between MS and MS/MS modes. The MS scan is performed over an m/z range of 
[50;2200] at 0.2 seconds/scan. The MS/MS time is regulated by the intensity of the 
selected peak on the MS spectrum; it ranges from 0.1 to 1.4 seconds/scan over the same 
m/z range. The five most abundant peptides, preferably doubly and triply charged ions, 
were selected on each MS spectrum for further isolation and Collision Induced 
Dissociation (CID) using an optimized collision energy depending on the charge state 
and the m/z of the ion. The selected peptides are then excluded for 0.8 seconds. The 
complete system was fully controlled by Compass Hystar (Bruker). 
 Protein identification 2.8.3
MS data collected during analysis were processed, converted to .mgf files using 
Compass Data Analysis 4 (Bruker). The mgf peak list files were then submitted to 
Mascot search engine (Matrix Sciences, London, UK) version 2.3.01 on a local server. 
Searches were performed against a composite target-decoy database generated using 
internally developed tools (http://msda.u-strasbg.fr) and containing the NCBI protein 
sequences of P. falciparum, the sequences of the chimerical STEVOR proteins and 
common contaminants (trypsin and human keratins). Searches were performed with a 
tolerance of 5 ppm for precursor ions and 0.02 Da for fragment ions allowing a 
maximum of two miss cleavages site for semitrypsin or semiAspN. 
Carbamidomethylation of cysteine residues, oxidation of methionine residues, 
acetylation of peptide N-terminal residues, and TMPP labelling of peptide N-terminal 
residues were searched as variable modifications. All spectra that yielded N-terminus 
identification were manually reinspected. 
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3 Results 
 Mutagenesis of the PEXEL motif of STEVOR and KAHRP  3.1
The human erythrocyte is extensively modified upon invasion by P. falciparum, which is 
facilitated by the export of various parasitic effector proteins into the host cell. The 
majority of these proteins contain the PEXEL motif that mediates trafficking beyond the 
parasitophorous vacuole (Hiller et al, 2004; Marti et al, 2004). The processing of the 
PEXEL motif in the ER was shown to be essential for successful export of the respective 
proteins (Boddey et al, 2009). Although cleavage of this pentameric amino acid motif after 
the conserved leucine by the aspartic acid protease Plasmepsin V as well as consecutive 
acetylation of the newly formed N-terminus was experimentally verified, the details of the 
entire process are still unknown. However, these steps represent a major bottleneck in the 
export of these virulence-relevant proteins, which renders them as promising drug targets 
(Haase & de Koning-Ward, 2010; Russo et al, 2010).  
So far, mutagenic studies on the PEXEL motif were mainly restricted to deletions of the 
whole motif as well as alanine exchanges of the conserved amino acids of different 
proteins (Boddey et al, 2010; Boddey et al, 2009; Hiller et al, 2004; Marti et al, 2004). 
Although these initial studies provided valuable information on the importance of this 
motif in guiding proper export, a more detailed analysis would dissect the motif into its 
relevant characteristics.  
In order to assess the variability of amino acids among all five PEXEL positions in 
relation to the export phenotype this study included an extensive mutagenesis analysis of 
the PEXEL motif of a GFP-tagged soluble exported protein of the STEVOR family. 
Several amino acids with different chemical properties were chosen for the exchange to 
test the importance of size, charge or polarity within the given sequence context (Figure 
12). Furthermore, mass spectrometry was conducted on chosen mutants to investigate the 
importance of PEXEL cleavage and acetylation in correlation with the export phenotype. 
In order to confirm their relevance some amino acid exchanges were repeated in a second 
GFP-tagged PEXEL protein, namely KAHRP.  
The first position (R
48
) of the PEXEL motif (apart from R
48
K) was already investigated 
by our former PhD student P. Henrich in his thesis (Henrich, 2008). For complementary 
reasons the results of this mutagenesis will be included and shortly discussed. In 
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continuation of this project, the present study concentrated on the second to fifth PEXEL 
position (L
49
-Q
52
). A. Günther contributed 11 of the STEVOR
1-80
 mutants under my 
supervision in the course of her teacher’s thesis. 
 
 
Figure 12. Mutagenesis screen of the PEXEL motif of STEVOR
1-80 
(A) Sequence logo representing the conservation of the PEXEL motif in 158 predicted P. falciparum 
proteins excluding the multiple gene families of var, rif and stevor. The height of each letter is 
proportional to the frequency of amino acids in each position. The total letter height indicates the amount 
of information (bits) contained in the amino acids at that position. Amino acid color coding: red, basic; 
purple, acidic; blue, hydrophobic; green, polar amino acids. Adaptation from Marti et al (2004). Substrate 
cleavage site residues are designated P3-P2-P1-P1’-P2’ with hydrolysis between P1 and P1’. 
Nomenclature adopted from Guruprasad et al (2011). (B) Histograms of relative occurrence of each amino 
acid in positions P2-P2’ of the PEXEL motifs of 158 predicted proteins by Marti et al (2004). Amino 
acids chosen for replacement of L
49
 (P2), L
50
 (P1), A
51
 (P1’) and Q52 (P2’) in STEVOR1-80 shown in red. 
Classification adopted from Alberts (2010). 
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 Subcellular localization of STEVOR1-80 mutants 3.1.1
The following mutagenesis analysis was conducted on a member of the PfSTEVOR 
protein family (gene ID: PF3D7_0631900, PlasmoDB), a transmembrane protein that 
localizes to the Maurer’s clefts in its full-length version. It was previously shown that a 
short soluble version of this protein comprising the first 80 amino acids including the 
signal peptide and PEXEL motif (aa 48-52) is translocated into the RBC cytosol thereby 
rendering it a suitable model protein to investigate PEXEL-mediated protein export 
(Przyborski et al, 2005). 
In this study the gene encoding the first 80 amino acids of STEVOR followed by GFP 
(STEVOR
1-80
) was cloned into the pARL1a+ vector under the PfCRT promotor for 
episomal transfection into the P. falciparum 3D7 strain. Single amino acid mutations 
were introduced into the PEXEL motif by megaprimer synthesis and subsequent overlap 
extension PCR followed by standard cloning procedures, sequencing and transfection. 
The parasites were positively selected for plasmid uptake with WR99210 within a period 
of 3-6 weeks and analysed under the confocal laser scanning microscope. The 
localization of the fluorescent proteins was determined for all stages of intraerythrocytic 
development. In addition, trophozoite-stage parasites were purified with a magnetic 
column to gain a better overview of the export phenotype. Representative images of at 
least 25 parasitized RBCs with young to mature trophozoites recorded on two or more 
different dates are shown for every mutant. The wild-type version of STEVOR
1-80
, 
representing proper PEXEL-mediated protein export, was characterized by an evenly 
distributed fluorescence within the RBC cytosol after successful translocation beyond 
the PVM. Furthermore, a stage-dependent proportion of the chimeric proteins was 
present in the ER of early trophozoites as well as residual fluorescence of lysis-resistant 
GFP in the food vacuoles of late-stage parasites as a consequence of haemoglobin 
digestion (Figure 13A). The amino acid exchanges within the first position of the 
PEXEL motif of STEVOR
1-80 
uniformly resulted in intraparasitic retention of the mutant 
proteins (Figure 13B). This phenotype was described previously for R
48
A and was 
attributed to a defect in cleavage by Plasmepsin V within the parasite ER, which renders 
the mutant proteins incapable to exit this compartment (Boddey et al, 2009).  
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Figure 13. Export phenotypes of wild-type and R
48
 (P3) mutants of STEVOR
1-80 
Confocal images of live P. falciparum-infected erythrocytes. Transfectant parasites at trophozoite stage 
expressing different chimeric GFP-tagged fusion proteins of wild-type and mutated STEVOR
1-80
. (A) 
Wild-type STEVOR
1-80
 was exported into the RBC, with residual fluorescence in the food vacuole as well 
as ER. (B) All parasites with mutations in R
48
 (P3) showed an intraparasitic retention. These data (apart 
from R
48
K) were generated by Dr. P. Henrich (Henrich, 2008). (C) Localization of BIP
GFP
 as a known 
soluble marker protein of the ER. Left images, differential interference contrast (DIC); middle images, 
GFP fluorescence; right images, overlay of both channels. Scale bar: 2 µm. 
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In contrast to previous assumptions, that lysine can replace arginine at P3 (Boddey et al, 
2009), R
48
K was not exported but instead also localized to a perinuclear compartment 
indicative of the ER, which was confirmed by comparison with parasites that expressed 
GFP-tagged BIP, an established soluble marker protein of this organelle (Figure 13C) 
(Kumar & Zheng, 1992). This result is in agreement with data acquired through in vitro 
cleavage assays using recombinant Plasmepsin V and synthetic PEXEL peptides, which 
characterize the lysine mutant (RP3K) as a non-cleavable peptide (Boddey et al, 2013). 
As recently shown, the residues that line the active site binding pocket of Plasmepsin V 
in the S3 subsite specifically complement the corresponding side-chains of arginine at 
P3, an interaction that is crucial for hydrolysis of the motif (Guruprasad et al, 2011). 
In summary, the conservation of this amino acid in almost all putatively exported 
PEXEL proteins (Figure 12A) as well as the results of P. Henrichs mutagenesis screen at 
this position points to a functional restriction that is limited to arginine and most likely 
relevant for cleavage by Plasmepsin V. 
In contrast, the amino acid exchanges within the second PEXEL position (L
49
) did not 
interfere with export of the chimeric proteins into the RBC cytosol (Figure 14A). All 
mutants showed a fluorescence pattern comparable to the STEVOR
1-80
 wild-type 
phenotype. This microscopic observation was further confirmed by quantitative analysis 
of relative fluorescence in the infected RBC cytosol of representative images using the 
FIJI software (Figure 14B). For this purpose, raw fluorescence intensities of the whole 
parasitized cells as well as the parasites only were measured in unmodified suitable 
images with subsequent background reduction (n=14 cells on average). From this the 
relative fluorescence in the parasites as well as the host cell cytosol were calculated and 
the latter presented in histograms for all mutants generated in this screen. The proportion 
of wild-type GFP-tagged STEVOR
1-80
 that is exported into the host cell cytosol is 
around 56%, taking into account the intra-ER as well as residual food-vacuolar pool of 
fluorescent protein in the parasite. The data obtained for L
49
 are in a similar range (L
49
H, 
E, Y slightly reduced), which supports the general conclusion based on sequence 
conservation data that this position is rather permissive towards different amino acid 
structures. On the contrary, mutagenesis of the third PEXEL position of STEVOR
1-80 
(L
50
) had a drastic effect on export of the mutant chimeric GFP proteins.  
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Figure 14. Export phenotypes of L
49
 (P2) and L
50
 (P1) mutants of STEVOR
1-80
 
Confocal images and quantification of P. falciparum parasites at trophozoite stage expressing chimeric 
GFP-tagged fusion proteins of wild-type and mutated STEVOR
1-80
. (A) Amino acid exchanges at position 
L
49
 (P2) do not interfere with a normal export into the RBC cytoplasm. Left images, differential 
interference contrast (DIC); middle images, GFP fluorescence; right images, overlay of both channels. 
Scale bar: 2 µm. (B) Relative fluorescence in iRBC cytosol demonstrating amount of 
exported  STEVOR
1-80
 protein in different P2 mutants. Error bars are standard error of the mean (SEM). 
wt, wild type. (C) L
50
 (P1) mutants are unable to be exported but instead localize to a bright spot in the 
parasite. Image order like in (A). (D) Relative fluorescence in iRBC cytosol demonstrating amount of 
exported STEVOR
1-80
 protein in different P1 mutants. Error bars are standard error of the mean (SEM). 
wt, wild type. 
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In all cases the fluorescence was confined to a very particular bright spot within the 
parasite, most likely representing a subdomain of the ER (Figure 14C). As described 
previously, the ER of Plasmodium contains several sub-compartments that are involved 
in export (Lee et al, 2008; Struck et al, 2008). Image analysis revealed a concomitant 
reduction in host cytosolic fluorescence from ~56% of the wild-type to an average of 6% 
in the mutants (Figure 14D). Since the P1 mutant LA in other PEXEL proteins was 
previously identified to be localized to the ER due to a defect in cleavage by 
Plasmepsin V, the data obtained here are consistent with the implicated functional 
importance of this amino acid at this position (Boddey et al, 2009). 
The amino acid exchanges of the fourth PEXEL position (A
51
) resulted in two different 
export phenotypes (Figure 15). The majority of mutant STEVOR
1-80 
proteins surrounded 
the parasite as a bright fluorescent ring indicative of an accumulation within the 
parasitophorous vacuole. Translocation into the RBC cytosol was reduced in those 
mutants from 56% to 12% on average (Figure 15B). Frequently, parasite-induced 
cytostomes for haemoglobin uptake were detectable as fluorescently labelled extensions 
of the PV into the cytosol. Interestingly, a few transfectant lines were able to partially 
(A
51
V) or completely (A
51
S, A
51
T) export the mutant GFP chimeric proteins into the 
host cell with a final localization identical to the wild-type STEVOR
1-80
. Since the 
sequence conservation of amino acids at this position is quite weak in all putative 
PEXEL proteins (apart from exclusion of charged amino acids), the findings of two 
different export phenotypes was quite surprising and the majority of mutant chimeric 
proteins being retained in the PV was unexpected, especially in comparison to the above 
described L
49 
mutants, where the export was not altered. After proteolytic cleavage in the 
ER, the remaining N-terminus is acetylated as proven by mass spectrometry in 
independent studies (Boddey et al, 2009; Chang et al, 2008; Osborne et al, 2010). 
Although post-translational acetylation after protein cleavage is a rather special process, 
N-terminal protein acetylation in general occurs very frequently in eukaryotic organisms 
(Starheim et al, 2012). However, its importance with regard to PEXEL-mediated protein 
export is uncertain so far (Boddey & Cowman, 2013).  
The data of the mutagenesis screen presented in this study here demonstrate that position 
P1’ (A51) is not as flexible in amino acid structure as previously assumed and the process 
of acetylation at this position might indeed influence the final localization of mutant 
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proteins. This hypothesis was investigated in more detail by mass spectrometric analysis 
as described in chapter 3.1.3.  
 
Figure 15. Export phenotypes of A
51
 (P1’) mutants of STEVOR1-80 
(A) Confocal images of live P. falciparum-infected erythrocytes with transfectant parasites at trophozoite 
stage expressing different chimeric GFP-tagged fusion proteins of mutated STEVOR
1-80
. 4 constructs 
were contributed by A. Günther under supervision (Günther, 2012). Mutations within position A
51
 (P1’) 
show two different phenotypes; A
51
S, T and partially V are exported into the RBC cytoplasm, whereas all 
other mutants are retained in the PV. Left images, differential interference contrast (DIC); middle images, 
GFP fluorescence; right images, overlay of both channels. Scale bar: 2 µm. (B) Relative fluorescence in 
RBC cytosol demonstrating amount of exported STEVOR
1-80
 protein in different P1’ mutants as 
determined by quantitative image analysis using FIJI. Error bars are SEM. wt, wild type.  
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In order to confirm the microscopic observations, some of the A
51
 mutants were 
subjected to differential lysis with tetanolysin and saponin followed by western blot 
analysis using α-GFP antibodies (Figure 16). Treatment of iRBCs with the bacterial 
toxin tetanolysin permeabilizes the erythrocyte membrane without affecting the PVM 
due to differences in membrane cholesterol content (Blumenthal & Habig, 1984). In a 
next step, the addition of saponin to tetanolysin-treated parasite pellets disrupts the PVM 
and releases the proteinaceous content of the vacuole, whereas the parasite plasma 
membrane stays intact (Ansorge et al, 1996; Ansorge et al, 1997; Siddiqui et al, 1979). 
As can be seen in Figure 16, the export of wild-type STEVOR
1-80
 as well as A
51
S into 
the host cell was confirmed by detection of the proteins in the tetanolysin supernatant 
representing the erythrocytic cytosol fraction. Depending on the overall developmental 
stage of the parasite culture (young trophozoites to schizonts) a reasonable proportion of 
exported STEVOR
1-80
 is endocytosed upon haemoglobin digestion and degraded in the 
food vacuole as indicated by the prominent band of 27 kDa in the saponin pellet 
fractions corresponding to lysis-resistant GFP.  
 
Figure 16. Western blot analysis of selected A
51
 mutants after differential lysis 
The localization of selected STEVOR
1-80
 proteins with mutations at position A
51 
was investigated by 
differential lysis of iRBCs using tetanolysin and saponin. After purification iRBCs were lysed with 
tetanolysin and divided into cytosolic supernatant (iRBC) and pellet. The PVM was further permeabilized 
by saponin treatment of the pellet to release the content of the vacuole (PV). The remaining pellet 
corresponds to the parasite fraction (P). All samples were probed with antibodies against α-GFP and 
subsequently against tubulin ( 50 kDa, to control for intact parasites as exemplified for A 51S). The upper 
main bands correspond to processed STEVOR
1-80 ( 31 kDa), whereas the lower main band represents GFP 
alone ( 27 kDa). kDa, kilodalton; P, parasite (top)/ pellet (bottom); Sap, saponin; SN, supernatant; Tet, 
tetanolysin. 
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In accordance with the microscopic observations, A
51
R and D accumulated in the 
supernatant of saponin-treated tetanolysin pellets, which is representative of the 
parasitophorous vacuolar compartment that both fluorescent proteins were confined to. 
Detection of tubulin in intact parasites was used as a control to exclude excessive lysis 
that would prevent proper sample fractionation. All STEVOR
1-80
 proteins showed a size 
rather corresponding to the processed form of the PEXEL motif (~31kDa) in contrast to 
the unprocessed version (~ 37 kDa). However, as previously mentioned, alternative 
cleavage within the signal sequence can occur and the determination of N-terminal 
processing by mass spectrometry is inevitable (Boddey et al, 2009).  
In the next step, the last position of the pentameric PEXEL motif was examined to 
address the question if the sequence conservation of E/Q/D (Q
52
 in STEVOR) was a 
limiting determinant for the successful translocation of the proteins into the RBC 
cytosol. Interestingly, most of the mutant STEVOR
1-80
 proteins were able to guide 
normal export into the host cell comparable to the wild type (Figure 17A). The only 
obvious deviation from this phenotype was detected in the two mutant strains where Q
52
 
was exchanged with positively charged amino acids (Q
52
K, Q
52
R). Here, the 
fluorescence was mainly limited to the PV and export beyond the PVM was reduced 
from 56% to 15% (Figure 17B). In the Q
52
D mutant, some parasites showed full export 
of the GFP chimera; however, a significant number of parasites exhibited only a partial 
export phenotype with a visible amount of protein retained in the PV. Since aspartic acid 
(D) is one of the conserved residues at this position (E/Q/D) this finding was unexpected 
but it indicates the importance of taking the individual sequence context into 
consideration. 
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Figure 17. Export phenotypes of Q
52
 (P2’) mutants of STEVOR1-80 
(A) Confocal images of live P. falciparum-infected erythrocytes with transfectant parasites at trophozoite 
stage expressing different chimeric GFP-tagged fusion proteins of mutated STEVOR
1-80
. 7 constructs 
were contributed by A. Günther under supervision (Günther, 2012). The majority of Q
52
 (P2’) mutants 
show the wild-type phenotype of proper PEXEL-mediated protein export, only positively charged amino 
acid replacements (Q
52
K, R) block traversal of the PVM, which results in a vacuolar retention. Left 
images, differential interference contrast (DIC); middle images, GFP fluorescence; right images, overlay 
of both channels. Scale bar: 2 µm. (B) Relative fluorescence in RBCs demonstrating amount of exported 
STEVOR
1-80
 protein in different P2’ mutants as determined by quantitative image analysis using FIJI. 
Error bars are standard error of the mean (SEM). wt, wild type.  
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 Subcellular localization of KAHRP1-69 mutants 3.1.2
Up to this point the mutagenesis screen on the export motif was conducted on 
STEVOR
1-80 
and revealed a more complex dimension of variability and conservation 
than originally assumed, especially in the fourth (A
51
) and fifth (Q
52
) PEXEL position. 
While A
51
 was shown to be more restricted than the sequence conservation data 
implicate, mutations in Q
52
 did not interfere with successful export of the respective 
proteins apart from positively charged replacements (Q
52
K, Q
52
R) despite the theoretical 
sequence restriction (E/Q/D).  
In the course of this study special attention was paid to A
51
, which is acetylated after 
cleavage, a process that might influence consecutive trafficking steps. Although 
STEVOR
1-80 
proved to be a good model protein for PEXEL-mediated export, selected 
mutations at this position were repeated in a second PEXEL protein, KAHRP, to confirm 
the data obtained before and prove their relevance. It was previously established that the 
first 69 amino acids of KAHRP, which contain a signal peptide as well as the PEXEL 
motif (aa 54-58), are sufficient to direct a chimeric GFP fusion protein to the cytoplasm 
of P. falciparum-infected erythrocytes (Marti et al, 2004).  
Therefore, the gene encoding the first 69 amino acids of KAHRP (gene ID: 
PF3D7_0202000, PlasmoDB) followed by the coding sequence for GFP (further denoted 
as KAHRP
1-69
) was cloned into the pARL1a+ vector under the PfCRT promotor for 
episomal transfection into the P. falciparum 3D7 strain. The following single amino acid 
replacements at position A
57
 were introduced by megaprimer PCR and standard cloning 
procedures: V, S, T, R, D. All constructs were sequenced and control digested prior to 
transfection. After transfection intraerythrocytic parasite stages were positively selected 
for plasmid uptake by WR99210 for the period of 3-6 weeks. The transfectant lines were 
analysed by confocal fluorescence microscopy and representative images of at least 25 
infected RBCs with young to mature trophozoites recorded on minimal 2 different dates 
are shown (Figure 18A, B). Furthermore, suitable representative images of each 
mutation (n=14 cells on average) were subjected to quantitative image analysis using 
FIJI to determine the relative amount of exported GFP-tagged protein in the RBC 
cytosol (Figure 18C). 
The distribution of the wild-type KAHRP
1-69
 was identical to STEVOR
1-80
 with a clear 
translocation of the GFP-tagged protein into the RBC cytoplasm, bright fluorescence of 
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lysis-resistant GFP in the food vacuole of mature parasite stages and some residual 
intraparasitic fluorescence indicative of ER localization (Figure 18A).  
The transfectant parasites expressing KAHRP
1-69 
with the mutations A
57
V, R and D 
showed a bright ring of fluorescence surrounding the parasite and a reduction in export 
to the host cell cytosol from ~62% to ~7% on average (Figure 18B, C). These data 
indicate that the soluble GFP chimeric proteins are secreted into the PV but are unable to 
cross the PVM. This phenotype is identical to the STEVOR
1-80 
A
51
R and D mutants thus 
confirming the previously acquired results. The replacement with valine at this position 
showed partial export ability in the STEVOR
1-80 
background, however this was absent in 
the KAHRP
1-69
 mutant with a clear defect in translocation. This difference might be 
attributed to the surrounding sequence context of these two proteins, which probably 
influences the outcome of the mutagenesis as reported previously in other studies 
(Boddey et al, 2009). 
Interestingly, the A
57
S mutant and the majority of A
57
T expressing parasites showed a 
normal export phenotype comparable to the wild type and identical to the respective 
STEVOR
1-80
 mutants. This finding provides additional proof that serine and threonine 
can replace alanine successfully at this position with regard to a possible functional role 
in processing or protein interactions. A minor proportion of the A
57
T expressing 
parasites also displayed retention in the PV, so the mutation might not be able to 
adequately replace the wild-type alanine in all parasites. This infrequent observation of 
different export phenotypes in one transfection has previously been reported (Boddey et 
al, 2009; Heiber et al, 2013).  
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Figure 18. Export phenotypes of A
57
 (P1’) mutants of KAHRP1-69 
Confocal images of live P. falciparum-infected erythrocytes and quantification of fluorescence in RBC 
cytosol. Transfectant parasites at trophozoite stage expressing different GFP-tagged fusion proteins of 
KAHRP
1-69 
are shown. (A) The wild-type PEXEL motif of KAHRP
1-69 
was able to guide export of the 
reporter into the RBC cytoplasm. A stage-dependent proportion can be found in the ER as well as the food 
vacuole. (B) Mutations at position A
57
 (P1’) resulted in different phenotypes; A57S and T showed a 
fluorescence distribution comparable to the wild-type with successful traversal of the PVM, whereas the 
other mutant proteins (A
57
V, R and D) were confined to the PV. Left images, differential interference 
contrast (DIC); middle images, GFP fluorescence; right images, overlay of both channels.  Scale bar: 2 
µm. (C) Quantification of exported KAHRP
1-69 
chimaeras determined by relative fluorescence in RBC 
cytoplasm. Error bars are SEM. 
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 Processing of particular STEVOR1-80 mutants 3.1.3
In addition to the localization of the different mutants, the next part of the study aimed at 
finding a correlation between the export of PEXEL proteins and processing of this motif. 
In particular, the cleavage and acetylation state of chosen STEVOR
1-80
 mutants was of 
interest in order to understand the observed implications of certain amino acid 
exchanges. Therefore, mass spectrometry was conducted, which represents a suitable 
tool to identify cleavage sites and protein modifications. This work was done in 
collaboration with Dr. C. Schaeffer-Reiss at the mass spectrometry platform in 
Strasbourg. In order to distinguish free N-termini from acetylated ones, N-tris (2,4,6-
trimethoxy-phenyl) phosphonium acetyl succinimide (TMPP) was used as a label. Apart 
from improving the ionization and fragmentation pattern of a sample, this labelling 
reagent can only bind to unmodified N-termini (Bland et al, 2014). In case of N-terminal 
acetylation, TMPP cannot access the peptide thus providing indirect proof of this protein 
modification.  
The aim was to analyse mutant STEVOR
1-80
 proteins of each PEXEL position that 
represent certain export phenotypes concerning retention or translocation of the chimeric 
proteins. The protein samples were collected from saponin-lysed iRBCs after magnetic 
purification and divided into supernatant and pellet fractions (this work was mainly done 
by S. Prior). After immunoaffinity chromatography with α-GFP agarose (this work was 
done by Dr. C. Sanchez), the proteins were separated on SDS-Gels, excised and labelled 
with TMPP after reduction and alkylation. Digestion with trypsin was carried out in the 
gel slices, the tryptic peptides were extracted, pooled and analysed by LC-MS/MS to 
determine the mass and amino acid sequence of N-terminal peptides.  
As can be seen in Table 1 the wild-type STEVOR
1-80
 was processed as expected with 
cleavage at P1 (L
50
) and N-terminal acetylation at P1’ (A51). The R48A mutant was not 
cleaved and consequently not acetylated most likely due to a disturbed interaction with 
the active site of Plasmepsin V that seems specifically suited to harbour arginine at this 
position (Guruprasad et al, 2011). In contrast, L
49
A was normally processed with respect 
to cleavage and acetylation, which is further supported by a normal export phenotype 
into the RBC cytoplasm. In line with R
48
A, L
50
A was also identified neither cleaved nor 
N-terminally acetylated. The fact that all mutants at both positions were unable to exit 
the ER clearly demonstrates the importance of the cleavage event for the first steps of 
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PEXEL-mediated trafficking. Furthermore, these results confirm published data on the 
processing of other PEXEL proteins such as GBP130 (Boddey et al, 2009). A more 
diverse processing pattern was determined for different A
51
 mutants (A
51
R, S, D) 
allowing interesting assumptions to be made. While A
51
S was normally processed, 
acetylated and exported to the host cell cytosol, A
51
R and A
51
D were cleaved but their 
N-termini were not acetylated. Both mutant GFP-tagged proteins accumulated in the PV 
and were unable to traverse the PVM. For the first time, these data indicated a possible 
relevance of acetylation in guiding proper translocation of a PEXEL protein beyond the 
PVM. 
 
Position Sequence 
Cleaved 
at P1 
Acetylated 
at P1‘ 
Export into 
RBC 
wt 
48
RLLAQ
52
 Yes Yes Yes 
R
48
 
48
ALLAQ
52
 No No No, parasite 
L
49
 
48
RALAQ
52
 Yes Yes Yes 
L
50
 
48
RLAAQ
52
 No No No, parasite 
A
51
 
48
RLLSQ
52
 Yes Yes Yes 
A
51
 
48
RLLDQ
52
 Yes No No, PV 
A
51
 
48
RLLRQ
52
 Yes No No, PV 
Q
52
 
48
RLLAA
52
 Yes Yes Yes 
Q
52
 
48
RLLAN
52
 Yes Yes Yes 
Q
52
 
48
RLLAR
52
 Yes Yes No, PV 
 
Table 1. Mass spectrometry conducted on different PEXEL mutants of STEVOR
1-80
 
Mass spectrometric analysis of mutant STEVOR
1-80 
proteins to determine the processing state of the 
PEXEL motif in comparison to their export phenotype. Proteins were extracted from saponin supernatants 
and pellets of P. falciparum transfectants lines followed by affinity purification. This was performed by S. 
Prior and Dr. C. Sanchez. Samples were separated by SDS gel electrophoresis, TMPP-labelled and 
subjected to tryptic digest followed by LC-MS/MS analysis. This part was conducted in collaboration 
with the group of Dr. C. Schaeffer-Reiss at the Laboratoire de Spectrométrie de Masse BioOrganique in 
Strasbourg. Cleavage of the PEXEL motif after P1 (L
50
) and consecutive N-terminal acetylation of P1’ 
(A
51
) was determined for the wild-type STEVOR
1-80
 protein as well as for L
49
A, A
51
S, Q
52
A, N and R 
mutants. Apart from Q
52
R, these proteins were also normally exported as assessed by fluorescence 
microscopy (chapter 3.1.1). The absence of PEXEL cleavage occurred in the R
48
A and L
50
A mutant 
proteins, which were retained within the parasite. A
51
R and D were cleaved but not acetylated and 
furthermore not exported beyond the PVM.  
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The mutant proteins of the last PEXEL position (Q
52
) also showed a different processing 
pattern in accordance to their cellular localization. Q
52
A and Q
52
N were normally 
processed and exported into the host cell, whereas Q
52
R was identified as being cleaved 
and acetylated but was clearly retained in the parasitophorous vacuole as described 
above. This result indicates that acetylation might be a necessary prerequisite but not 
entirely sufficient for protein export. Other factors such as protein interactions, 
membrane targeting or chaperone guiding might be involved in the correct trafficking 
process and these might be influenced by mutagenesis at this position.   
Several attempts were made by our collaborators to analyse KAHRP
1-69
 wild type, A
57
S 
and A
57
R by mass spectrometry but, due to unsuitable protease cleavage sites in the 
protein sequence, this was unfortunately without any success.  
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 Characterization of a putative N-acetyltransferase (PfNAT) 3.2
The previous experiments revealed that the A
51
 mutant proteins that were limited to the 
PV (A
51
D, R) were in fact cleaved but not N-terminally acetylated. This finding led to 
the assumption that acetylation or related interactions during this process might be an 
important prerequisite for the proper targeting of PEXEL proteins beyond the PVM. 
Although the majority of eukaryotic proteins are co-translationally acetylated at the N-
terminus (e.g. 70-90% in human cell lines) and involvement of this modification in 
protein degradation, interactions and localization has been implicated, the exact 
biological function remains elusive (Starheim et al, 2012). This lack of knowledge is 
even more prominent for post-translational N-α-acetylation after proteolytic cleavage 
events as observed in the PEXEL motif (Helsens et al, 2011; Wang et al, 2010). 
Published examples include among others the discovery of processed chloroplast 
proteins in Arabidopsis thaliana. Interestingly, the new N-termini of these proteins after 
cleavage in the plastid were predominantly occupied by alanine, serine, valine or 
threonine, which are also preferential substrates of the NatA transferases (Bienvenut et 
al, 2012). This observation is in accordance with the ability of A
51
S, T and V to replace 
the wild-type alanine in the STEVOR
1-80 
background as presented in chapter 3.1.1. As a 
consequence, the second part of this study concentrated on the identification of a 
putative N-acetyltransferase that could be responsible for this apparently important post-
translational protein modification.  
 Identification of PfNAT  3.2.1
The bioinformatic search in PlasmoDB (Version 11.0) for a putative N-acetyltransferase 
(NAT) in P. falciparum revealed 10 candidates with a suitable transferase domain (Table 
2). Since recent studies identified Plasmepsin V as an ER-resident protein and most 
likely cleavage takes place in this compartment, it was suggested that the consecutive 
acetylation process is localized to the ER (Chang et al, 2008) or maybe other 
compartments along the export pathway such as the Golgi complex or even the PV. As a 
consequence the putative N-acetyltransferase was expected to possess sequences, which 
allow the protein to enter the secretory pathway (signal peptide or transmembrane 
domain). This limitation was only fulfilled by one of the ten candidate NATs. Therefore, 
this protein (gene ID in PlasmoDB: PF3D7_1437000, previous ID: PF14_0350) was 
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chosen for the study and will henceforth be termed P. falciparum N-acetyltransferase 
(PfNAT). It has a length of 544 aa, no signal peptide but two N-terminal transmembrane 
domains separated by a small loop region, and a C-terminal putative N-acetyltransferase 
domain that is highly conserved among different Plasmodium species (Figure 19A, B). A 
secondary structure prediction of the carboxy (C)-terminus (aa 380-525) using the 
prediction program PSIPRED (Buchan et al, 2013) revealed a sequence of α-helices and 
ß-sheets that is characteristic of the GCN5-related N-acetyltransferase (GNAT) domain 
profile with a structurally conserved topology of ß1-α1-α2-ß2-ß3-ß4-α3-ß5-α4-ß6 that 
forms a three-dimensional V-fold (Figure 19C, D) (Vetting et al, 2005). In contrast to the 
so-called HAT core (ß2-ß3-ß4-α3-ß5-α4) the N-(ß1-α1) and C-terminal (ß6) parts are 
usually less conserved. Proteins of this huge family catalyse the transfer of an acetyl group 
from the CoA donor to a primary amine of the acceptor and are involved in various 
cellular processes of prokaryotes and eukaryotes such as N-terminal protein acetylation 
(NATs), histone acetylation (HATs), neurohormone production (SNATs), antibiotic 
resistance (AAC) and others (Dyda et al, 2000; Gautschi et al, 2003; Vetting et al, 2005). 
Gene ID 
UniProt 
ID 
Protein 
Length 
# Exons 
# TM 
Domains 
SignalP 
Scores 
Description 
PF3D7_0109500  -  155 2 0 0 N-acetyltransferase, putative 
PF3D7_0629000 C6KTC5 291 1 0 0 conserved protein, unknown function 
PF3D7_0805400 C0H4R5 225 6 0 0 acetyltransferase, putative 
PF3D7_0823300 Q8IB67 1465 4 0 0 
histone acetyltransferase GCN5 
(GCN5) 
PF3D7_0924900 C0H559 184 9 0 0 conserved protein, unknown function 
PF3D7_1003300 Q8IK04 152 1 0 0 N-acetyltransferase, putative 
PF3D7_1144800 Q8IHR9 658 1 0 0 
conserved Plasmodium protein, 
unknown function 
PF3D7_1244100 Q8I4Y9 1296 5 0 0 
N-alpha-acetyltransferase 15, NatA 
auxiliary subunit, putative 
PF3D7_1323300 Q8IE83 352 1 0 0 
acetyltransferase, GNAT family, 
putative 
PF3D7_1437000 Q8IL96 544 3 2 0 N-acetyltransferase, putative 
Table 2. Database search of putative N-acetyltransferases in P. falciparum 3D7 
Search on PlasmoDB for N-acetyltransferases in Plasmodium retrieved 10 ortholog groups with 10 
representative genes in P. falciparum strain 3D7 (last access: 1/4/14). Additional information concerning 
protein length, number of exons and transmembrane domains, probability to contain signal peptides as 
well as the putative function is provided. The candidate gene chosen for this study is marked in bold red.  
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Figure 19. PfNAT as a putative N-acetyltransferase 
(A) Schematic drawing of PfNAT (gene ID in PlasmoDB: PF3D7_1437000). The protein consists of 
544 aa, 2 N-terminal transmembrane domains (TM I, II) and a C-terminal NAT domain (core region aa 
423-501) as predicted by SMART and InterProScan4 programs (Quevillon et al, 2005; Schultz et al, 
1998). TM I, II, transmembrane domain I and II; LC, low complexity region; CC, coiled-coil region; NAT 
domain, N-acetyltransferase domain. (B) Alignment of C-termini of putative NATs in different 
Plasmodium species using ClustalW shows high sequence conservation. List of gene IDs see Appendix. 
Amino acid colouring represents physiochemical properties: small, hydrophobic, aromatic no tyrosine 
(red); acidic (blue); basic no histidine (magenta); hydroxylic, sylfhydrylic and amines plus glycine 
(green). Consensus symbols: fully conserved residue (*); amino acids with strongly similar properties (:); 
amino acids with weakly similar properties. (C) Secondary structure prediction of the C-terminus (aa 380-
523) using PSIPRED reveals a distinct sequence of α helices and ß sheets characteristic of the transferase 
domain of GCN5-related NATs (GNATs) as depicted in (D) (Vetting et al, 2005).  
PCH             IYEASDISNRKYIENKKTIPFRLNDLRRNIFDSKLNDDEDINYKFINRKIIGCVGIIPYK 418 
PB              VCEPSDITNRKNIDNKKTVPLRLNDLRRNIFDGKLNDDEDINYKFVNRKIIGCVGIIPYK 402 
PF              LFNISEISNRHFMETKRNVSSGFNEIRRNIFNCKVQDEEDFNKNILNKKIVGCVGIVPFK 438 
PK              LCNIGDIANKELIESRRTVPYRLDEIRRNIFRSKTNDDDDSTFRFVNRKIVGCVGIVPFK 451 
PV              LCNIGDIANKDLIESRRTVPFPLNEIRKNIFQSKTNDDDDSTFRFVNRKIVGCVGIVPFK 467 
                : : .:*:*:. ::.::.:.  ::::*:***  * :*::* . .::*:**:*****:*:* 
 
PCH             GDNSIAQLVRMVVKKDNRRMRIGSRLLTQLENFAHEHNYQELKVFTNNLNTDSLYFVKQN 478 
PB              GDNSIAQLVRMVVKKDNRRMRIGSRLLTQLENFAHEHNYQELKVFTNNLNTDSLYFVKQN 462 
PF              GDNTIAQLVRMVVKKDNRRMRIGSRLLTQLENFAHEQNYNELKVFTNNLNTDSLYFVKQN 498 
PK              GDNSIAQLVRMVVKKDNRRMRIGSRLLTQLENFAHEQNYQELKVFTNNLNTDSLYFVKQN 511 
PV              GDNSIAQLVRMVVKKDNRRMRIGSRLLTQLENFAHEQNYQELKVFTNNLNTDSLYFVKQN 527 
                ***:********************************:**:******************** 
 
PCH             GFDLSQIVRRGLMRGDLLIWSKILNKDDFYKFHGSDIKNYTS--NILD- 524 
PB              GFDLSQIVRRGLMRGDLLIWSKILNKDDFYKFHGLDIKSYTN--NILD- 508 
PF              GFNLSQIVRRGLMRGDLLIWSKILNKDDFYKFNSPEIQSYTN--NILD- 544 
PK              GFNLSQIVRRGLMRGDLLIWSKILNKDDFYKFNSSGTNQYVKSMNLGEY 560 
PV              GFNLSQIVRRGLMRGDLLIWSKILNRDDFYKFNSSGTNQYVKSMNLGEY 576 
                **:**********************:******:.   :.*..  *: :  
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In order to assess the localization of PfNAT inside the parasite, the full-length coding 
sequence was cloned without the stop codon into the pARL1a+-GFP vector under the 
PfCRT promotor and episomally transfected into the P. falciparum 3D7 strain. After 6 
weeks of positive selection using WR99210 the transfectant parasites were analysed in all 
stages under the confocal fluorescence microscope and images of at least 30 infected 
RBCs of young to mature trophozoite stages were taken at different occasions. As can be 
seen in Figure 20A, the GFP-tagged transmembrane protein localizes to an intraparasitic 
perinuclear compartment reminiscent of the ER, which is characterized by a perinuclear 
ring that extends upon maturation of the parasite.  
 Colocalization with other ER proteins 3.2.2
To investigate whether PfNAT actually occupies the same subcellular compartment as 
Plasmepsin V (PfPMV, gene ID in PlasmoDB: PF3D7_1323500), the protease that 
cleaves the PEXEL motif beforehand, transfectant parasites were established that co-
expressed PfPMV
GFP
 and PfNAT
mCherry
. To do so, the gene encoding full-length 
Plasmepsin V (590 aa) was cloned from 3D7 gDNA into the pARL1a+-GFP vector and 
transfected episomally into P. falciparum 3D7 parasites. Transfectant selection and 
microscopic analysis was carried out as described above. Indeed, both fluorescent 
proteins were localized to the same perinuclear compartment (Figure 20B). As a control, 
that this result was not caused by an unspecific co-expression of the two fluorescent 
tags, single transfectants of PfPMV
GFP
 and PfNAT
mCherry 
were analysed with the same 
result (Figure 20A). Furthermore, a putative acetyl-CoA transporter was identified by 
bioinformatics research in the course of this study that potentially delivers the acetyl-
CoA necessary for the acetylation process into the ER. The protein sequence of the 
chosen gene (gene ID: PF3D7_1036800), henceforth termed P. falciparum acetyl-CoA 
transporter (PfAcT) shows some homology to the mammalian transporter AT-1 (33% 
sequence identity to human AT-1, 96% coverage, e-value 8e
-84
), which was previously 
described as an ER-resident transporter that regulates the acetylation state of several ER-
based proteins (Jonas et al, 2010). PfAcT is the only protein in P. falciparum (according 
to PlasmoDB, Version 11.0) having this putative function and existing homologues in 
other Plasmodium species.  
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Figure 20. Localization of PfNAT and other marker proteins within the ER  
Confocal images of live P. falciparum-infected erythrocytes. Transfectant parasites at trophozoite stage 
expressing different fluorescent fusion proteins from episomal plasmids are shown. (A) Localization of 
the putative transferase PfNAT (tagged to GFP or mCherry). GFP-fusion proteins of Plasmepsin V 
(PfPMV) as well as a putative acetyl-CoA transporter (PfAcT) occupy the same perinuclear compartment 
that is indicative of the ER.  
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(Figure 20 continued) (B) Cotransfection of PfNAT
mCherry 
with the latter two proteins confirms this 
assumption although different subcompartments of the ER might be targeted as indicated by a slightly 
different localization within one parasite. Left images, differential interference contrast (DIC); middle left 
images, GFP or mCherry fluorescence; middle right images, nuclear staining with Hoechst (A) or 
mCherry fluorescence (B); right images, overlay of all channels. Scale bar: 2 µm. (C) Western blot 
analysis of parasites expressing PfNAT
GFP ( 91 kDa), PfAcTGFP ( 97 kDa) and PfPMVGFP (  96 kDa). 
Transfectants were isolated from RBCs by saponin lysis and mixed with loading buffer. Detection with α -
GFP antibodies confirmed the predicted sizes although slight deviations occurred due to protein sequence -
specific migration characteristics. 
 
Therefore the gene encoding the full-length protein (590 aa) including 10 putative 
transmembrane domains was amplified from cDNA of the 3D7 strain and cloned into the 
pARL1a+-GFP transfection vector. Transfection of the 3D7 strain and selection by 
WR99210 was followed by confocal fluorescence analysis as described above. 
Furthermore, the construct was used for a cotransfection with PfNAT
mCherry
 similar to 
PfPMV
GFP
. Indeed, both single and double transfectants showed a clear ER-restricted 
localization of PfAcT
GFP
 in the parasite comparable to PfNAT and PfPMV (Figure 20A, 
B). Interestingly, although all three proteins were generally limited to the ER, the 
microscopic data of the cotransfectants implicated certain differences in distribution 
within this compartment by means of an imperfect colocalization of PfNAT
mCherry
 with 
the others. This indication of a functional subdivision of the ER in P. falciparum was 
previously reported (Struck et al, 2008). The proper size of the fusion constructs was 
confirmed by western blot analysis of parasite lysates and detection with α–GFP 
antibodies (Figure 20C). Slight deviations from the expected masses probably resulted 
from sequence-specific characteristics such as hydrophobicity, charge distribution or 
various transmembrane domains (Rath et al, 2009; Shi et al, 2012). 
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 Endogenous tagging of PfNAT 3.2.3
Up to this point the localization of PfNAT in the ER has been determined using 
transfectants, which episomally overexpressed the GFP-tagged protein. In order to 
demonstrate the endogenous expression and ER targeting of this protein, a single 
crossover strategy was applied to introduce a C-terminal GFP tag under the gene-
specific promotor by homologous recombination. For this purpose a gene fragment 
containing 1.1 kb of the 3’ end of the PfNAT gene including an intron was amplified 
from 3D7 gDNA as a homology region and cloned without a stop codon into the 
pARL1a+-GFP vector that was devoid of the previously used PfCRT promotor (Figure 
21A). P. falciparum 3D7 parasites were transfected and positively selected with 
WR99210 as described above and, upon reappearance of the parasites, cycled for 3-4 
weeks without the selection marker followed by 1 week in presence of WR99210. When 
the replication rate of the parasites was stabilized gDNA was extracted and subjected to 
PCR in order to confirm recombination events. Suitable primer pairs were chosen to 
control for quality of the gDNA, presence of episomal plasmid as well as recombination 
of the plasmid into the locus of PfNAT. Since the first cycle did not result in any single 
crossover recombination, the transfectant parasites were either cycled for a second round 
off the selection drug or the cycles without drug pressure were prolonged to 4-10 weeks. 
After the second cycle a minor proportion of parasites had successfully recombined 
along the homology region and inserted the plasmid into the PfNAT locus as confirmed 
by sequencing of the recombination PCR band (Figure 21B). After a limiting dilution of 
this mixed population over the period of 3 weeks using a starting parasitaemia of 0.25 
and 0.5 parasites per well in 96-well plates, a clonal population deriving from only one 
fluorescent clone out of 30 microscopically analysed potential clones could be obtained 
and verified by PCR. While the episomal, promotor-free construct was non-fluorescent, 
the parasite line expressing GFP-tagged PfNAT under the endogenous promotor 
exhibited a significant fluorescence in the ER as described for the episomally 
overexpressed version (Figure 21C). Furthermore, the correct size of the fusion protein 
was confirmed by western blot analysis (Figure 21D). This finding provides proof that 
the gene is indeed expressed and the corresponding PfNAT protein is synthesized in 
detectable quantities and localized to the expected subcellular compartment, namely the 
ER.  
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Figure 21. Endogenous tagging of PfNAT with GFP via homologous recombination 
Establishment of clonal parasites that express PfNAT
GFP
 under the endogenous promotor after 
homologous recombination. (A) Design of the integration plasmid pARL-PfNAT-3’-GFP. The gene 
fragment encoding the C-terminal part of PfNAT was cloned without a stop codon as a region 
homologous to PfNAT (blue, ~1 kb) for single crossover recombination. The sequences encoding GFP and 
the PbDHFR-TS 3’UTR as a terminator region were inserted downstream. The positive selection marker 
cassette (black box) is shown as well as the primers (black arrows) used for PCR analysis (a-e). bla, 
ampicillin resistance gene; CAMpro promotor of the CAM gene; chrXIV, chromosome 14; HRP2ter and 
PbDTter, terminator regions of the HRP2 and PbDHFR-TS genes; hatched boxes, introns. (B) 
Representative PCR analysis of genomic DNA from cycled transfectants to determine recombination 
events. Clonal parasites (clone F9) after limiting dilution showed the same band pattern. As a control 
transfectants prior to drug cycling are shown that express the plasmid in an episomal manner. Primers 
were chosen to detect the plasmid (P, c+d, 1.1 kb), genomic DNA (G, a+b, 1.6 kb) as well as integration 
of the plasmid after recombination (I.1, a+d, 1.7 kb and I.2, a+e, 2.3 kb). Unspecific bands appear in I.1 
(0.6 kb) and I.2 (1.5 kb) of the control as well as integrants. M, DNA size ladder. (C) Confocal images of 
live P. falciparum-infected RBCs at the trophozoite stage show an intraparasitic localization of PfNAT
GFP
 
to the ER. Left images, differential interference contrast (DIC); middle left images, GFP fluorescence; 
middle right images, nuclear staining with Hoechst; right images, overlay of all channels.  Scale bar: 2 µm. 
(D) Western blot analysis of parasite lysates derived from PfNAT
GFP
 expressing clones after saponin 
treatment. The predicted size of PfNAT
GFP
 (~91 kDa) was approximated as confirmed by α-GFP antibody 
detection. 
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In summary, this part of the study included the identification of a putative N-acetyl 
transferase in P. falciparum (PfNAT) that might be involved in the acetylation of 
PEXEL proteins after their proteolytic cleavage. The localization of this protein in the 
ER together with the ER-resident protease Plasmepsin V (PfPMV) as well as a newly 
identified putative acetyl-CoA transporter (PfAcT) using GFP or mCherry fusion 
proteins indicate a local accumulation of factors involved in PEXEL processing within 
this compartment. The detectable expression of PfNAT under its endogenous promotor as 
well as the final targeting site of the protein was confirmed by introducing a GFP-tag 
into the locus via single crossover recombination.  
 Mutagenesis of the putative catalytic domain of PfNAT 3.2.4
In the next step the putative function of PfNAT was addressed by active-site 
mutagenesis. The analysis of dominant-negative phenotypes can be a valuable tool to 
address enzyme function, especially if the protein of interest is essential. In the context 
of PEXEL processing, this method was previously described for Plasmepsin V, where an 
episomal overexpression of a catalytically dead active-site mutant of PfPMV clearly 
competed with the endogenous enzyme for substrate binding and revealed a mixed 
population of cleaved and uncleaved HRPII protein (Russo et al, 2010).  
Since the above-mentioned results implicate acetylation as a prerequisite necessary for 
proper export of PEXEL proteins the following mutagenesis experiment tested the 
hypothesis that the episomal expression of a catalytically impaired PfNAT could have a 
dominant-negative effect on the normal export phenotype of STEVOR
1-80
. 
This part of the study was done in collaboration with Dr. M. Deponte who kindly 
established a three-dimensional model of the C-terminus of PfNAT based on the proper 
alignments with a structurally resolved putative streptothricin acetyltransferase domain 
from Bacillus anthracis (Protein Data Bank, PDB ID: 3PP9, unpublished) as well as a 
putative GNAT from Staphylococcus aureus (PDB ID: 3D8P, unpublished) (Figure 22A, 
B) (Berman et al, 2000). Based on this model and manual alignment of other GNATs, 
suitable amino acids were identified that might play an important role in catalysis or 
binding of acetyl-CoA to the active site. Consequently, mutations included PfNAT 
Y
493
A, R
456
M, T
484
V and N
488
L, with Y
493
A as a single mutant and RTN as a triple 
mutant. 
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Figure 22. Molecular model of NAT domain from 3PP9 and PfNAT (by Dr. M. Deponte) 
Establishment of a model of the PfNAT C-terminus by Dr. M. Deponte to identify amino acids that are 
important for catalysis or binding of acetyl-CoA. The model is based on crystal structure-derived 
sequence alignments with a putative streptothricin acetyltransferase from Bacillus anthracis (PDB ID: 
3PP9) as well as an acetyltransferase of the GNAT family from Staphylococcus aureus (PDB ID: 3D8P). 
(A) 3D model of 3PP9 chain A zoomed to catalytic site in complex with acetyl-CoA. Three potentially 
relevant amino acids are shown with their molecular distance to acetyl-CoA: Y
143
 (3.41 Å); T
132
 (3.76 Å) 
and N
136
 (2.95 Å). Not shown: R
104
 potentially binds acetyl-CoA, but not inside the active center (3.45 Å). 
(B) A stable 3D model of the PfNAT C-terminus (aa 393-522) including the putative transferase domain 
was created in automated mode on the SWISS-MODEL Server (Biasini et al, 2014)based on a suitable 
sequence alignment (force field energy: -6,53MJ/mol) with 3D8P. Y
130
 from 3D8P cannot be clearly 
aligned, however in PfNAT the tyrosine two amino acids upstream (Y
493
) was chosen for mutagenesis. 
Furthermore, R
456
, T
484
 and N
488
 were identified as candidates with a putative function in catalysis or 
binding of acetyl-CoA. (C) Alignment of C-termini of putative orthologous NATs in Apicomplexa as well 
as the previously mentioned bacterial transferases 3D8P and 3PP9 (resolved crystal structures). Detailed 
gene IDs are listed in the Appendix. The amino acids chosen for replacement mutagenesis are framed in 
black boxes. The active site tyrosine is framed in red without a counterpart in Plasmodium. Due to their 
sequence conservation G
461
 and G
499
 of PfNAT are assumed to be of structural relevance. PF, Plasmodium 
falciparum; PB, Plasmodium berghei; BB, Babesia bovis; TP, Theileria parva; CM, Cryptosporidium 
muris; TG, Toxoplasma gondii; NC, Neospora caninum; ET, Eimeria tenella. Amino acid colours and 
consensus symbols see description of Figure 19. 
 
PF NTIAQLVRMVVKKDNRRMRIGSRLLTQLENFAHEQNYNELKVFTNNLNTDSLYFVKQNGF 500 
PB NSIAQLVRMVVKKDNRRMRIGSRLLTQLENFAHEHNYQELKVFTNNLNTDSLYFVKQNGF 464 
BB PNVAQMVRLVVSKKCRNMKVGSQMLNHLENFAMGFGYSEIRVYTNNLNTAYLQFLKQNGF 313 
TP PNVGQMVRLVVTRKRRNMRVGSRLLDYLEKKAMEMGYNEIRVFTNNLNTAYLQFLKQHSF 276 
CM PKIARLLRLVVGVESRRMRIGTRLLAQMENFAKEYGYREIHLYTNNLSTSPIKFIGQHGY 227 
TG NKTAQLVRLVVDRSLRRQHIGSLLLNTFINYAVQQHYSVVRLYTNNLNNDSIRFAKTKGF 476 
NC NKTAQLVRLVVDRSFRRQHIGSLLLNTFISYALQQHYSVVRLYTNNLNSDSIRFAKTKGF 445 
ET LQEGQLVRLVVSPGSRGAGVGSRLLSSAVGFAASCRCRSIEVFANSLNASSASFFRNRQF 320 
3D8P --MSALKKMFVDKGYRNLKIGKKLLDKVIMTCKEQNIDGIYLGTIDKFISAQYFYSNNGF 135 
3PP9 --YAYIEDITVDKKYRTLGVGKRLIAQAKQWAKEGNXPGIXLETQNNNVAACKFYEKCGF 148 
    . :  : *    *   :*. ::      .       : : : .       *     : 
 
PF NLSQIVRRGLMRGDLLIWSKILNKDDFYKFNSPEIQSYTNNILD- 544 
PB DLSQIVRRGLMRGDLLIWSKILNKDDFYKFHGLDIKSYTNNILD- 508 
BB VIRQIVRRGLMRGDLIIWNKTLSQPNDVVTEIPSRANVDATFIPE 358 
TP QIIQVVRRGLMRGDLIIWNKVLNQVDHPKQDDASPTFGNAMFIPD 321 
CM QLVQVISRGLMRGDLLLWRKSFERSD--ESSIIERNNIGERLVLD 270 
TG ELQQVVRRGLMRGDLLKWQKKLEAPGVTQRRSRAFNLPSSILD-- 519 
NC ELQQVVRRGLMRGDLLKWQKKLEAPGVTQRKTRTFNLPSSVLD-- 488 
ET ELVQVVRRNLMRGDLLRWRMTLDCDGRTLEPKTDTSSIDDLQSE- 364 
3D8P -------REIKRGDLPSSFPKLDVDNRFYYRNLKD---------- 163 
3PP9 VIG--------GFDFLVYKGLNXTSDEVAIYWYLHF--------- 176 
                  *:          .                    
 
A B
C
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The amino acid exchanges were chosen with the aim to conserve structural features 
while abolishing functional characteristics of the respective side chains with the prospect 
of rendering the expressed protein catalytically dead. In addition, two glycines with 
overall noticeable sequence conservation in aligned GNAT domains were targeted 
assuming a structural relevance, with G
499
A as a single mutant and G
461
A/G
499
A as a 
double mutant (Figure 22C). The mutations were introduced into the full-length coding 
sequence of PfNAT using megaprimers followed by overlap extension PCR and 
subsequently cloned into the pARL1a+-mCherry vector under the PfCRT promotor. 3D7 
parasites were co-transfected with constructs encoding wild-type or mutated 
PfNAT
mCherry
 and STEVOR
1-80 
and positively selected using WR99210 and blasticidin S 
(BS). As a control to confirm the same localization of both fluorescent tags, if fused to 
the same gene, parasites were co-transfected with plasmids encoding PfNAT
GFP
 as well 
as PfNAT
mCherry
. After drug selection the parasite lines were analysed by confocal 
fluorescence microscopy as described above. As can be seen in Figure 23A the signals of 
PfNAT
mCherry
 and PfNAT
GFP
 colocalize within the same parasite. In contrast,  
STEVOR 
1-80 
shows the expected translocation into the RBC cytosol if co-expressed 
with the wild-type PfNAT
mCherry
, while the transferase is again retained in the ER 
compartment (Figure 23B).  
Despite different mutations in the putative catalytic domain or conserved sequence 
motifs of PfNAT co-expression with STEVOR
1-80 
did not alter the export phenotype of 
the PEXEL protein and no dominant-negative effect could be observed (Figure 23C). 
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Figure 23. Mutagenesis of the putative catalytic domain of PfNAT 
Confocal images of live P. falciparum-infected erythrocytes. Transfectant parasites at trophozoite stage 
expressing different fluorescent fusion proteins from episomal plasmids are shown. (A) Cotransfection of 
PfNAT
mCherry
 and PfNAT
GFP
 shows a spatial overlap of both fusion proteins occupying the same 
compartment. (B) Cotransfection of wild-type PfNAT
mCherry 
with STEVOR
1-80
 shows the residence of the 
putative transferase in the ER as well as the export of the soluble PEXEL protein into the RBC cytoplasm. 
(C) All transfectants bearing mutations in the putative catalytic domain (Y, RTN) or other conserved 
sequences (G, GG) of PfNAT
mCherry
 exhibit the normal export phenotype of co-expressed STEVOR
1-80
 
with no dominant-negative effect. wt, PfNAT wild type; Y, mutation of PfNAT Y
493
A; G, G
499
A; GG, 
G
461
A/G
499
A; RTN,  R
456
M, T
484
V and N
488
L. Left images, differential interference contrast (DIC); middle 
left images, GFP fluorescence; middle right images, mCherry fluorescence; right images, overlay of all 
channels. Scale bar: 2 µm. 
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 Knockout attempts on PfNAT 3.2.5
In the past gene disruptions in P. falciparum were mainly achieved by single crossover 
homologous recombination, more recent methods include the selection of double 
crossover integrants using a combination of positive and negative selection markers 
(Limenitakis & Soldati-Favre, 2011; Maier et al, 2006). Furthermore, the use of site-
specific recombinases such as the DiCre/loxP system for conditional gene deletion has 
recently been adapted to P. falciparum (Collins et al, 2013). 
Both methods were used in an attempt to delete the PfNAT gene in order to investigate 
its putative role in PEXEL-mediated protein export. 
3.2.5.1 Via double crossover recombination (pCC/pHTK vector system) 
Double crossover recombination is achieved by the replacement of the targeted gene via 
two flanking homologous segments with the cassette expressing the positive selection 
marker gene. In P. falciparum this event is greatly enhanced by negative selection 
against the plasmid backbone using plasmid encoded thymidine kinase (TK, pHTK 
vector) of the Herpes simplex virus or the bifunctional cytosine deaminase/uracil 
phosphoribosyl transferase (CDUP, pCC vector) from Saccharomyces cerevisiae. These 
proteins convert normally innocuous ganciclovir and 5-FC, respectively, into toxic 
metabolites that inhibit the de novo pyrimidine biosynthesis pathway and nucleic acid 
synthesis directly (Duraisingh et al, 2002; Maier et al, 2006; Ménard, 2013). Only 
parasites that remove the plasmid backbone with the negative selection marker cassettes 
by double crossover recombination survive the treatment with the compounds. Both 
vector systems were employed for the following experiments. Furthermore, pCC1 and 
pCC4 vectors harbouring the human DHFR gene (selection with WR99210) or 
blasticidin S deaminase gene from A. terreus (selection with BS) as positive selection 
markers were used. 
Two different sets of PfNAT homology regions flanking the positive selection cassettes 
were cloned into the pHTK, pCC1 and pCC4 vectors comprising either 0.5 kb of 5’ and 
3’ terminal gene fragments or 1 kb of flanking 5’ and 3’ untranslated regions (UTR) 
(Figure 24A). P. falciparum 3D7 parasites were transfected with these constructs and 
positively selected on WR99210 or BS. Unfortunately, no parasites transfected with 
plasmids containing the PfNAT flanking UTRs ever reappeared despite repeated 
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transfections. This might indicate either plasmid instability or a regulatory effect of these 
sequences on the positive selection cassettes as putative promotor/terminator regions. 
Consequently, the expression of hDHFR and BSD might be disturbed leading to 
sensitivity towards the compounds. Upon reappearance, the transfectants were either 
immediately exposed to different concentrations of the negative selection markers (4 
µM, 10 µM, 20 µM ganciclovir; 0.23 µM, 0.46 µM, 1 µM, 6µM 5-FC) or cycled off the 
positive selection marker for at least 3 weeks followed by reapplication to increase 
single crossover parasite populations prior to negative selection pressure. The 
concentrations tested for ganciclovir and 5-FC were based on personal communication 
with experienced collaborators, IC50 measurements obtained with the transfectants and 
observations in the parasite cultures concerning death and recovery rates. The 
recommendations included a dosage that would kill most of the parasites (~IC90) but 
prevent toxic ‘bystander’ effects on integrants as repeatedly reported (Maier et al, 2006). 
The parasite population that successfully undergoes double crossover recombination 
should reappear 5-17 days after drug-induced clearance (A. Maier, personal 
communication). In this study, a dosage of 0.23 µM and 0.46 µM 5-FC was insufficient 
to significantly reduce the parasite population, although these concentrations were 
recommended by our collaborators. Differences in culture conditions or parasite strains 
might explain these results. In contrast, 1 µM and 6 µM of 5-FC proved to be suitable 
concentrations with reproducible recovery periods of 6-21 days, depending on construct 
and cycle. Similarly, 4 µM of ganciclovir had nearly no effect on parasite growth, 
whereas 10 µM and 20 µM were sufficient to clear the parasites from the culture for 15-
21 days. Following negative selection and parasite recovery, gDNA was extracted from 
the cultures and subjected to PCR analysis. Primers were carefully chosen to control for 
sufficient quality of the gDNA, presence of episomal plasmid as well as 5’ or 3’ 
recombination of the plasmid into the locus of PfNAT. Furthermore, the same primers 
were used in different combinations to ensure their functionality and negative control 
templates such as parental gDNA of untransfected 3D7 parasites as well as the pure 
plasmid DNA were included (Figure 24B). The length of the PCR fragments 
representative of recombination was in the same range as the gDNA control in order to 
ensure that negative results could not be attributed to PCR-related amplification 
problems. If the quality of the control bands (plasmid, gDNA) was unsatisfactory, the 
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PCR was repeated under different conditions until a clear result was obtained. In 
summary, no parasite population with double crossover recombination was obtained 
with any construct despite the use of variable drug concentrations and cycling conditions 
(Table 3). This result was in accordance with a prior set of investigations using the pCC 
vector system carried out by my colleague Dr. C. Sanchez. 
 
Figure 24. Knockout strategy for PfNAT using the pCC/pHTK vector system and PCR analysis 
Disruption of the PF3D7_1437000 (PfNAT) gene in P. falciparum by double crossover recombination 
using the pHTK/pCC1/4 vector system with positive (WR, BS) and negative (5-FC, ganciclovir) selection. 
(A) Design of the knockout plasmids as exemplified for pHTK-PfNAT-InGene. Two sets of regions 
homologous to PfNAT were chosen to flank the positive selection marker cassette; either 0.5 kb of 
terminal gene fragments (blue) or 1 kb of adjacent UTRs (green). The start codon of the 5’ gene fragment 
was mutated to ATT to prevent successful transcription in case of single crossover events. Selection 
marker cassettes (black boxes) for positive selection encoded either hDHFR (pHTK/pCC1 vectors) or BS 
(pCC4 vector) and for negative selection either vTK (pHTK vector) or CDUP (pCC vectors). Primers 
used for PCR analysis are shown as black arrows (a-g). bla, ampicillin resistance gene; CAMpro and 
HSP86pro, promotors of the CAM and HSP86 genes; chrXIV, chromosome 14; HRP2ter and PbDTter, 
terminator regions of the HRP2 and PbDHFR-TS genes; hatched boxes, introns. (B) Representative PCR 
analysis of genomic DNA from cycled transfectants to determine recombination events. Control DNA 
from the parental strain 3D7 and the initial plasmids was included. Primers were chosen to detect the 
plasmidal 5’ (P5’, c+d, 0.7 kb) and 3’ homologous regions (P3’, e+f, 0.6 kb), genomic DNA (G, a+b, 1.8 
kb) as well as integration of the plasmid after recombination along the 5’ (I5’, a+d, 2.0 kb) as well as 3’ 
(I3’, e+g, 1.8 kb) fragments. M, DNA size ladder. 
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Since the accessibility of the PfNAT locus to genetic manipulation could be verified in 
aforementioned experiments (see chapter 3.2.3) and both vector systems (pCC, pHTK) 
have proven useful for gene knockouts in previous studies (Duraisingh et al, 2002; Maier 
et al, 2008) the inability to gain double crossover integrant parasites indicates a possible 
essentiality of the gene although it is not a definite proof. A gene knockout screen by 
Maier et al (2008) estimated that one fourth of the investigated PEXEL proteins are 
essential for intraerythrocytic parasite growth. Assuming a putative role of PfNAT in 
propagating correct export of PEXEL proteins the disruption of this gene could have 
drastic effects on parasite viability even under laboratory conditions. 
 
Table 3. Cycling of transfectants to acquire knockout of PfNAT via double crossover recombination 
Summary of different attempts to gain knockout parasites using the pHTK/pCC vector system. Only 
parasites with in-gene homologous regions emerged from the drug selection after transfection. Parasites 
were either directly (cycle no. 0) subjected to negative selection (5-FC or ganciclovir) or cultured in 
absence of the positive selection drug (WR, BS) for at least three weeks prior to reapplication of the first 
drug and subsequent negative selection drug (cycle no. 1). In order to reinforce loss of episomes, parasites 
were cycled for a second round off the positive selection drug (cycle no. 2). The reappearance periods 
after drug application varied from immediate (0 days) and medium (7-21 days) to no recovery at all (-). 
After negative selection, genomic DNA was collected from the parasites and analysed by PCR.  
construct
positive 
selection 
drug (+conc.)
cycle no.
duration 
OFF 1
st 
drug (days)
reappearance 
after 1
st
 drug 
exposure (days)
negative selection drug 
(+conc.)
reappearance 
after 2
nd
 drug 
exposure (days)
pCC1-PfNAT-InGene WR (5nM) 0  -  - 5-FC (1 µM) 9
0  -  - 5-FC (6 µM) 21
1 31 7 5-FC (1 µM) 7
1 31 7 5-FC (6 µM) 7
2 27 0 5-FC (1 µM) 7
2 27 0 5-FC (6 µM) 7
pCC4-PfNAT-InGene BS (9 mM) 0  -  - 5-FC (0.23 µM) 0
0  -  - 5-FC (0.46 µM) 0
1 31 11 5-FC (6 µM) 14
1 37 12 5-FC (6 µM) 9
pCC4-PfNAT-InGene BS (9 mM) 0  -  - 5-FC (1 µM) 6
(2
nd
 transfection) 0  -  - 5-FC (6 µM) 9
1 31 7 5-FC (1 µM) 14
1 31 7 5-FC (6 µM)  - 
2 27 0 5-FC (1 µM) 16
2 27 0 5-FC (6 µM) 16
pHTK-PfNAT-InGene WR (5nM) 0  -  - ganciclovir (4 µM) 0
1 31 13 ganciclovir (10 µM) 21
1 31 13 ganciclovir (20 µM) 15
2 27 7 ganciclovir (10 µM) 10
2 27 7 ganciclovir (20 µM) 16
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3.2.5.2 Via conditional excision (DiCre/loxP system) 
As an alternative approach to dissect the function of the candidate N-acetyltransferase a 
conditional gene knockout based on the DiCre/loxP recombinase system was attempted 
(Andenmatten et al, 2013; Jullien et al, 2003). The DiCre recombinase recognizes 34 bp 
short loxP sites that flank a sequence of interest and mediates site-specific excision or 
inversion of the intervening part depending on the relative orientation of the loxP motifs . 
The regulation of recombinase activity is achieved by its expression in two separate, 
enzymatically inactive polypeptides, each fused to the FK506-binding protein 12 
(FKBP12) or FKBP12-rapamycin binding protein (FRB). The addition of rapamycin 
induces heterodimerization of the two components, which restores recombinase activity. 
The system has successfully been employed in Toxoplasma gondii but only recently 
been adapted to P. falciparum with a good excision efficiency (close to 100%) within the 
time span of a single intraerythrocytic growth cycle (Andenmatten et al, 2013; Collins et 
al, 2013). For this part of the study, the gene fragment encoding the C-terminal part of 
PfNAT including the putative acetyltransferase domain was chosen to be flanked by 
loxP sites (‘floxed’) with the aim to gain enzymatically inactive enzyme upon successful 
conditional excision. This sequence of PfNAT (~890 bp of 3’ end w/o stop codon) was 
synthesized (by GENEART) including intron removal and codon optimization in order 
to ensure that single homologous recombination occurs in front of the 5’ flanking loxP 
site and not within the sequence fragment encoding the NAT domain (Figure 25A). This 
artificial sequence was cloned with a separating loxP site downstream to a gene fragment 
(~1 kb) of PfNAT that served as homology region. The resulting insert was exchanged 
with the SERA5 fragment of the pHH1-SERA5del3-preDiCre vector (kindly provided 
by M. Blackman), which has previously been used for this system (Collins et al, 2013).  
Although the newly introduced loxP site was inserted into a coding region of the PfNAT 
gene, it was intentionally placed within a putatively unstructured part of the translated 
protein to cause minimum interference with protein function. The vector backbone 
already contained two loxP sites in the terminator region (PbDT 3’UTR) and the hDHFR 
cassette promotor region (CAM 5’UTR). Although the final construct had 3 instead of 2 
loxP sites in the same orientation the excision by the recombinase was supposed to 
include the complete ‘floxed’ part (M. Blackman, personal communication). The 
plasmid was transfected into the 3D7-based 1G5-DiCre clonal strain (kindly provided by 
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M. Blackman) that constitutively expresses the two inactive recombinase subunits after 
integration into the SERA5 locus (Collins et al, 2013). The parasites were positively 
selected using WR99210 and subjected to different cycling periods off the drug ranging 
from 3.5-7 weeks after which drug pressure was reapplied. Furthermore, parasites were 
cycled a second and third time (3 weeks no drug) to ensure loss of episomes. In order to 
check for recombination events gDNA was extracted and subjected to PCR with the 
aforementioned considerations (see chapter 3.2.5.1). In addition primers were used to 
detect the DiCre cassette in the parasites (Figure 25B). 
 
Figure 25. Knockout strategy for PfNAT using the DiCre recombinase system and PCR analysis 
Conditional partial excision of the PF3D7_1437000 (PfNAT) gene in P. falciparum after single crossover 
recombination using the DiCre/loxP recombinase system and rapamycin was attempted. (A) Design of the 
knockout plasmid as exemplified for pHH1-PfNAT-Cterm-loxP. In this construct, the gene fragment 
encoding the C-terminal part of the transferase including the NAT domain was codon-optimized (3’ 
synth) and flanked by loxP sites (black arrows) for excision. A region homologous to PfNAT ( 1 kb, HR) 
was cloned 5’ to this sequence, a triple HA tag as well as the PbDHFR-TS 3’UTR as a terminator region 
are inserted downstream. The positive selection marker cassette (black box) is shown as well as the 
primers used for PCR analysis (a-e). The expression cassette for the DiCre recombinase subunits is stably 
inserted into the genome of the parental 1G5 strain (Collins et al, 2013). bla, ampicillin resistance gene; 
CAMpro promotor of the CAM gene; HRP2ter and PbDTter, terminator regions of the HRP2 and PbDHFR-
TS genes; hatched boxes, introns. (B) Representative PCR analysis of genomic DNA from cycled 
transfectants to determine recombination events. Control templates from the parental strain 1G5 and the 
initial plasmid were included. Primers were chosen to detect the plasmid (P, c+e, 1.5 kb), genomic DNA 
(G, a+b, 0.6 kb) as well as integration of the plasmid after recombination (I.1, a+e, 1.8 kb and I.2, a+d, 1.4 
kb). In addition the presence of the DiCre cassette within the parental 1G5 strain was confirmed by 
specific primers (D, 0.7 kb).  
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Despite different cycling conditions and PCR-confirmed presence of episomal plasmid 
within the transfectants no single crossover integration into the locus of PfNAT could be 
detected in any of the cultures (Table 4). One possible explanation could be that the 
translated loxP, though very short (11 aa), interferes with protein structure or motifs in a 
negative manner thereby reducing PfNAT function. In order to circumvent this problem, 
a second set of vectors was constructed that contained larger resynthesized sequence 
parts of PfNAT with loxP sites in the first intron (PfNAT-1
st
Intr) or even 50 bp into the 
5’ UTR (PfNAT-fullsynth). Furthermore, the redundant third loxP site was removed 
from these vectors (øloxP). Although the successful expression and correct localization 
of codon-optimized full-length PfNAT
synth
 could be confirmed in the context of episomal 
expression of a GFP-tagged fusion protein (Figure 26), no single crossover 
recombination occurred so far with these transfectants (ongoing experiments).  
 
 
Table 4. Cycling of transfectants to acquire knockout of PfNAT via DiCre-mediated excision 
Summary of different attempts to gain knockout parasites using the DiCre/loxP recombinase system. 
Parasites of the 1G5 strain (kindly provided by M. Blackman) were transfected with single crossover 
integration constructs containing loxP-flanked codon-optimized sequences of PfNAT. Transfectants were 
cultured in absence of the positive selection drug (WR, BS) for at least three weeks prior to reapplication. 
The cycles were repeated to reinforce loss of episomes and accumulate potential integrants. After 
recovery of the parasites (0-16 days), genomic DNA was collected and analysed by PCR.  
 
construct
positive selection 
drug (+conc.)
cycle no.
duration OFF 
1
st
 drug (days)
reappearance after 1
st 
drug exposure (days)
pHH1-PfNAT-Cterm-loxP WR (5nM) 1 26 0
1 33 8
1 48 16
2 26 0
3 25 0
3 41 0
pHH1-PfNAT-1
st
Intr-PbDTøloxP WR (5nM) 1 26 3
2 26 0
pHH1-PfNAT-1
st
Intr-CAMøloxP WR (5nM) 1 26 3
2 26 4
pHH1-PfNAT-fullsynth-PbDTøloxP WR (5nM) 1 23 3
2 26 0
pHH1-PfNAT-fullsynth-CAMøloxP WR (5nM) 1 21 3
2 26 4
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Figure 26. Localization of PfNAT
synth 
Confocal images of live P. falciparum-infected erythrocytes. Transfectant parasites at trophozoite stage 
expressing codon-optimized full-length PfNAT
synth
 from episomal plasmids are shown. In accordance with 
previous constructs the putative transferase localizes to a perinuclear compartment that is indicative of the 
ER. Left image, differential interference contrast (DIC); middle image, GFP fluorescence; right image, 
overlay of all channels. Scale bar: 2 µm. 
 Knockdown attempts on PfNAT using the DD system 3.2.6
The inducible regulation of proteins can provide valuable insights into their function 
during cell development, especially if a knockout of the respective gene is unavailable. 
In recent years, the destabilization domain (DD) system was successfully used for this 
purpose in different cell systems and some studies have confirmed its applicability in the 
malaria parasite P. falciparum (Armstrong & Goldberg, 2007; Banaszynski et al, 2006; 
Chu et al, 2008; de Azevedo et al, 2012). The method is based on the fusion of the DD 
tag, which consists of a mutant form of the human FK506-binding protein 12 (FKBP), to 
a protein of interest. Upon expression, the fusion protein is unstable and targeted to 
proteasomal degradation unless stabilized by the small synthetic cell-permeable ligand 
Shield-1 (commercial name: D/D-solubilizer, Clontech) that binds to the DD tag. This 
drastic change in protein quantity by removal or addition of the ligand therefore enables 
the functional analysis of the protein of interest.  
In order to explore the role of PfNAT despite the occurring inability to knock out the 
gene, a functional knock down on protein level was attempted using the DD system. For 
this purpose the 330 bp gene encoding a variant DD domain, DD24 (kindly provided by 
M. de Azevedo), was cloned C-terminally with an additional HA tag into the pARL-
PfNAT-3’-GFP vector previously used for single crossover recombination (see chapter 
3.2.3) and transfected into P. falciparum 3D7 parasites. After positive selection with 
WR99210 the transfectants were constantly grown in the presence of the stabilizing 
ligand (200 nM D/D solubilizer, Clontech) and cycled 3-4 weeks off WR99210 followed 
by 1 week under drug pressure. After a few days of recovery gDNA was isolated and 
analysed by PCR. Suitable primer pairs were chosen to control for quality of the gDNA, 
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presence of episomal plasmid as well as recombination of the plasmid into the locus of 
PfNAT. Furthermore, negative control templates were used including parental gDNA of 
untransfected 3D7 parasites as well as the pure plasmid DNA. Indeed, single crossover 
homologous recombination into the endogenous locus appeared after the first cycle and 
clonal populations were obtained by limiting dilution (Figure 27A). 
 
Figure 27. Localization of PfNAT
GFPDD24
 during intraerythrocytic parasite development  
Establishment of clonal parasites that express PfNAT
GFPDD24
 under the endogenous promotor after 
homologous recombination (A) Representative PCR analysis of genomic DNA from cycled transfectants 
(clone D8) to determine recombination events. Control templates from the parental strain 3D7 and the 
initial plasmid were included. Primers were chosen to detect genomic DNA (G, 1.7 kb), the plasmid (P, 
1.9 kb), as well as integration of the plasmid after recombination (I.1, 2.5 kb and I.2, 1.7 kb). Unspecific 
bands repeatedly appeared in the plasmid control and to a minor extent in the integrants. (B) Confocal 
overview image of purified live P. falciparum-infected RBCs shows fluorescence of PfNAT
GFPDD24
 in 
every parasite. Overlay of GFP fluorescence and DIC image. (C) Confocal image of a single parasite at 
the trophozoite stage shows the ER localization of PfNAT
GFPDD24
 as previously observed for episomal as 
well as single crossover PfNAT
GFP
. (D) Microscopic observation of PfNAT
GFPDD24
 fluorescence 
throughout the intraerythrocytic cycle. Protein expression is present in ring stages and continues through 
trophozoite (I: early, II: mature) and schizont development until the formation of daughter merozoites. 
Left images, differential interference contrast (DIC); middle images, GFP fluorescence and nuclear 
staining with Hoechst (D); right images, overlay of all channels. Scale bar: 2 µm. 
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The microscopic analysis of one clonal line (clone D8) revealed the same intraparasitic 
perinuclear localisation of PfNAT
GFPDD24 
as in the previous experiments thereby 
confirming the proper expression and targeting of the DD-tagged fusion protein to the 
ER (Figure 27B, C). Due to the clonal character all parasites were fluorescent, which 
greatly improved the detection. As can be seen in Figure 27D, the protein is already 
expressed in ring stages early during intraerythrocytic development and fluorescence 
continues until the formation of daughter merozoites. After schizont rupture the released 
merozoites also still show a weak fluorescent pattern indicating a fragmentation of the 
ER and distribution of parental or synthesis of new protein.  
3.2.6.1 Microscopic quantification of PfNATGFPDD24 regulation 
Having established a clonal line of parasites expressing PfNAT
GFPDD24 
the next step 
assessed the regulation of the protein by the DD system using microscopic analysis on 
single cell level. As previously published, the effects of removal/addition of the ligand 
on protein de-/stabilization are quite rapid with measurable differences observed already 
6 hours later, though peaks are reached around 20 hours later (Armstrong & Goldberg, 
2007).  
For this part of the study a comparison at 24 hours after ligand removal was considered a 
good time point to ensure significant differences in protein levels. This can be clearly 
seen in Figure 28A by the uniform reduction in fluorescence intensity of PfNAT
GFPDD24
 
in parasites cultured without the ligand for this time period. In addition, a western blot 
analysis of parasite lysates at this time point confirmed a reduced amount of fusion 
protein in the sample without ligand compared to the treated ones, whereas the loading 
control using antibodies directed against human Band III protein revealed equal amounts 
of sample (Figure 28B). This finding supports the assumption that a reduction in 
fluorescence intensity can be attributed to a decrease in the amount of fluorescent 
protein. 
For the single cell quantification PfNAT
GFPDD24
 parasites were split into one sample with 
maintained ligand exposure (200nM D/D solubilizer, Clontech) and one without ligand 
in the medium. In order to exclude any unspecific results related to the ligand itself the 
same procedure was repeated for the PfNAT
GFP
 clonal parasites. After 24 hours all 
samples were purified on the MACS column and analysed under the confocal 
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microscope using the same settings for each (Figure 28C). Special attention was given to 
optimize pinhole and gain settings in order to prevent saturation of the maximum 
fluorescence intensity signals. The focal plains were carefully chosen based on the 
brightest representation in the histograms and every four images a new overview field 
was taken to reduce fluorescence decrease due to photobleaching. For quantification, the 
mean pixel intensities in the fluorescence channel of 20 RBCs infected with trophozoite-
stage parasites were measured in unprocessed images using the FIJI program. In each 
picture the mean pixel intensities of uninfected RBC were determined and deducted from 
the respective iRBC values. Finally, the decrease in fluorescence intensity was plotted as 
percentage compared to PfNAT
GFP 
+ligand (Figure 28D). The ligand itself did not 
exhibit any significant effects on the fluorescence intensity of PfNAT
GFP
 apart from a 
slight decrease in untreated parasites (9%). However, the addition of the HADD24 tag to 
this protein resulted in a striking reduction in fluorescence intensity in the range of 30%. 
This phenomenon has previously been documented to a minor extent for soluble DD24 
tagged reporter proteins (GFP and luciferase) and might be caused by imperfect 
stabilization of the fusion protein in the presence of the ligand or increased degradation 
due to the DD tag itself (de Azevedo et al, 2012). The removal of the ligand for 24 hours 
resulted in a further reduction in fluorescence by about 50% compared to the treated 
parasites (to 35% of treated PfNAT
GFP
 strain). In addition PfNAT
GFPDD24 
parasites that 
were continuously grown without the stabilizing ligand were investigated and a similar 
result was obtained (to 38% of treated PfNAT
GFP
 strain). It is worth mentioning that 
these parasites did not show any obvious defect in growth, which might be due to an 
insufficient downregulation of PfNAT or target effects that are characterized by other 
determinants such as cytoadhesion for example. 
Taken together, these data represent a first indication that the DD system is potentially 
useful to target an ER-resident transmembrane protein for proteasomal degradation.  
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Figure 28. Microscopic quantification of ligand-based regulation of PfNAT
GFPDD24
 
Analysis of downregulation of PfNAT
GFPDD24
 on protein level upon ligand removal. (A) Confocal 
overview image of clonal parasite line that was continuously cultured with ligand (+, 200 nM D/D 
solubilizer) or for 24 hours in absence of ligand (-). For comparative reasons image acquisition was 
strictly under the same conditions and settings. The reduction in fluorescence is clearly vis ible. Left 
images, differential interference contrast (DIC); middle images, GFP fluorescence; right images, overlay 
of all channels. Scale bar: 20 µm. (B) Western blot analysis of parasites depicted in (A). Membrane 
fractions of equal samples (treated, non-treated) were obtained by hypotonic lysis, the pellets were 
resuspended in equal amounts of loading buffer and subjected to SDS-PAGE and Western blot detection 
using α-GFP antibodies. The expected size of PfNATGFPDD24 is 107 kDa, however PfNATGFP also runs 
slightly higher. As a loading control, the membranes were probed with α-human Band III antibodies. (C) 
Confocal images of single PfNAT
GFPDD24 
expressing parasites that were continuously cultured with ligand 
(+, 200 nM D/D solubilizer) or for 24 hours in absence of ligand (-). Image settings were optimized to 
prevent saturation and strictly kept unchanged for all data acquisitions. These kinds of images were the 
basis for the single cell microscopic quantification as summarized in (D). Left images, differential 
interference contrast (DIC); middle images, GFP fluorescence; right images, overlay of all channels. Scale 
bar: 2 µm.  (D) Histogram representing the relative difference in fluorescence intensities of PfNAT
GFP
 
(─DD tag) and PfNAT
GFPDD24
 (+ DD tag) expressing single parasites treated with or without ligand. The 
bars represent relative mean pixel intensities of 20 imaged parasitized RBCs with a background deduction 
of uninfected RBCs. PfNAT
GFP
 parasites under ligand exposure were set to 100% as a reference point. 
Error bars represent the relative standard error of the mean (rSEM). A ~50% reduction in fluorescence of 
PfNAT
GFPDD24
 upon ligand removal is clearly visible.  
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3.2.6.2 Flow cytometric analysis of PfNATGFPDD24 regulation 
To further characterize the regulation potential of the DD system the sensitivity of single 
cell microscopy was complemented by the statistical advantages of fluorescence-based 
flow cytometry, which facilitates the acquisition of data from thousands of cells. A time 
course was conducted over 48 hours with PfNAT
GFPDD24 
parasites that were tightly 
synchronized prior to ligand removal. Cultures of ring-stage parasites of a high 
parasitaemia (~5%) were divided into ligand-treated (200 nM D/D-solubilizer) and 
untreated samples. Every 12 hours a small volume was removed, medium was 
exchanged and fresh drug added to the treated culture. The samples were either directly 
used for FACS analysis or washed and incubated for 10 min at 37°C with ethidium 
bromide (EtBr, 1 µg/ml final) to determine developmental stages. Fluorescence signals 
of PfNAT
GFPDD24
 samples plus and minus ligand was collected in the GFP channel (FL1-
H) of the FACScalibur, whereas EtBr staining was collected in the respective channel 
(FL2-H). 50 000 cells were counted per measurements and plotted as an overlay of 
treated (green line) and untreated (grey line) samples (Figure 29A). A region of interest 
excluding background fluorescence was determined (M2) and information such as the 
geometric mean and gated events was collected for this selected area. The comparison of 
the geometric means of the two samples at one time point was regarded as representing 
the shift in mean GFP fluorescence intensity and therefore as the determinant for 
downregulation of PfNAT
GFPDD24
 upon ligand removal. The plots in Figure 29A are 
representative examples from one of two independent time-course experiments. The 
histograms in Figure 29C and D depict the geometric mean (in %) of untreated parasites 
compared to ligand-treated parasites (= 100% reference) at 12 hour-intervals for GFP 
and EtBr summarized for both time-courses. At the 24-hour and 36-hour time points a 
clear difference in the GFP fluorescence can be observed in the treated culture with a 
larger proportion of parasites in M2 exhibiting around 30% brighter fluorescence 
intensity (shift in geometric mean). The staining with EtBr reveals that these parasites 
are in the trophozoite to schizont stages where the fluorescence signal is strongest, 
whereas the low signal during other time-points is not properly resolvable. An important 
aspect of this experiment was to assess if the untreated parasites have an immediate 
growth defect or developmental delay, since the effect of ligand-removal on protein 
quantity was reported to occur as early as 6 hours (Armstrong & Goldberg, 2007).  
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Figure 29. Flow cytometric analysis of ligand-based regulation of PFNAT
GFPDD24 
Investigation of reduction in PfNAT
GFPDD24
 fluorescence intensity upon ligand removal during a 48-hour 
time course.  Synchronous parasites were divided into ligand-treated (200nM) and untreated cultures at 
time point 0. Every 12 hours samples were removed and directly analysed with the flow cytometer or 
stained with EtBr for stage determination. 50 000 cells were counted per measurement. (A) Fluorescence 
curves depicting intensities of GFP fluorescence (left) and EtBr fluorescence (right) of ligand-treated 
(green line) and untreated (black line) parasites at indicated time points. A difference in GFP fluorescence 
is obvious at 24- and 36-hour time points, where the parasite reach trophozoite and schizont stages. (B) 
Purification of a 24-hour sample to 90% parasitaemia reveals a distinct difference in GFP fluorescence of 
treated (blue line) versus untreated (black line) parasites, whereas the developmental stages are 
comparable (EtBr curves). (C) Histogram representing the relative difference of GFP fluorescence in 
terms of geometric mean at each time point of untreated samples compared to ligand-treated ones. A 
reduction of 30% is indicated at the 24- and 36-hour time points. (D) Histogram representing the relative 
difference of EtBr fluorescence in terms of geometric mean at each time point of untreated samples 
compared to ligand-treated ones. No significant differences are observed. (C) and (D) summarize data of 
two independent time course experiments. Error bars represent the standard error of mean (SEM). (E) 
Histogram representing a 50% reduction in GFP fluorescence intensity (based on shift in geometric mean) 
of the untreated sample of (B), which was purified after 24 hours.  
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As shown in Figure 29D, there was no obvious shift in geometric mean of EtBr 
fluorescence intensity corresponding to a visual overlap of untreated and treated samples 
during 48 hours. This result was also obtained with the parental strain 3D7 (data not 
shown). This indicates that neither the removal of the ligand in PfNAT
GFPDD24 
parasites 
nor the ligand itself (at 200 nM concentration) has any negative effects on growth within 
one cycle. To further characterize the extent of downregulation of PfNAT
 GFPDD24
 the 
flow cytometric analysis was repeated with parasites that were purified 24 hours after 
ligand removal to more than 90% parasitaemia (Figure 29B). The peaks of GFP 
fluorescence are much more defined than in the previous time course and clearly show a 
shift towards higher fluorescence intensity in treated samples as represented in the 
histogram by a 50% higher geometric mean (Figure 29E). This result is not due to a 
difference in developmental stage of the two samples as shown by the clear overlay of 
the EtBr graphs, which indicate a mixed population of trophozoites and schizonts in both 
cultures. Taken together, these findings provide the proof of principal that the DD 
system can be successfully applied to a transmembrane protein of P. falciparum with a 
downregulation of around 50%.  
The effect of the ligand on the viability of parental 3D7 as well as PfNAT
GFPDD24
 clonal 
parasites was investigated over a period of 4 days to determine any possible unspecific 
growth reduction or a specific developmental delay due to downregulation of the 
transferase in PfNAT
GFPDD24
 parasites (Figure 30). Initial cultures of 0.5% parasitaemia 
were supplied with fresh medium (± 200 nM ligand) every day and diluted if they 
reached 4%. Parasitaemias of each culture were determined 2-3 times a day on Giemsa-
stained thin blood smears (min. 1000 cells/slide) and the determination was repeated in 
an independent experiment with similar results. As shown in Figure 30A, the growth of 
PFNAT
GFPDD24
 parasites was comparable between treated and untreated cultures. 
Although the parasites showed a slight developmental delay under ligand treatment 
(after 48 and 72 hours) they reached the parasitaemia of the untreated culture and no 
clear separation of the curves could be observed. This finding suggests that the 
downregulation of PFNAT
GFPDD24
 by approximately 50% in absence of the ligand does 
not entail any significant growth defects. Furthermore, 3D7 parasites showed the same 
multiplication rate independent of ligand addition thereby excluding any unspecific 
effects of the compound at this concentration (Figure 30B). However, it needs to be 
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mentioned that previous studies indeed report a slight delay in development of parasites 
treated with ligand at a higher concentration (500nM) with 11% and 25% lower 
parasitaemia than the untreated controls after the first and second reinvasion cycle, 
respectively (de Azevedo et al, 2012). At higher concentrations the difference is even 
more prominent and toxic effects increase, which is the reason why this study used only 
200 nM of D/D-solubilizer.  
  
Figure 30. Effects of stabilizing ligand on parasite growth 
Growth curves of PfNAT
GFPDD24
 clonal parasites as well as parental 3D7 parasites to determine possible 
effects of the ligand on parasite viability. Parasites of ~0.5% parasitaemia were cultured in presence or 
absence of D/D solubilizer (200nM) over the period of 4 days. Medium was exchanged daily and 
parasitaemia was monitored regularly by counting of Giemsa-stained thin blood smears (~1000 
cells/slide). After 63 hours, the culture was diluted to one fifth (asterisk) to prevent overgrowth. Data of 
one determination are shown as representative examples, with comparable results in a second independent 
experiment, both carried out by S. Prior. (A) Clonal PfNAT
GFPDD24
 parasites did not exhibit an obvious 
difference in growth between ligand-treated and untreated cultures. Slight deviations in the curves after 48 
hours and between 71-95 hours are very likely within the range of natural developmental variations. (B) 
Untransfected 3D7 parental parasites did not show any influence of the ligand on parasite development 
within the observed time frame. 
3.2.6.3 Cotransfection with STEVORmCherry 
Previous studies using fluorescence-based data reported a 75% reduction of soluble 
luciferase
GFPDD24
 in ligand-free samples of stably transfected parasites compared to 
treated controls (ligand concentration: 500 nM) (de Azevedo et al, 2012). It is still 
unclear to what extent the DD system is applicable for regulation of transmembrane 
proteins with co-translational insertion in the ER that might facilitate escape from 
proteasome degradation in the absence of the ligand. To my knowledge, only falcipain-2 
has been tagged with a destabilization domain in P. falciparum and there is no 
quantitative information given on the extent of downregulation of this transmembrane 
protein (Armstrong & Goldberg, 2007). Having established that the amount of putative 
acetyltransferase central to this study (PfNAT) can be reduced by half using the DD 
system the question of its functional relevance was addressed. Although 50% are not 
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sufficient for a conditional knock down of the protein it was worth to explore if an 
intermediate negative effect on protein export could be observed upon destabilization of 
PfNAT
GFPDD24
. For this purpose an episomal construct encoding STEVOR
1-80 
tagged to 
mCherry (STEVOR
mCherry
) was generated and transfected into PfNAT
GFPDD24
 clonal 
parasites. After positive selection using blasticidin S the parasites were divided into 
ligand-treated (200 nM) and untreated samples and the export phenotype of 
STEVOR
mCherry
 was examined several days later under the confocal microscope. Despite 
an obvious reduction in GFP fluorescence intensity corresponding to reduced levels of 
PfNAT
GFPDD24 
in untreated parasites, no difference in export of STEVOR
mCherry
 could be 
observed (e.g. partial retention in the ER or PV) and the protein was properly 
translocated into the RBC cytosol (Figure 31). In order to assess in detail, whether the 
amount of exported PEXEL protein was different in both cultures, a quantification of 
STEVOR
mCherry 
in the different compartments would have been interesting. However, 
this approach was unsuitable due to the episomal character of the constructs that leads to 
uneven protein expression due to plasmid concatomers. Although this particular 
experiment could not confirm any functional link between the downregulation of PfNAT 
and export of a PEXEL protein, the manipulation of the transferase by the DD system 
allows future investigations to target a wider range of possible effects (see chapter 4.2 
for details).  
 
Figure 31. Export of STEVOR
mCherry
 in PfNAT
GFPDD24
 parasites 
Confocal images of live P. falciparum-infected erythrocytes. Transfectant parasites at trophozoite stage 
expressing endogenously tagged PfNAT
GFPDD24
 as well as episomally encoded STEVOR
mCherry
. The 
parasites were continuously cultured in presence (+) or absence (-) of ligand (200 nM D/D solubilizer). 
The export of STEVOR
mCherry
 appears identical in both samples. Left images, differential interference 
contrast (DIC); middle left images, GFP fluorescence; middle right images, mCherry fluorescence; right 
images, overlay of all channels. Scale bar: 2 µm. 
  
RESULTS 
115 
3.2.6.4 Pulse-chase analysis of protein export in PfNATGFPDD24 parasites 
Pulse-chase analysis using incorporation of low-energy radioisotopes such as 
[
35
S]methionine into the proteome is often used to follow the process of protein 
trafficking (Alberts, 2008; Ansorge et al, 1996; Bullen et al, 2012). In order to assess the 
impact of downregulation of the putative transferase on protein export into iRBCs, a 
pulse-chase experiment was conducted by Dr. C. Sanchez using the clonal parasite line 
established in this study (PfNAT
GFPDD24
) as well as control parental 3D7 P. falciparum 
parasites. It was assumed that reduced levels of PfNAT might alter the overall 
acetylation state of PEXEL proteins leading to impaired export of these into the host 
cell. For complementary reasons the results of this investigation will be presented here 
despite my pregnancy-associated forced absence due to the prohibited handling of 
radioisotopes. In order to assure sufficient reduction of PfNAT prior to the metabolic 
labelling of newly synthesized proteins with [
35
S]methionine (‘pulse’), parasites were 
cultured in absence of the stabilizing ligand (D/D solubilizer, 200 nM) for 24 hours. For 
comparison a second sample was continuously supplied with the compound. 
Furthermore, a potential unspecific effect of the ligand on protein export was assessed 
by preparing parental 3D7 parasites in parallel. Prior to the pulse, synchronized parasites 
of young trophozoite stage were purified under sterile conditions using the magnetic 
MACS column, washed and then labelled with [
35
S]methionine in methionine-free 
medium for 1 hour at 37°C. After subsequent washing steps, the infected erythrocytes 
were returned to the incubator in complete medium supplemented with non-labelled 
methionine (‘chase’) and samples were taken at various time points (0, 1, 3, 5 hours). 
The cytosolic content of the iRBCs was released by mild hypotonic lysis and separated 
from the parasite pellets. Proteins were precipitated using trichloroacetic acid (TCA), 
immobilized on filter papers and washed with TCA and ethanol followed by liquid 
scintillation counting. The percentages of radiolabelled protein in the supernatants, 
corresponding to the fraction that was exported from the parasites into RBCs, are 
depicted in Figure 32. In summary, PfNAT
GFPDD24
 parasites showed a higher 
accumulation of radiolabelled proteins in this fraction when the putative transferase was 
stabilized by continuous ligand treatment compared to untreated samples (Figure 32A). 
This difference was most prominent at the 1-hour time point with a marked increase in 
ligand-treated samples (21% vs. 9% in untreated). It was previously shown with a 
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conditional protein aggregation system that a period of 1-2 hours is sufficient for 
trafficking of a PEXEL protein from the parasite to the PV and beyond (Saridaki et al, 
2008). Consequently, this increase most likely represents the pool of radiolabelled 
proteins that got exported and lower levels in the untreated samples indicate an 
impairment of this process in the background of reduced levels of PfNAT. The slight 
decrease in radiolabel observed over time might be caused by decay of labelled proteins 
(functional 20S proteasome subunits were identified in erythrocytes) or, more likely, by 
concomitant re-uptake of RBC cytosolic content into parasites upon haemoglobin 
digestion (Neelam et al, 2011). In contrast to the difference observed in PfNAT
GFPDD24
 
parasites,  both curves of the control parental 3D7 parasites showed the same pattern 
excluding any unspecific effects of the ligand on protein export (Figure 32B). 
 
 
Figure 32. Pulse-chase analysis of protein export in regulated PfNAT
GFPDD24
 clonal line 
Data kindly provided by Dr. C. Sanchez. Analysis of [
35
S]methionine-labelled proteins exported from P. 
falciparum parasites in dependence of ligand-based downregulation of PfNAT
GFPDD24
. Parasites were 
cultured in absence of the ligand (D/D solubilizer, 200 nM) for 24 hours or, alternatively, in continuous 
supply. The labelling period with [
35S]methionine (‘pulse’) was 1 hour followed by incubation in 
complete culture medium (‘chase’) and sample removal at 0, 1, 3 and 5 hours after removal of the external 
radioisotope. Protein samples were subjected to mild hypotonic lysis and divided into parasite and 
supernatant fraction. Incorporation of radioactive label was measured by liquid scintillation counting and 
is shown here for the supernatant corresponding to the content of the RBC cytosol. (A) PfNAT
GPFDD24 
clonal parasites cultured with (+) or without (-) ligand. A difference between both samples can be 
observed suggesting reduced protein export under destabilizing conditions of PfNAT. (B) Parental 3D7 
parasites were used as a control to exclude unspecific effects of the ligand itself on protein export. Error 
bars are SEM. 
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4 Discussion 
 Mutagenesis of the PEXEL motif of STEVOR and KAHRP  4.1
During its intraerythrocytic development, P. falciparum establishes a complex 
trafficking system to export proteins involved in nutrient acquisition, cytoadherence and 
immunoevasion into the red blood cell (Elsworth et al, 2014). These parasite-induced 
alterations largely contribute to the pathogenesis of the disease and have initiated intense 
research to uncover common principles that might be suitable targets for 
pharmacological interventions. The discovery of the pentameric PEXEL motif 
(RxLxE/Q/D) allowed the prediction of several hundreds of putatively exported parasite 
proteins (Hiller et al, 2004; Horrocks & Muhia, 2005; Marti et al, 2004). Cleavage of 
this export motif by Plasmepsin V inside the endoplasmic reticulum (ER), acetylation of 
the newly formed N-terminus as well as the identification of a putative ATP-powered 
translocon in the parasitophorous vacuolar membrane (PVM) for entry of PEXEL 
proteins into the host cell represent important findings to further understand this 
complex process (Bullen et al, 2012; Chang et al, 2008; de Koning-Ward et al, 2009; 
Riglar et al, 2013; Russo et al, 2010). However, the exact role of the PEXEL motif 
within each step of the export pathway, its sequence limitations and the relevance of 
acetylation after processing has not been entirely elucidated (Boddey & Cowman, 2013).  
The aim of this study was to identify amino acids within the PEXEL motif that might be 
functionally important in guiding proper export of these proteins into the host cell.  While 
previous studies focussed on various deletions or alanine exchanges of the conserved 
amino acids at positions P3
6
 (R), P1 (L) and P2’ (E/Q/D), essential information 
concerning the potential variability of amino acids at each position in relation to the 
export phenotype and processing of the motif is still missing (Boddey et al, 2010; 
Boddey et al, 2009; Hiller et al, 2004; Marti et al, 2004).  
In order to expand the available data set, an extensive mutagenesis screen was conducted 
over the PEXEL motif (
48
RLLAQ
52
) of a member of the STEVOR protein family. The 
amino acid of each position (apart from R
48
, which was extensively studied by Dr. P. 
Henrich (2008)) was exchanged by site-directed mutagenesis with amino acids of 
                                                 
6
 By convention, amino acid residues in a substrate undergoing cleavage are designated P1, P2, P3 etc. in 
the N-terminal direction from the cleaved bond (P1-P1’). Likewise, the residues in C-terminal direction 
are designated P1', P2', P3' (Schechter & Berger, 1967).  
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variable biochemical properties to assess the influence of size, charge or hydrophobicity. 
For simplification, a short GFP-tagged version of STEVOR that comprises the PEXEL 
motif and an adequate linker region (STEVOR
1-80
), was used. While the full-length 
STEVOR protein is usually inserted via transmembrane domains into parasite-derived 
Maurer’s clefts that are tethered to the host cell plasma membrane, STEVOR1-80 
translocates as a soluble protein into the red blood cell cytoplasm as previously 
described (Przyborski et al, 2005). After successful transfection of P. falciparum 
parasites with various constructs the export phenotypes of the chimeric GFP-tagged 
proteins were analysed by confocal laser scanning microscopy. In an attempt to find a 
correlation between processing of the PEXEL motif and protein export some 
representative mutants were furthermore chosen for mass spectrometric analysis to 
determine their N-terminal cleavage and acetylation state. 
The mutagenesis of the P3 position (R
48
) resulted in complete retention of all mutant 
proteins within the parasite ER (data from P. Henrich (2008) apart from R
48
K). This result 
is in agreement with former studies on KAHRP and GBP130 and was attributed to a defect 
in cleavage by Plasmepsin V (Boddey et al, 2010; Boddey et al, 2009). Mass spectrometric 
analysis on R
48
A indeed identified uncleaved protein N-termini. Interestingly, lysine was 
repeatedly proposed to functionally substitute for arginine at this position (Boddey et al, 
2009; Hiller et al, 2004; Marti et al, 2004), an assumption that is in contradiction to the 
results of this screen as well as recently published data (Boddey et al, 2013). A detailed 
structural model of Plasmepsin V, which is based on available crystal structures of three 
other Plasmodium Plasmepsins (II-IV), revealed a specific precondition of the active site 
to accommodate arginine at the P3 position (Guruprasad et al, 2011). In contrast to this 
observed sequence restriction, the P2 position of the PEXEL motif (L
49
) appeared very 
tolerant towards amino acid exchanges with a wild-type export phenotype in all mutants. 
Furthermore, L
49
A was normally processed with cleavage after P1 (L
50
) and acetylation of 
the new N-terminus at P1’ (A51) as shown by mass spectrometry. Since all mutant proteins 
showed the same localization it is appealing to extrapolate the mass spectrometric result to 
all L
49
 mutants. However, detailed LC-MS/MS analysis of a broader selection of mutants 
should generally be considered to validate this assumption.  
Mutation of the conserved P1 position (L
50
) was characterized by intraparasitic protein 
retention localized to a bright spot within the ER, which could represent a special 
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subcompartment (Lee et al, 2008). Similar to R
48
A, L
50
A was neither cleaved nor 
acetylated, which substantiates the importance of this position in PEXEL processing. In 
addition, this study could not confirm alternative cleavage within the putative signal 
sequences of these mutants by signal peptidase. This alternative processing was proposed 
by Boddey et al (2009) based on observations of minor subpopulations of KAHRP and 
GBP130 proteins with P3A and P1A mutations that entered the default secretory 
pathway into the PV. The results of our study indicate that Plasmepsin V is dominant over 
signal peptidase in temporal or spatial terms and that the release of PEXEL proteins from 
the ER in native conditions depends on this enzyme.  
An important outcome of this screen was the sequence restriction at position P1’ (A51), the 
residue to be N-acetylated after cleavage. Nearly all mutant chimeric proteins were 
retained in the PV with a clear defect in translocation to the erythrocyte cytoplasm. The 
only replacements capable of displaying the wild-type phenotype were serine (A
51
S), 
threonine (A
51
T) and partially valine (A
51
V). Although alignments of putative PEXEL 
proteins suggest a certain degree of diversity at P1’ an over-representation of these amino 
acids is obvious (Figure 12). Importantly, this bias is probably caused by preferential 
acetylation of these residues by N-acetyltransferases (Bienvenut et al, 2012), a post-
translational modification that is characteristic of PEXEL processing (Chang et al, 2008). 
Mass spectrometric analysis revealed normal processing of exported STEVOR
1-80 
and 
A
51
S proteins, whereas PV-retained A
51
D and R mutants were cleaved but not acetylated. 
At that time, this was the very first indication of a functional relevance of acetylation for 
export of PEXEL proteins and prompted further investigations into this direction (see 
chapter 4.2). In support of this finding, a recent publication confirmed this result for 
mutation of P1’ to aspartic acid in the PEXEL proteins REX3 (SD), KAHRP (AD) 
and PfEMP3 (AD) with a clear retention in the PV as well as cleaved but non-acetylated 
(mixed with acetylated) N-termini determined for REX3 (Tarr et al, 2013).  
In addition to the fluorescence-based microscopic determination the localization of some 
chosen A
51
 mutants was assessed by differential lysis of iRBCs with tetanolysin (disrupts 
RBC membrane) and saponin (permeabilizes PVM) followed by western blot analysis 
(Bhattacharjee et al, 2008). It could be shown that wild-type STEVOR
1-80 
as well as A
51
S 
entered the tetanolysin supernatant representative of the RBC cytosolic fraction, whereas 
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A
51
D and R both accumulated in the supernatant of saponin-treated parasite pellets thereby 
confirming their restriction to the parasitophorous vacuole (Figure 16).  
Since the folding of GFP can interfere with the proper localization of tagged proteins it is 
recommendable to confirm some of the most important mutant phenotypes with smaller 
tags (HA, c-myc, FLAG) and immunofluorescence detection (Deponte, 2012; Knuepfer et 
al, 2005a). 
In order to proof that the results were not restricted to STEVOR
1-80 
some mutations at 
position P1’ were repeated in a second PEXEL protein. A short soluble GFP-tagged 
version of KAHRP (KAHRP
1-69
, PEXEL motif: 
54
RTLAQ
58
), a major component of 
parasite-derived knobs on the RBC surface, was chosen for this part (Knuepfer et al, 
2005b). Similar to STEVOR
1-80
, A
57
S and T were properly translocated into the RBC 
cytoplasm, whereas A
57
D and R localized to a bright ring around the parasite indicative 
of the PV. In contrast to the partially exported A
51
V of STEVOR
1-80
, the corresponding 
mutant protein was not exported in the sequence context of KAHRP. Unfortunately, 
technical difficulties prevented mass spectrometric analysis of these mutants. 
Remarkably, position P2’ (Q52) of the PEXEL motif, despite being quite conserved 
(E/Q/D), was rather permissive towards variable amino acids while maintaining the 
wild-type export phenotype. Only replacements with positively charged amino acids 
(Q
52
K, R) abolished translocation capability with an accumulation of the GFP-tagged 
proteins in the PV. Apparently, in this sequence context drastic charge changes from 
polar uncharged (Q; E/D: negative) to positive seem to interfere with either processing 
of the PEXEL motif or consecutive export steps such as protein interactions (e.g. with 
chaperones) or membrane targeting (Boddey & Cowman, 2013). Mass spectrometric 
analysis determined normal processing of Q
52
A and N, which was in accordance with the 
localization of these constructs. In this context, it needs to be mentioned that previous 
studies are contradictory concerning alanine exchanges of P2’ (E/Q/DA) with some 
authors claiming a clear retention in the PV (Boddey et al, 2009; Przyborski et al, 2005) 
while others report normal export (Bhattacharjee et al, 2012a; Gruring et al, 2012). 
Possible explanations for this discrepancy include the use of diverse vector systems 
harbouring different promoters that might affect the timing and levels of expression, 
processing and subsequent export of mutant chimaeras. Additionally, a sufficient 
distance between the PEXEL motif and the GFP linker is crucial for proper targeting 
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(Chang et al, 2008; Knuepfer et al, 2005a). The effect of alanine mutations could also be 
influenced by the downstream sequence context of different model proteins. This 
hypothesis was supported by a decreased export efficiency of the REX3 P2’A mutant 
only when combined with multiple downstream mutations in the linker region between 
the PEXEL motif and GFP (Tarr et al, 2013). Taken together the microscopic and mass 
spectrometry data acquired in the course of this study as well as the above-mentioned 
publication (ibid.), there is accumulating evidence in favour of the wild-type export 
phenotype of P2’A.  
Interestingly, Q
52
R was also cleaved and N-acetylated despite its lacking ability to guide 
proper export. Guruprasad et al (2011) implicated that D
189
 in the S2’ subsite of 
Plasmepsin V might specifically interact with the polar to negative side chains of E/Q/D 
in position P2’, which would exclude tolerance of positively charged amino acids (R, K). 
Since this assumption would predict a disturbed cleavage of Q
52
R, which was not the 
case, it is more likely that additional factors apart from cleavage and acetylation might 
be involved in facilitating translocation of PEXEL proteins beyond the PVM. The same 
conclusion was drawn by Tarr et al (2013) based on an export-deficient REX3 mutant 
that accumulated in the PV despite normal processing.  
The ability of the newly formed N-terminus to act as an independent signal sufficient for 
proper trafficking of the protein is controversial. A previous study generated a PEXEL 
protein whose N-terminus (xE/Q/D) was cleaved by signal peptidase instead of 
Plasmepsin V. The resulting fragment was identically processed but not exported beyond 
the PVM (Boddey et al, 2010). From this observation the authors deduced that the 
information required for PEXEL-mediated protein sorting resides predominantly in the 
N-terminal RxL sequence and is coupled to events occurring prior or directly during 
cleavage such as binding to PI(3)P in the ER or interaction of Plasmepsin V with 
chaperones for transfer of cleaved proteins (Bhattacharjee et al, 2012b; Boddey et al, 
2010; Russo et al, 2010). However, a more recent study bypassed PI(3)P binding and 
cleavage by Plasmepsin V using a viral capsid protease domain fused to mature PEXEL 
N-termini (xE/Q/D) that releases them upon self-cleavage in the ER (Tarr et al, 2013). In 
contrast to the former study, these constructs were efficiently exported (normal 
processing including acetylation was identified in both studies). The authors attributed 
this discrepancy to differences in cleavage efficiency and accuracy between the signal 
DISCUSSION 
122 
peptidase and the capsid protease. It was further shown that a free processed N-terminus 
with an adequate distance to folded domains such as GFP is necessary for proper export 
and that the composition of the linker region in combination with the mature N-terminus 
can influence the final localization of the protein (Knuepfer et al, 2005a; Tarr et al, 
2013). However, the new N-terminus (Ac-xE/Q/D) is very short and the sequences 
downstream share little conservation among all putatively exported proteins. It is still 
unclear if there is a specific interaction of the acetylated N-terminus with the 
translocation machinery or if general characteristics such as charge or tertiary structure 
of this region determine subsequent trafficking steps (Spielmann & Gilberger, 2010). In 
this context it is of great importance to resolve how PEXEL proteins progress beyond 
the ER. Different models have been proposed including chaperone- or receptor-mediated 
interactions as well as vesicular trafficking via default or specialized secretory pathways 
to the PV or confined subcompartments harbouring translocons (PTEX) (Boddey & 
Cowman, 2013; Elsworth et al, 2014). Furthermore, the increasing number of identified 
PEXEL-negative exported proteins (PNEPS) with no single identifiable motif implicates 
a more complex export system than originally assumed (Heiber et al, 2013).  
The dissection of the PEXEL motif and its role in protein export can greatly enhance our 
understanding of this process that is essential to parasite viability and pathogenesis. The 
mutagenesis screen conducted in this study on the PEXEL motif of STEVOR and 
KAHRP expands the present data set to hitherto unknown details especially by including 
positions P2 and P1’. In accordance with previous studies the mutagenesis of P3 (R48) 
and P1 (L
50
) revealed a strict limitation to these amino acids in the context of proper 
processing by Plasmepsin V (Boddey et al, 2010; Boddey et al, 2009; Hiller et al, 2004; 
Marti et al, 2004; Russo et al, 2010). Position P2 (L
49
) was permissive towards all 
introduced amino acid exchanges and maintained normal export and processing thereby 
challenging any functional role. The relevance of acetylation was indicated for the first 
time by mutations in P1’ (A51) resulting in non-acetylated chimeric proteins that were 
incapable to cross the PVM. In contrast acetylation-prone replacements into serine or 
threonine recovered the wild-type phenotype. These important results could be 
confirmed on a microscopic basis with KAHRP as a second model protein.  
Surprisingly, mutations at P2’ (Q52) did not interfere with export apart from positively 
charged amino acids, which confined the mutant proteins to the PV. This was 
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unexpected given the sequence conservation of all putative PEXEL proteins at this 
position. The mass spectrometry analysis of the Q
52
R mutant revealed normal processing 
despite export deficiency. This observation points to additional aspects to be considered 
in this process such as the influence of downstream sequence context or the nature of 
interaction with the export machinery (e.g. protein interactions, membrane targeting).  
 Characterization of a putative N-acetyltransferase (PfNAT) 4.2
Virtually all PEXEL proteins are N-acetylated after Plasmepsin V-mediated cleavage of 
their motif (Chang et al, 2008). Although the exact role of this N-acetylation is still 
unclear the addition of an acetyl-group to the primary P1’ amine might engage in 
relevant interactions during PEXEL-mediated protein export such as chaperone 
recruitment, receptor interaction, membrane targeting or direct recognition by the 
translocon. A functional relevance of co-translational N-terminal acetylation with 
respect to protein stability, interaction and localization has been shown in several studies 
including different organisms (Arnesen, 2011; Dikiy & Eliezer, 2014; Scott et al, 2011; 
Starheim et al, 2012). In addition, accumulating data elucidate the less frequent process 
of post-translational N-acetylation (Helbig et al, 2010; Helsens et al, 2011; Polevoda & 
Sherman, 2000; Van Damme et al, 2011b). Interesting examples in the context of 
PEXEL proteins are plant chloroplast proteins that become acetylated after cleavage of 
their chloroplast transit peptide (Bienvenut et al, 2012; Zybailov et al, 2008). 
The results of the study presented here as well as recently published data (Tarr et al, 
2013) indicate this post-translational modification as a necessary prerequisite for proper 
translocation of the proteins into the RBC cytosol. This conclusion is based on the 
identification of non-acetylated P1’ mutants of STEVOR and REX3 that were retained in 
the PV. Interestingly, the only mutations that were able to functionally replace the 
endogenous alanine at P1’ (A51S, T, partially V) in guiding proper export represent 
specific acetylation sites of NatA acetyltransferases (Helbig et al, 2010). The next part of 
this study aimed at identifying the N-acetyltransferase in P. falciparum (PfNAT) 
responsible for this modification. Like Plasmepsin V this enzyme might represent an 
essential bottleneck and is of great relevance to understand and possibly intervene with 
the export process of Plasmodium effector proteins.  
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Commonly, co-translational N-acetylation occurs in the cytosol and some theories exist 
on Plasmepsin V and the putative NAT acting on PEXEL motifs on the cytoplasmic side 
of the ER (Römisch, 2012). However, different independent studies using brefeldin A, 
an inhibitor of anterograde ER transport, as well as PEXEL mutants with artificial ER-
retention signals demonstrate that cleavage by Plasmepsin V most likely happens within 
the ER compartment (Chang et al, 2008; Osborne et al, 2010; Przyborski et al, 2005). 
Consequently, the identification of PfNAT was based on a selection of proteins with a 
putative transferase domain as well as entry signals into the secretory pathway (signal 
peptide or transmembrane domain). Only one out of ten candidate genes in P. falciparum 
(PfNAT, gene ID: PF3D7_1437000, PlasmoDB) fulfilled these requirements and was 
therefore chosen for further studies. The putative acetyltransferase domain shows 
considerable sequence similarity in the orthologous proteins across other Plasmodium 
species and even other apicomplexan genera (Figure 19, Figure 22). The full-length 
protein was episomally expressed in P. falciparum and localized to the intraparasitic 
perinuclear compartment characteristic of the ER. In addition, the search for a protein 
that would shuttle the negatively charged acetyl-CoA across the ER membrane retrieved 
a putative acetyl-CoA transporter (PfAcT, gene ID: PF3D7_1036800) based on sequence 
similarity to the mammalian AT-1 transporter (Jonas et al, 2010). Interestingly, an 
independent review recently proposed both genes as suitable candidates for the process 
of N-acetylation in PEXEL proteins (Boddey & Cowman, 2013). Co-expression of 
PfNAT, Plasmepsin V and PfAcT tagged to mCherry and GFP localized all proteins to 
the same compartment indicating a spatial accumulation of potentially connected 
functional components. The correct molecular weights of these fusion proteins were 
confirmed by Western blot analysis and no processing of the proteins was observed. To 
further characterize PfNAT, the expression under the endogenous promotor as well as 
the final localization was investigated by successful single crossover recombination of a 
GFP-tagged version into the respective locus. This clonal line expressing PfNAT
GFP
 
exhibited fluorescence in the ER throughout the complete intraerythrocytic development 
until the release of daughter merozoites. Although PCR analysis revealed recombination 
within the homology region, Southern blot detection of this clonal line should be 
conducted to confirm the nature and copy number of plasmid integration.  
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As previously mentioned, the use of small tags (e.g. FLAG, c-myc, HA) in combination 
with immunofluorescence analysis can circumvent the problem of GFP tags that 
potentially interfere with targeting of a protein to its natural destination (Deponte, 2012). 
Therefore, recombinant parasites expressing PfNAT
FLAG
 under the endogenous promotor 
were created (data not shown). However, this parasite line was abandoned since Western 
blot analysis with different anti-FLAG antibodies repeatedly showed multiple unspecific 
bands. Furthermore, the generation of antibodies specific to PfNAT was initiated by 
cloning and affinity-purification of two His-tagged peptides from E. coli lysates but 
could not be finalized (data not shown).  
In the next step, the biological function of PfNAT as a putative transferase was 
investigated by active-site mutagenesis. The effect of mutations that render enzymes 
catalytically dead and produce dominant-negative phenotypes has been repeatedly 
exploited (Campillo et al, 2005; Wagner & Benkovic, 1990). The total enzymatic 
activity of Plasmepsin V was elegantly shown in P. falciparum to be decreased by 
episomal co-expression of an inactive version that competed for substrate binding 
resulting in a mixed population of cleaved and uncleaved PEXEL protein (Russo et al, 
2010). The identification of the active site within the transferase as well as amino acids 
that might be essential to catalysis was a prerequisite for this part of the study. In 
collaboration with Dr. M. Deponte he a developed stable protein model of the C-terminal 
acetyltransferase domain of PfNAT, which was based on suitable crystal structure-
derived sequence alignments with two bacterial acetyltransferases (PDB IDs: 3D8P, 
3PP9). Since 3PP9 was resolved in complex with acetyl-CoA, the active site of this 
enzyme could be determined as well as amino acids that are in close proximity to be 
likely involved in the catalytic reaction or binding of the thioester (R
104
, 3.45 Å; T
132
, 
3.76 Å; N
136
, 2.95 Å; Y
143
, 3.41 Å). The comparison with PfNAT indicated a similar 
binding pocket and corresponding amino acids could be identified for mutagenesis (R
456
; 
T
484
; N
488
). Although the active site tyrosine that is frequent among NATs (Y
130
 in 
3D8P, Y
143 
in 3PP9) was replaced by valine in this model the closest tyrosine two amino 
acids upstream (Y
493
) was chosen for mutagenesis (Toleman et al, 2004; Vetting et al, 
2005). Furthermore, two highly conserved glycines were included (G
461
, G
499
) that might 
be of structural relevance within the transferase domain. All amino acid replacements of 
the site-directed mutagenesis were carried out under the consideration of maintaining 
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structural integrity while abolishing functional characteristics (e.g. similar size, different 
functional groups). It was assumed that some of these mutations would impair the 
catalytic potential of PfNAT thereby reducing the acetylation state of PEXEL proteins to 
reveal an intermediate export phenotype. To test this hypothesis the mCherry-tagged 
transferase bearing single, double or triple mutations of the previously mentioned 
residues was co-expressed with STEVOR
1-80 
in P. falciparum parasites and analysed by 
fluorescence microscopy.  
In summary, all mutant parasites showed a wild-type export phenotype of this PEXEL 
protein into the RBC cytoplasm and no dominant-negative effect could be observed. One 
possible explanation for this result could be that the function of PfNAT is not impaired 
despite mutations in the putative active site or that the prediction was incorrect. 
Furthermore, the effects of the mutations, if relevant at all, might be diminished in the 
background of endogenously expressed wild-type enzyme. It would be interesting to 
approach the function of the transferase by allelic replacement of the endogenous gene 
with a mutant gene harbouring non-synonymous as well as synonymous mutations in the 
codons of all previously mentioned amino acids. The nature of recombination events 
would also provide valuable information on a possible essentiality of the gene as 
previously shown for Plasmepsin V (Russo et al, 2010). Finally, the outcome of this part 
of the study might indicate that PfNAT has different biological targets than exported 
proteins.  
Interestingly, parallel studies by my colleague Dr. C. Sanchez using wild-type and 
mutated PfNAT expressed in yeast strains lacking the catalytic NatA subunit (ΔArd1p) 
clearly indicated a functional relevance of this enzyme (unpublished, data not shown). It 
could be shown that a fragment of PfNAT including the putative transferase domain 
(excluding transmembrane and terminal regions) could compensate the growth defect 
and heat stress susceptibility of yeast Δard1 mutants (Lee et al, 1989; Mullen et al, 
1989). Since PfNAT and Ard1p both harbour the GCN5-related N-acetyltransferase 
domain (Gautschi et al, 2003), this result is likely due to functional complementation as 
postulated in previous studies on histone acetyltransferases and deacetylases (Gaglio et al, 
2013; Wang et al, 1997). Remarkably, the above-mentioned active-site mutations 
decreased the ability of PfNAT to rescue temperature sensitivity of the yeast Δard1 strain.  
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To further advance our understanding of its biological function the deletion of the PfNAT 
gene was attempted in the next part of this study. In P. falciparum the replacement of the 
endogenous gene by double crossover recombination is enhanced by negative selection 
against the vector backbone. Negative selection marker cassettes on the plasmids encode 
enzymes that convert exogenously-added innocuous compounds into toxic ones, thereby 
selecting for parasites that remove these cassettes by double crossover recombination 
events. For this purpose, vector systems with two different negative selection markers 
were employed encoding either thymidine kinase (TK, pHTK vector) of the H. simplex 
virus or the bifunctional cytosine deaminase/uracil phosphoribosyl transferase (CDUP, 
pCC vector) from S. cerevisiae (Duraisingh et al, 2002; Maier et al, 2006; Mullen et al, 
1992). Both enzymes convert normally harmless ganciclovir and 5-FC, respectively, into 
toxic metabolites that inhibit the de novo pyrimidine biosynthesis pathway and nucleic 
acid synthesis directly. For disruption of the PfNAT gene two sets of homology regions 
were cloned into the pCC and pHTK vectors to flank the positive selection cassettes for 
the allelic exchange: ~1 kb each of 5’ and 3’ untranslated regions (UTR) adjacent to the 
open reading frame of the gene as well as ~0.5 kb of gene terminal regions (PfNAT has a 
length of 2.2 kb including 2 introns). Previous studies proved the length of 0.5 kb to be 
sufficient for gene targeting in the parasite (Witola et al, 2008). After transfection and 
positive selection of P. falciparum parasites the transfectants were either directly 
subjected to negative selection pressure or prior to this cycled repeatedly off the positive 
selection drug to accumulate single crossover integrants for improved gene targeting. 
Unfortunately, no parasites harbouring constructs with the (more promising) UTRs as 
homology regions emerged despite repeated transfections. This might be due to 
regulatory effects of these sequences exerted on the intermediate positive selection 
markers or plasmid instability in the parasites. Different drug concentrations of 5-FC and 
ganciclovir were tested (based on IC50/90 values and literature data, parasite survival rates 
and personal communication with experienced collaborators) as well as various parasite 
cycling rounds and periods followed by careful PCR analysis of extracted genomic 
DNA.  
In summary, it was not possible to generate knockout parasites with a disrupted PfNAT 
locus although both vector systems have been successfully applied in P. falciparum 
(Duraisingh et al, 2002; Maier et al, 2008). There are several potential reasons for this 
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failure including methodological aspects such as suboptimal homology regions (too 
short, spacing problematic), toxic ‘bystander’ effects on integrants caused by high drug 
dosage (Maier et al, 2006), low initial transfection efficiency, insufficient cycling 
periods or plasmid instability under selective pressure. However, this result could also 
implicate an essential role of PfNAT as shown for Plasmepsin V and calpain (Russo et 
al, 2010; Russo et al, 2009). A genetic knockout screen by Maier et al (2008) on 83 P. 
falciparum genes revealed that 36% seemed inaccessible to gene disruption and the 
authors commented, ”While the inability to select for double crossover homologous 
recombination for some genes is not definitive proof that they are essential under 
laboratory conditions it is consistent with the proposition that they serve an important 
function in growth of the parasite in the host erythrocyte.” Interestingly, they identified 
11 essential PEXEL proteins out of 46 tested (24%) implicating a biological role of these 
proteins during intraerythrocytic parasite development. In case of a putative role of 
PfNAT in propagating correct export of PEXEL proteins the disruption of this gene 
could exert drastic consequences on parasite viability. It would be useful to investigate 
whether the knockout attempts are more successful in the presence of an episomal 
version of PfNAT, a general method to determine essentiality of a gene (Slavic et al, 
2010). This idea was approached by co-transfecting a construct encoding the FLAG-
tagged transferase together with the pCC knockout plasmid followed by dual positive 
selection with WR99210 and blasticidin S. Unfortunately, no parasites recovered from 
the transfection. 
As an alternative approach, the conditional excision of the gene sequence encoding the 
PfNAT transferase domain was attempted using the loxP/DiCre recombinase system, 
which has recently been adapted to P. falciparum (Andenmatten et al, 2013; Collins et 
al, 2013; Yap et al, 2014). This method is based on the expression of the DiCre 
recombinase in two inactive subunits, which dimerize upon addition of rapamycin. The 
active enzyme then recognizes short loxP motifs that flank a DNA region of interest in 
clonally pre-selected parasites and mediates effective excision or inversion of the 
intervening sequence within one intraerythrocytic growth cycle (Collins et al, 2013). For 
this study, the gene sequence encoding the C-terminal part of PfNAT including the 
transferase domain was flanked by loxP sites and recodoned to ensure recombination to 
occur upstream within a preceding homology region (~ 1kb). After transfection into the 
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constitutively DiCre expressing P. falciparum 1G5 strain (kindly provided by M. 
Blackman) the parasites were subjected to consecutive cycles off the positive selection 
marker in order to select for single crossover integration events. Genomic DNA of these 
parasites was analysed by PCR but no recombination event could be observed in any of 
the cultures despite various cycling conditions. One possible explanation could be the 
unavoidable placement of the 5’ loxP site into an exonic region of the gene. Although 
this part of the protein is supposedly unstructured the effect of the additional motif (11 
amino acids) might disturb its integrity (Costantini et al, 2007). To circumvent this 
problem, a second set of vectors was constructed, which comprised longer synthetic 
parts of PfNAT with the initial loxP site placed in an intron or the preceding UTR. 
Furthermore, a third pre-existing redundant loxP site in the original vector (also 
provided by M. Blackman) was removed to optimize the construct. Despite these 
attempts none of the plasmids have integrated so far (ongoing experiment). The efficient 
expression of the recodoned sequence of PfNAT as a necessary prerequisite for 
successful recombination was controlled by transfection of parasites with a construct 
encoding a GFP-tagged full-length version (PfNAT
synth
). The synthetic protein was 
indeed expressed and localized to the parasite ER as expected. However, transfection 
efficiency was extremely low and fluorescent parasites were rapidly lost upon 
continuous culture. This observation might indicate a reduced preference for 
replacement of the endogenous gene with the synthetic one and explain the inability to 
recover single crossover integrants.  
As a consequence of the occurring failure to knock out the PfNAT gene, the next part of 
this study used the FKBP degradation domain system to conditionally knock down this 
putative transferase on protein level. This method is based on the fusion of a protein of 
interest to a destabilizing domain (DD) derived from the human FKBP protein. This tag 
targets the chimeric protein to proteasomal degradation unless stabilized by the small 
ligand Shield1 (commercial name D/D solubilizer, Clontech) (Banaszynski et al, 2006; 
Chu et al, 2008). It has been successfully applied in other organisms (Herm-Gotz et al, 
2007; Madeira da Silva et al, 2009) and to some extent in P. falciparum as exemplified 
by downregulation of parasite calpain, falcipain-2, RESA and CDPK-1 (Armstrong & 
Goldberg, 2007; Azevedo et al, 2013; de Azevedo et al, 2012; Russo et al, 2009).  
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Provided with the opportunity of this modulation system (kindly supplied by M. Ganter 
and M.F. Azevedo) the endogenous PfNAT was tagged with a variant destabilization 
domain (DD24) and subsequently analysed by microscopy as well as flow cytometric 
analysis. For this purpose, an integration construct encoding GFPDD24 was introduced 
into the PfNAT locus of the P. falciparum 3D7 strain by single crossover recombination 
along a 3’-terminal homology region (~1 kb). A clonal population was retrieved by 
limiting dilution, which exhibited the same expression and localization of PfNAT
GFPDD24
 
as the previously generated PfNAT
GFP
. The parasites were continuously grown in the 
presence of 200nM ligand (D/D solubilizer) to ensure sufficient stabilization with 
minimal toxic side effects. Microscopic as well as Western blot analysis 24 hours after 
removal of the ligand revealed an obvious decrease in PfNAT
GFPDD24
 fluorescence. 
Using single-cell microscopic quantification the reduction of protein levels was around 
50% compared to ligand-treated parasites and an unspecific effect of the ligand alone on 
fluorescence levels could be excluded. However, in comparison to clonal PfNAT
GFP
 
expressing parasites the addition of the DD tag itself diminished fluorescence intensity 
by around 30%. This observation has previously been reported (though to a lesser 
extent) and has been attributed to possible instability or mistargeting of DD-tagged 
fusion proteins even in the presence of the ligand (de Azevedo et al, 2012). The 
sensitivity of single cell quantification was complemented by the advantage of flow 
cytometric analysis to acquire data for a large number of cells. The downregulation of 
PfNAT
GFPDD24
 upon ligand removal for 24 hours was determined for purified parasite 
samples (>90% parasitaemia, 50 000 cells counted) to be in the above-mentioned range 
of 50% compared to the ligand-treated control while developmental stages and 
parasitaemias were similar in both samples.  
From these data it can be concluded that the DD system was successfully applied to 
reduce protein levels of endogenously tagged PfNAT by 50%. The downregulation of 
soluble reporter fusion proteins was around 95% in initial studies on mouse embryonic 
fibroblasts (Chu et al, 2008). However, it was reported to be considerably less in the 
Plasmodium parasite system with ~70% on average at 0.5 µM of ligand (de Azevedo et 
al, 2012). The effectiveness is assumed to be even more diminished for membrane 
proteins due to their likely inaccessibility to proteasomal degradation, but some 
DISCUSSION 
131 
successful applications have been reported (Banaszynski et al, 2006; Schoeber et al, 
2009).  
Although 50% reduction of protein levels is not enough to knock down the transferase 
this approach showed successful modulation of a Plasmodium transmembrane protein, 
which might allow to infer important functional information from further investigations. 
In this context, it was examined if PfNAT
GFPDD24
 parasites displayed an abnormal 
growth if cultured in absence of the ligand as a consequence of reduced transferase 
levels. Neither a flow cytometric determination over the period of 48 hours nor careful 
evaluation of parasitaemias in Giemsa-stained slides over 4 days (by S. Prior) revealed 
any obvious difference in parasite development. Furthermore, the effect of diminished 
PfNAT on export of a PEXEL protein was assessed by episomal expression of mCherry-
tagged STEVOR
1-80
 in the clonal parasite line. It was assumed that STEVOR
mCherry
 
might accumulate in the PV as a consequence of reduced acetylation. While microscopic 
analysis clearly showed an expected decrease in fluorescence levels of PfNAT
GFPDD24
 in 
ligand-free parasite samples, the localization of STEVOR
mCherry
 was comparable in both 
treated and untreated cultures. It would be interesting to quantify the protein distribution 
in order to determine any subtle changes in trafficking of STEVOR
mCherry
 but the 
episomal expression will likely falsify the result due to uneven protein levels caused by 
plasmid concatomers. The use of a conditional export system would as well be 
worthwhile to detect any temporal delays in export of the PEXEL protein caused by 
disturbed acetylation. Unfortunately, the well-established Conditional Aggregation 
Domain (CAD) System is based on the same FKBP domain and utilizes the same ligand, 
which renders it incompatible with the DD system (Rivera et al, 2000; Saridaki et al, 
2008). 
To further characterize PfNAT future investigations should analyse a broader range of 
possible targets that might be affected by downregulation of the transferase. For this 
purpose, a pulse-chase experiment on the PFNAT
GFPDD24
 expressing parasites was 
conducted to determine if the total amount of [
35
S]-methionine radiolabelled (‘pulsed’) 
proteins exported to the erythrocyte cytoplasm changes dependent on different 
transferase levels (Wiser & Lanners, 1992). The results indeed indicated a reduction in 
export of proteins in samples that were pulsed after the ligand was removed for 24 hours 
(data acquired by Dr. C. Sanchez). This difference was not observed in the parental 
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control parasite line excluding any unspecific effect of the stabilizing ligand on protein 
export. Despite this promising outcome the exact function of PfNAT in protein export 
still needs to be verified. First of all, it is of major importance to provide evidence that 
this protein is indeed an N-acetyltransferase. The establishment of an in vitro acetylation 
assay to detect enzyme-specific transfer of radiolabeled acetyl-CoA onto suitable 
substrates is a necessary step in further investigations and has proven useful in other 
studies (Costantini et al, 2007; Herrera et al, 1997; Pradeepa et al, 2009). Suitable 
fragments of PfNAT (no transmembrane domains, removal of terminal signal sequences) 
were cloned in the course of this study for heterologous expression in E. coli and 
purified. Unfortunately, the majority of recombinant transferase accumulated in bacterial 
inclusion bodies despite various modifications in culture conditions, which prevented the 
finalization of this project (data not shown). Since extraction from inclusion bodies and 
refolding of the denatured protein into a functionally intact enzyme is challenging 
further optimizations might be worthwhile to pursue in order to increase solubility 
(Costa et al, 2014; Gopal & Kumar, 2013).  
Although several attempts to knock out the gene encoding PfNAT failed, it was possible 
to delete the orthologous gene (gene ID: PBANKA_061180, PlasmoDB) in the rodent 
malaria parasite P. berghei suggesting that it is dispensable for the development in the 
murine host (in collaboration with M. Singer). The knockout parasites exhibited a 
slightly reduced blood-stage growth rate per day in mice (~80% of wild type). It would 
be interesting to investigate possible effects of this gene deletion in mosquito stages or 
after bite-back transmission to the rodent hosts. The replacement of the PbNAT gene 
with a selection marker cassette encoding mCherry enabled the expression of this 
fluorescent marker under the endogenous promotor. Similar to GFP-tagged PfNAT, 
continuous intraparasitic expression throughout the entire intraerythrocytic development 
was observed with increased fluorescence in schizonts and male gametocytes. This 
finding was interesting, since previous studies reported an enrichment of putatively 
exported proteins in early gametocytes of P. falciparum, some of them with PEXEL 
motifs (Silvestrini et al, 2010). If the observed increase in expression of PbNAT in 
gametocytes is pure coincidence or indicates a functional relevance of the protein in 
gametocytogenesis remains to be elucidated. The ability to knock out the orthologous 
gene in P. berghei implicates that methodological limitations might hamper the same 
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progress in P. falciparum. An alternative explanation could be a redundancy in the 
rodent parasite with another enzyme potentially replacing the function of PbNAT in a 
knockout background. In support of this hypothesis the genome of P. berghei harbours 
as second putative NAT with an entry signal for the secretory pathway in contrast to the 
human parasite (gene ID: PBANKA_112760, PlasmoDB). In addition, the essentiality of 
the transferase (in case of its proposed function in export) might be determined by the 
relevance and extent of PEXEL-mediated protein export in both species. P. falciparum 
shows a highly expanded PEXEL-positive exportome, which is in part attributed to the 
expansion of species-specific protein families (DnaJ, PHIST, STEVOR, RIFIN etc.) as 
well as the unique devotion to present PfEMP1 on the surface of iRBCs (Boddey & 
Cowman, 2013). In comparison to more than 400 putative PEXEL proteins in P. 
falciparum only 75 were identified in P. berghei and it is assumed that PEXEL-negative 
proteins represent a larger proportion in this species (Pasini et al, 2013). As a 
consequence, deletion of PbNAT might be less detrimental in the rodent parasite 
compared to PfNAT in P. falciparum. Finally, a completely different biological target of 
this protein should be taken into consideration. Given the observed sequence similarities 
to transferase domains of homologous proteins in other apicomplexan species (Figure 
22) that have a reduced or absent PEXEL repertoire it is tempting to assign an 
alternative or more general function to this enzyme (Gohil et al, 2013; Hsiao et al, 2013; 
Marti et al, 2004). An interesting example of ER-based protein acetylation includes the 
transient lysine acetylation of BACE1, a key enzyme in generation of Alzheimer’s 
disease amyloid ß-peptide, by ATase1 and ATase2 (Ko & Puglielli, 2009). This 
modification also occurs in other proteins and seems essential for proper trafficking of 
BACE1 to the Golgi apparatus, since non-acetylated intermediates are retained and 
degraded in an ER-Golgi intermediate compartment. Consequently a general role of 
these membranous transferases as protective chaperones mediating correct maturation of 
secretory proteins via acetylation has been implicated (Jonas et al, 2010). 
 
In conclusion this part of the study identified a putative N-acetyltransferase in 
P. falciparum (PfNAT) that might be responsible for the prevalent acetylation of PEXEL 
proteins after cleavage by Plasmepsin V. The localization of this transmembrane protein 
was exclusively limited to the parasite ER and addition of a GFP tag to the endogenous 
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protein via genetic single crossover recombination proved expression throughout the 
entire intraerythrocytic development. A model of the putative acetyltransferase domain 
was established in collaboration with Dr. M. Deponte to determine amino acids suitable 
for active-site mutagenesis. Despite several different mutations in this domain no 
dominant-negative effect on export of the PEXEL protein STEVOR
1-80
 could be 
observed. For further characterization several attempts were made to delete the gene 
encoding PfNAT by double-crossover recombination as well as conditional excision 
using the loxP/DiCre recombinase system. However, these approaches were 
unsuccessful although the knockout was possible in the rodent malaria parasite P. 
berghei (in collaboration with M. Singer). Alternatively, the downregulation of the 
transferase on protein level was achieved using the Destabilizing Domain (DD) system. 
The reduction of endogenously DD-tagged PfNAT was in the range of 50% in ligand-
free compared to ligand-stabilized parasites as determined by quantitative microscopy as 
well as flow cytometric analysis. No defect in parasite growth or export of STEVOR
1-80
 
was detected in parasites with destabilized protein levels. The applicability of the DD 
system to membrane proteins of P. falciparum could be confirmed in this study. 
Furthermore, the clonal parasite line expressing regulable levels of PfNAT form the 
basis for future investigations on the function of this interesting protein. 
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5 Outlook 
In conclusion, this study could show that single amino acid replacements at crucial 
positions of the PEXEL motif can disturb the processing and final localization of an 
exported model protein. In addition, the acetylation state of the mature N-terminus after 
cleavage of the export sequence seems to be a necessary prerequisite for correct protein 
trafficking. Apart from this modification, recent studies added more complexity by 
pointing out the importance of sequence stretches downstream of the mature N-terminus 
(Tarr et al, 2013). A potential convergence of export pathways of PEXEL-positive and -
negative exported proteins (PPEPs and PNEPs, respectively) was even suggested based 
on the findings that their N-termini are functionally exchangeable under certain 
circumstances (Gruring et al, 2012). In order to gain a better understanding it seems 
crucial to dissect the nature of the export machinery involved in the transfer of exported 
proteins from the ER to the PV and beyond. The identification of interaction partners 
such as chaperones, special cargo receptors or the translocon complex could be 
attempted by co-immunoprecipitation of conditionally exported PEXEL proteins 
(Saridaki, 2008). Specifically, the combination of the STEVOR
1-80
 mutants generated in 
this study tagged to the conditional aggregation domain (CAD) of the Reverse Protein 
Dimerization
TM
 system (Rivera et al, 2000) would result in the retention of these mutant 
chimaeras in the ER. Subsequently, upon ligand-dependent release, the proteins should 
resume their trafficking route all at once, which allows for controlled timing of fixation 
and subsequent pull-down of putative accessory factors. It is tempting to speculate that 
mutant chimaeras of STEVOR
1-80
 might engage in different interactions depending on 
their processing state (cleaved vs. uncleaved, acetylated vs. unacetylated) or export 
phenotype (Q
52
R normally processed, but not exported). However, the transient nature of 
these interactions and possible contamination with unspecific proteins during co-
immunoprecipitation might be challenging.  
In addition to the data obtained in this study, the biological function of the putative 
transferase (PfNAT) and moreover the proposed link to PEXEL-mediated protein export 
should be characterized in more detail. Since deletion of the gene was unsuccessful and 
downregulation on protein levels was only partially achieved (~50%), further suitable 
molecular tools should be investigated that might be based on transcript stability or 
translational control. Unfortunately, RNA interference (RNAi) is unavailable in P. 
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falciparum due to the absence of the enzymology required for RNAi-based ablation of 
gene expression (Baum et al, 2009). Alternatively, two interesting approaches include 
the use of the inducible bacterial glmS ribozyme (Prommana et al, 2013) for conditional 
cleavage of target mRNA and a newly described regulable tetracycline repressor (TetR)-
based protein-RNA interaction using TetR-binding RNA aptamers for inhibition of 
target mRNA translation (Goldfless et al, 2012).  
Furthermore, the above-mentioned downregulation of PfNAT on protein level using the 
destabilization domain (DD) tag should be exploited in more detail to reveal possible 
effects on protein export in general and to support the results obtained from the pulse-
chase experiment (chapter 3.2.6). Antibody-based detection of known exported proteins 
(e.g. KAHRP, PfEMP1, and STEVOR) in the iRBC cytosol might reveal a signal 
reduction in parasites with reduced levels of PfNAT. This comparative approach could 
be extended to FACS analysis of iRBC surface epitope recognition using pooled human 
sera of malaria-exposed patients. Although several components of the cytoadherence 
complex (including PfEMP1) are PNEPs, indirect effects of reduced transferase levels 
might occur based on the identification of various parasite chaperones (DnaJ, Hsp40, 
Hsp70-x) among the PEXEL protein repertoire that assist in correct trafficking of these 
PNEPs (Kulzer et al, 2012; Kulzer et al, 2010). In addition, surface electron microscopy 
could be employed to investigate if reduced levels of PfNAT lead to a disturbed 
assembly of the cytoadherence complex including morphological alterations of the 
knobs (size, density, elevation) on the surface of iRBCs (Rug et al, 2006).  
The establishment of an in vitro acetylation assay as a fundamental proof of PfNAT 
functionality was already suggested (chapter 4.2). An important point to consider in this 
respect is the composition of eukaryotic NATs as complexes consisting of catalytic and 
auxiliary subunits (Starheim et al, 2012). The focus of this study was limited to one 
protein (PfNAT) assuming that it would fulfil all necessary requirements for full 
transferase activity. This hypothesis of one protein combining several functions is 
exemplified by the bifunctional P. falciparum thymidylate synthase-dihydrofolate 
reductase (TS-DHFR), an essential enzyme in folate biosynthesis that usually consists of 
two separate proteins in other organisms (Dasgupta & Anderson, 2008). However, the 
activity of PfNAT might indeed depend on the formation of a functional complex and 
the identification of additional accessory protein(s) using crystal structural analysis or 
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co-immunoprecipitation followed by mass spectrometry might be a necessary step prior 
to subsequent biochemical experiments.  
Finally, another interesting aspect is the characterization of the putative transporter 
(PfAcT) identified in this study that might supply the lumen of the ER with the 
membrane-impermeable acetyl-CoA necessary for the N-terminal acetylation process. 
Loss-of-function studies using gene deletion or knockdown approaches in P. falciparum 
parasites as well as transport studies in artificial liposomes or heterologous expression 
systems such as Xenopus laevis oocytes might prove to be useful for this purpose (Jonas 
et al, 2010; Summers et al, 2014). 
Future investigations on the role of the PEXEL motif, the relevance of N-terminal 
acetylation and the secretory machinery involved in the process of protein export and 
host cell remodelling will hopefully contribute to the identification of novel attractive 
targets for therapeutic interventions against this deadly parasite. 
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Vector maps 
 
Figure 33. pARL-STEVOR
1-80
-GFP (original vector by T. Gilberger) 
 
Figure 34. pARL-PfNAT-3'-GFPHADD24 (HADD24 tag provided by M. Azevedo) 
 
Figure 35. pCC and pHTK vector systems (provided by A. Maier & N. Hertrich), 
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Figure 36. pHH1-PfNAT_C-term-loxP (provided by M. Blackman) 
 
Sequences 
Lower cases represent introns in genomic DNA, brackets contain new and old gene IDs. 
 
STEVOR (PF3D7_0631900, PFF1550w) 
ATGAAGATGTATTACCTTAAAATGTTATTGTTTAACTTTTTAATAAATGTTTTAGTATTACCACATTATgtatgtaaaaa 
aaaaaaatacataattattagaataatataaatatacataataaaagaattattatattttgagtacgcatttattaata 
atcgttttttttttttctagGAAAATTATCAAAATAACCATTATAACATAAGGCTCATACCAAATAACACATACAGAATA 
ACGATAAAATCAAGACTCTTAGCACAAACCCAAATCCATAATCCACATTATCATAATGATCCAGAACTCAAAGAAATAAT 
TGATAAATTGAACGAAGACGCAATAAAGAAATACCAACAAACTCATGATCCATATGAACAATTACAAGAAGTAGTAGAAA 
AAAATGGAACAAAATATAAAGGTGGTAATGATGCAGAACCTATGTCAACGCTAGAAAAAGAATTATTGCAAACATATGAA 
GAAGTGTTTGGTAACGAAAGTGATATGTTGAAGTCGGGAATGAATACAAATGTTGATGAAAAATCTTCAACATGTGGATG 
TACTGATATTAATGGTGTGAAATTAGCAAAAACAAAAGGAAGAGATAAGTATTTAAAACACTTAAAACATAGATGTACCC 
GTGGTATATGTTTTTGCTCAGTTGGTAGTGCATTGTTAACTATGTTCGGTTTGGCAGTTGCAAAAAAAGCTGCCGTTGAT 
GCCATCCTTCCTGTATATGTAGCAGCGATTAAAAAGTGTGTATCCTCCAGTTCATTATTTCATATATTTCATGGTGGTTC 
ATTAACTACAGCTCTTAAAGCAACCGAAGCGTGTGCAAGTGTTGCAGGTCCAGATATAGTCATACCTGCTACAGGTGCTG 
CTATAGGTGCATTTCCCCCTTATGGTATTGCAGCTTTAGTACTACTTATATTAGCTGTTCTACTTATAATATTATACATA 
TGGTTATATAGAAGAAGAAAAAATTCATGGAAACATGAATGCAAGAAACATTTATGTAAGTAA 
1023 bp 
KAHRP (PF3D7_0202000, PF02_0020) 
ATGAAAAGTTTTAAGAACAAAAATACTTTGAGGAGAAAGAAGGCTTTCCCTGTTTTTACTAAAATTCTTTTAGTCTCTTT 
TTTAGTATGGGTTTTGAAGTGCTCTAATAACgtaagttcataaataatatatatatatatatatatatatatatataatt 
atgtgtattttataactttgacatatgtgtatattctttattttttttacctaatattttatatatatatttatatatta 
gtttatttgaacaatatttactccatatatttatttcatatatatatatatatatatatatatatgtgatgtttaaaaaa 
tatgaaatatatatttatatattattattttcttattttatttttattttattttattttattttaattttattttattt 
tattttaattttattttaattttattttaattttattttaattttattttaattttattttattttaattttattttatt 
ttattttaattttattttattttattttaattttattttattttattttaatttaattttattttttttttcatatagTG 
CAATAATGGAAACGGATCCGGTGACTCCTTCGATTTCAGAAATAAGAGAACTTTAGCACAAAAGCAACATGAACACCATC 
ACCACCATCACCATCAACATCAACACCAACACCAAGCTCCACACCAAGCACACCACCATCATCATCATGGAGAAGTAAAT 
CACCAAGCACCACAGGTTCACCAACAAGTACATGGTCAAGACCAAGCACACCATCACCATCATCACCACCATCATCAATT 
ACAACCTCAACAACCCCAGGGAACAGTTGCTAATCCTCCTAGTAATGAACCAGTTGTAAAAACCCAAGTATTCAGGGAAG 
CAAGACCAGGTGGAGGTTTCAAAGCATATGAAGAAAAATACGAATCAAAACACTATAAATTAAAGGAAAATGTTGTCGAT 
GGTAAAAAAGATTGTGATGAAAAATACGAAGCTGCCAATTATGCTTTCTCCGAAGAGTGCCCATACACCGTAAACGATTA 
TAGCCAAGAAAATGGTCCAAATATATTTGCCTTAAGAAAAAGATTCCCTCTTGGAATGAATGATGAAGATGAAGAAGGTA 
AAGAAGCATTAGCAATAAAAGATAAATTACCAGGTGGTTTAGATGAATACCAAAACCAATTATATGGAATATGTAATGAG 
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ACATGTACCACATGTGGACCTGCCGCTATAGATTATGTTCCAGCAGATGCACCAAATGGCTATGCTTATGGAGGAAGTGC 
ACACGATGGTTCTCACGGTAATTTAAGAGGACACGATAATAAAGGTTCAGAAGGTTATGGATATGAAGCTCCATATAACC 
CAGGATTTAATGGTGCTCCTGGAAGTAATGGTATGCAAAATTATGTCCCACCCCATGGTGCAGGCTATTCAGCTCCATAC 
GGAGTTCCACATGGTGCAGCCCATGGTTCAAGATATAGTTCATTCAGTTCCGTAAATAAATATGGAAAACACGGTGATGA 
AAAACACCATTCCTCTAAAAAGCATGAAGGAAATGACGGTGAAGGAGAAAAAAAGAAAAAATCAAAAAAACACAAAGACC 
ACGATGGAGAAAAGAAAAAATCAAAAAAACACAAAGACAATGAAGATGCAGAAAGCGTAAAATCAAAAAAACACAAAAGC 
CACGATTGTGAAAAGAAAAAATCAAAAAAACACAAAGACAATGAAGATGCAGAAAGCGTAAAATCAAAAAAAAGTGTTAA 
AGAAAAGGGAGAAAAGCATAATGGAAAAAAACCATGCAGCAAAAAAACTAACGAAGAAAATAAAAATAAAGAAAAAACCA 
ATAATTCAAAATCAGATGGATCAAAAGCTCATGAAAAAAAAGAAAATGAAACAAAAAACACCGCTGGAGAAAATAAAAAA 
GTAGATTCTACTTCAGCTGATAATAAATCAACAAATGCTGCTACACCAGGCGCAAAAGATAAAACTCAAGGAGGAAAAAC 
TGACAAAACAGGAGCAAGTACTAATGCCGCAACAAATAAAGGACAATGTGCTGCTGAAGGAGCAACTAAGGGAGCAACTA 
AAGAAGCAAGTACTTCTAAAGAAGCAACAAAAGAAGCAAGTACTTCTAAAGAAGCAACAAAAGAAGCAAGTACTTCTAAA 
GAAGCAACAAAAGAAGCAAGTACTTCTAAAGGAGCAACTAAAGAAGCAAGTACTACTGAAGGAGCAACTAAAGGAGCAAG 
TACTACTGCAGGTTCAACTACAGGAGCAACTACAGGAGCTAATGCAGTACAATCTAAAGATGAAACTGCCGATAAAAATG 
CTGCAAATAATGGTGAACAAGTAATGTCAAGAGGACAAGCACAATTACAAGAAGCAGGAAAGAAAAAGAAGAAAAGAGGA 
TGCTGTGGTTAA 
2412 bp 
PfNAT (PF3D7_1437000, PF14_0350)  
ATGAATATATTTAAGCAGAAAGAGAATACACCTAATACTATATCTCATGTTTTGATGAgtaattatatatttaataaata 
aaaaaaaacttatataatatatataatatgtaaattaaaagaataactttttcatgtgatagtgtaaaacttatggaaaa 
catatatatattataatatatataaatatatattttttatcctttttaatttttttttttttttttttttttttccctct 
ctcaacagACAAGCATAAAGGAAAATTTCCGGAAGCGATAGTATCAATCAGGCAGTTAGAAGAAAGAGACATAAATGAAG 
TGAGACAATTGTTGTATGATCATTTTAATTCTTTAACTTTACCAGCAGTTATATATTGGTCAATACAACATATTTATGAT 
TTATTAGTTATTATAGTAATAAATTATATATTTTTTTTGGATTTAAAAAAAATATTTTATTTTCTTATAATATTTTTAAT 
ATATTTATATATAAGAGCCAAGTTAGAATTTTTAAATCATATAAGAAAAGATTGCCCAGATTTGGAAAATTTATATAAGA 
GTTACATTAACGTGGAAGGATGTAATTTTTGGGTAGCTGAAGTTTATGATAATAATTTTGGTTCAGCTAGCCGAACAACG 
TGTAGTGATATACATGAAAGAGAAAAAATTATATTAGAACAAGAAGAACAGGAAAAGTTATTATCAAATAATAATAAAGG 
AAATAATAATAACACCCTAGATGAAAAGGGTGGAGAAGTGGATCAAAAATTATTTAAACATAATTTAGAAAATAATGAAT 
ATAATAATGAAACACAAAATAAAGTATTAGATCATGTGAAAGAAAATAAGGAAATCAATATTAACAATAATAAAGAAGAT 
AATAAAAAGGACAACAAAAAGGATAATAAAAAAGATAATAAAAAGGATAATAAAAAAGATAATAATAATAATAATAATAA 
TAATAATAATAATAAAGATAATAAAAAAGAGATTACTTCTAATTTTACGTCTGATAATAATAACTCTAATTATAATAATT 
TATATTATAAATCAAATGATCAAATTAATAACAACAGTGAAAATCAAAAAGATAATGTAAAAGAAAATTTGAAAGATACA 
TCATCTACACAGAATGTGTGTGAAGAAAAAAATAATAATGACACATGTAATGAACAAAATAAAGACAATAATAATAACAA 
TAATAATAATAATAATAATAATAATAATCAATTAAGTAAATTTAATATTTTTAAAAATAAAAAAAGTAGTAATGATGATA 
AAGATAATAATGAAAATTGTTCTAACGAAAAAAAAAATAAACTATTATTTAATATAAGTGAAATATCAAATAGACACTTT 
ATGGAAACAAAAAGAAATGTTTCATCAGGATTTAATGAAATAAGAAGAAATATATTTAATTGTAAAGTACAGGATGAAGA 
AGATTTTAATAAAAATATCCTAAATAAAAAAATTGTAGGATGTGTAGGTATAGTACCGTTTAAAGGTGACAATACAATTG 
CACAACTTGTTCGTATGGTTGTAAAAAAAGATAATAGAAGAATGAGAATTGGTAGCCGATTATTAACTCAATTAGAAAAT 
TTTGCACATGAACAAAATTATAATGAATTAAAAGTTTTTACTAACAATTTAAATACTGATAGCTTATATTTCGTTAAGCA 
AAATGGTTTTAATTTATCTCAAATTGTTAGGAGAGGTCTAATGAGAGGTGATTTATTAATATGGTCAAAAATACTTAATA 
AAGATGATTTTTATAAATTTAATTCTCCAGgtaataatcttaaagatttaaaattactcaacttggaagaatattaattt 
ttaattgttatttgctaattgttaattgttaatttttaatttttaatttttaatttttaatttttaatttttaattttta 
atttttaatttttttttttttttttttttgtaatattttattgtttttgttattatgaatttattattttacgtaaattt 
ttttttttttttaaatatatatgattatacatatcatatatatatatatatatatatatatatatatacataaatcagat 
gaatatttctttatatgtatatatgaatatatctaaatatatattatgtatacatattttcccttttcatttctcttttt 
gtatactttgcttctacagAAATACAGAGCTATACAAATAATATCTTGGATTGA 
2214 bp 
PfAcT (PF3D7_1036800, PF10_0360)  
ATGTTCAATCGTTTATTTGAAAATTTTGAATATAATTTTTTCATAAAAAGAAAGAAGTTAAAATATGATACGAAAGATGG 
ACAATATGTGAAACAAAATATATCAAAAAGAAATAAGGACTATTATAATATAATATTCTTATTATCACTATATACTATAC 
AAGgtataagaaaaatagtacatttgagaagatataatattcgaaatataacattttttttaaataaacaaaaatgagaa 
taaaacatatttatataatatatatatatatatatatatatatatatatatatttatttatttatatatatgtttatgta 
tttattaattacacatatttaatttatatcattttttcttcaagGTGTACCAATTGGAGTTTCATCCGTAGTACCATTGA 
TCATACAAGATAAAGTCAGCTATTCTCAATTGAGTATATTATCATTAGTTAGTATACCTTTCAGgtaaattataatacac 
ttttaaaatatttgtgtaacccccactaaacctatatatatgtatacgattactattttttttaatatgtatcattatta 
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tatttttcagCATAAAATTATTATGGGCACCTATAGTTGATTCGGTATATAATAAAAGAATTGGAAGGAGGAAAAGTTGG 
ATAATACCACTACAGgttggatttatatattctaatcatttgcattatgaaatagatgtctacaaatggcgtatacatat 
aattatttactatttgtatatacgaattatttatactatattaatttttttatttatttgtaattttttttttttttttt 
tttattttagCTATTTTGCAGTTTTACGATGATATATTTTAGTAATCATGTCAGTATTTGGTTAGGAGAAAAAGACAATA 
TTCCGAACTTATTTTTCTTAACACTTTTTTTCTTCCTTCTCTTTTTTCTAATGGCTACACAAGATATTGCCGTGGACGGG 
TGGGCTTTAACCATGCTTTCTGAAGAAAATAAAAAgtaaaaatggactaacaccacattgaatataaatatacacaattt 
ggatataaccattatataatatatgcttattatatattattatatatatatatatatatatatatatatattaatataca 
cgttatcataatttattgatttatttatatttttttagAGCGGCTTCTACGTGCAATATACTGGGACAAAACATAGGATA 
TTGCTTATCGCAATTATCCTTTTTAACATTAAATAACAAAAACATATGCTTCTATATATTCAAAAAATATATTAAGTTTA 
TGTATTTAATATTCAATAAATCAACATATTATAGAAATGTCTATGAAAAGTTGGATCTTTTGTACCCATCATTTCAACCA 
TTTGTTGATATGAAAAAGTTTTTAAAATTCTGGGGGACATTTATACTAATGCTTACTATATTTACCTGTTTTAAGAAAGA 
GATGTCAGATCAAAATGAAGAAAAAAATAAATTAAAAAATAGTAATGAAATGGATAATTATAATATTTCAGAAGCACAAA 
AGTGTGACGATAAAATGAATAACGCAAAAATGAATTATCCTAAAAAAATAAATAACCAAATAAGAACAAATGAACATATA 
AAAATAAATGATATAAAACAAACCAATATTCAAAAACAATCTAGTGAAATAAACGAATTTGCAAATGCAAAAGATACCTA 
TAAAACATTGTACGAATTATTATTTCTACCCCCAATGAAAATATTTATTATTTTATTCTTAATTAACCGTTTGCCATTTG 
CTTCTGTAGAGGTAGGAACAAATTTTAAAATGTTAAAAAGAGGGATAACTAAAGAGGAATTTGCTATATTTAATCCACTG 
TATATACCTGTATCAATTATATCCCCAGCTATTATTGGGAAAATTATACAAAAATTGAAGCCACTGGATGTTTATTATTT 
TGGATATGTATTAAGATATTTTTCTAATATTATTTTATCTACCTTACTACCTATAACCAAATATATGTATTCAAATAAAA 
CACAAAGTACAAATATGAAATTTTATTTTTATTATATGTATATATATATGGCACAAGTGTTTAATCATTTCTCAATCGAT 
TTAATGACTGTCTCATCGgtaatcatataaaatacaaaataaaagaaataaatattatatagtgtaaatatattcacatc 
tatatattttaaaatatgtttgtacaacatggtaaaatattctgatataataattatatatatatatatatatatatgat 
gcatttctttttatggttagATGAGTTTTCAAAATATAATATCAGACCCTAAAATAGGAGGGACATATATGACCTTTTTA 
AATACTGTGAATAATTTGGGCTCACACgtaatttgataatatacgtacatatatatatatatatatatatatatatatat 
aaatatataaatatatatatgtatatattattatttgatataatactaacttatttgttatatcatttcgacaatatttc 
tttttctcttttcttcttagTGGTCTACTATATTTTTATGGTTACTTGATTACACTGATAAGGAATTTTGTTATAAAGgt 
atatatgatttttctattttagttatatatatatatatataatatctttatttaaataacaattatttgttctacagGAA 
AATGTGTTCTTGTTGATGGATTTTATATTCAGATGATATTGTCCTTTATAGTTGGAATAATAATTAACAAATATATTCTA 
AGTTTTACGAGAAAGCTACAAgtaaaaatgaatctatattattattatagattatatatatatatatatatatatatata 
tatatatatatatatatatatgtgtatatatacctgaaaaaattatagttcgccgtatttcatatattctcttttttttt 
ttttttttttttttttttttatagGCTTTTCCTTTAGAAGATTGGAGAACGAAATATATTGGAAAAGAATTTTAA 
2955 bp 
PfPMV (PF3D7_1323500, PF13_0133) 
ATGAATAATTATTTTTTAAGGAAAGAAAATTTTTTTATATTGTTTTGTTTTGTTTTTGTGAGTATCTTTTTTGTATCAAA 
TGTAACAATAATAAAATGTAATAATGTGGAAAATAAAATTGACAATGTTGGAAAAAAAATTGAAAATGTGGGAAAAAAAA 
TTGGCGATATGGAAAATAAAAATGACAATGTGGAAAATAAAAATGACAATGTGGGAAATAAAAATGACAATGTAAAAAAT 
GCTTCTTCAGATTTGTATAAATATAAATTATATGGTGATATAGATGAATATGCTTATTATTTTCTAGATATAGATATAGG 
GAAACCATCGCAAAGAATTTCTTTAATTCTAGATACAGGTTCATCTTCGTTAAGTTTCCCGTGTAATGGTTGTAAAGATT 
GTGGTATTCATATGGAAAAACCATATAACTTGAATTATTCAAAAACATCATCTATTTTATATTGTAATAAATCCAATTGT 
CCTTATGGTTTAAAATGTGTAGGAAATAAATGTGAATATCTTCAATCGTATTGTGAAGGGTCTCAAATATATGGTTTTTA 
TTTTTCAGATATTGTTACTTTACCATCTTATAATAATAAAAATAAAATATCTTTTGAAAAATTAATGGGCTGTCATATGC 
ATGAAGAAAGTTTATTTCTACATCAACAAGCCACAGGAGTTCTAGGGTTTAGTTTGACCAAACCGAATGGGGTTCCAACA 
TTTGTTGATTTACTTTTTAAACATACTCCTTCTTTAAAACCCATATATTCAATATGTGTGTCTGAGCATGGAGGTGAATT 
AATCATAGGTGGTTATGAACCGGATTACTTCTTAAGTAATCAAAAAGAGAAACAAAAAATGGACAAGTCAGATAATAATA 
GTAGTAACAAAGGAAACGTTTCTATAAAATTAAAAAATAATGATAAAAATGATGATGAGGAAAATAATTCAAAAGATGTA 
ATTGTATCTAATAATGTTGAAGATATTGTGTGGCAAGCTATTACAAGAAAATATTACTATTACATAAAAATATATGGTTT 
AGATTTATATGGTACAAACATTATGGATAAAAAAGAATTAGATATGTTAGTAGATTCAGGTAGTACATTTACACATATTC 
CAGAAAATATTTATAACCAAATAAATTATTATTTAGATATTTTATGTATACATGATATGACTAATATATATGAAATAAAT 
AAAAGATTAAAATTAACAAACGAGTCATTAAATAAACCATTAGTATATTTTGAAGATTTTAAAACAGCATTAAAAAATAT 
TATTCAAAACGAAAATTTATGTATTAAAATAGTTGATGGAGTACAATGTTGGAAAAGTTTAGAAAACCTACCAAATTTAT 
ATATTACCTTGTCGAATAATTATAAAATGATATGGAAACCTAGTTCCTATCTATATAAAAAGGAAAGCTTCTGGTGTAAA 
GGTTTAGAAAAACAAGTTAATAATAAACCTATTTTAGGGTTAACCTTTTTTAAAAATAAACAAGTTATTTTTGATTTACA 
ACAAAATCAAATTGCATTTATAGAATCTAAATGCCCATCTAATTTAACATCATCAAGACCAAGAACCTTTAATGAATATA 
GAGAAAAAGAAAATATCTTCTTAAAAGTTTCTTATATTAATTTATATTGTTTATGGCTATTATTGGCCTTAACCATACTC 
TTATCTCTTATTCTTTATGTCAGAAAAATGTTTTACATGGATTATTTTCCTTTGAGTGATCAAAATAAATCTCCCATACA 
GGAATCAACATAG 1773 bp 
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DD24 tag 
ATGGGAGTGCAGGTGGAAACCATCTCCCCAGGAGACGGGCGCACCTTCCCCAAGCGCGGCCAGACCTGCGTGGTGCACTA 
CACCGGGATGCTTGGAGATGGAAAGAAAGTTGACTCCTCCCGGGACAGAAACAAGCCCTTTAAGTTTATGCTAGGCAAGC 
AGGAGGTGATCCGAGGCTGGGAAGAAGGGGTTGCCCAGATGAGTGTGGGTCAGGGAGCCAAACTGACTATATCTCCAGAT 
TATGCCTATGGTGCCACTGGGCACCCAGGCATCATCCCACCACATGCCACTCTCGTCTTCGATGTGGAGCTTCTAGAACT 
GGAATAA 
327 bp 
loxP  
ATAACTTCGTATAGCATACATTATACGAAGTTAT 
34 bp 
GFP tag 
ATGAGTAAAGGAGAAGAACTTTTCACTGGAGTTGTCCCAATTCTTGTTGAATTAGATGGTGATGTTAATGGGCACAAATT 
TTCTGTCAGTGGAGAGGGTGAAGGTGATGCAACATACGGAAAACTTACCCTTAAATTTATTTGCACTACTGGAAAACTAC 
CTGTTCCATGGCCAACACTTGTCACTACTTTCGCGTATGGTCTTCAATGCTTTGCGAGATACCCAGATCATATGAAACAG 
CATGACTTTTTCAAGAGTGCCATGCCCGAAGGTTATGTACAGGAAAGAACTATATTTTTCAAAGATGACGGGAACTACAA 
GACACGTGCTGAAGTCAAGTTTGAAGGTGATACCCTTGTTAATAGAATCGAGTTAAAAGGTATTGATTTTAAAGAAGATG 
GAAACATTCTTGGACACAAATTGGAATACAACTATAACTCACACAATGTATACATCATGGCAGACAAACAAAAGAATGGA 
ATCAAAGTTAACTTCAAAATTAGACACAACATTGAAGATGGAAGCGTTCAACTAGCAGACCATTATCAACAAAATACTCC 
AATTGGCGATGGCCCTGTCCTTTTACCAGACAACCATTACCTGTCCACACAATCTGCCCTTTCGAAAGATCCCAACGAAA 
AGAGAGACCACATGGTCCTTCTTGAGTTTGTAACAGCTGCTGGGATTACACATGGCATGGATGAACTATACAAA 
717 bp 
mCherry 
ATGGTGAGCAAGGGCGAGGAGGATAACATGGCCATCATCAAGGAGTTCATGCGCTTCAAGGTGCACATGGAGGGCTCCGT 
GAACGGCCACGAGTTCGAGATCGAGGGCGAGGGCGAGGGCCGCCCCTACGAGGGCACCCAGACCGCCAAGCTGAAGGTGA 
CCAAGGGTGGCCCCCTGCCCTTCGCCTGGGACATCCTGTCCCCTCAGTTCATGTACGGCTCCAAGGCCTACGTGAAGCAC 
CCCGCCGACATCCCCGACTACTTGAAGCTGTCCTTCCCCGAGGGCTTCAAGTGGGAGCGCGTGATGAACTTCGAGGACGG 
CGGCGTGGTGACCGTGACCCAGGACTCCTCCCTGCAGGACGGCGAGTTCATCTACAAGGTGAAGCTGCGCGGCACCAACT 
TCCCCTCCGACGGCCCCGTAATGCAGAAGAAGACCATGGGCTGGGAGGCCTCCTCCGAGCGGATGTACCCCGAGGACGGC 
GCCCTGAAGGGCGAGATCAAGCAGAGGCTGAAGCTGAAGGACGGCGGCCACTACGACGCTGAGGTCAAGACCACCTACAA 
GGCCAAGAAGCCCGTGCAGCTGCCCGGCGCCTACAACGTCAACATCAAGTTGGACATCACCTCCCACAACGAGGACTACA 
CCATCGTGGAACAGTACGAACGCGCCGAGGGCCGCCACTCCACCGGCGGCATGGACGAGCTGTACAAGTAA 
711 bp 
 
List of homologous genes of PfNAT in Plasmodium spec. (PlasmoDB, access: 5/5/14) 
Organism + strain   Gene ID 
Plasmodium falciparum 3D7  PF3D7_1437000 
Plasmodium falciparum IT   PFIT_1438200  
Plasmodium berghei ANKA  PBANKA_061180  
Plasmodium chabaudi chabaudi PCHAS_061350  
Plasmodium knowlesi H  PKH_131240  
Plasmodium vivax Sal-1   PVX_084690  
Plasmodium yoelii yoelii 17X  PY17X_0614300  
Plasmodium yoelii yoelii YM PYYM_0613400  
Plasmodium cynomolgi strain B PCYB_132200  
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List of homologous genes of PfNAT in other Apicomplexa  
1. By Marcel Deponte, input sequence PBANKA_061180 (EuPathDB, access: 25/3/14) 
Babesia bovis T2Bo   BBOV_III007850 
Cryptosporidium muris RN66 CMU_001670 
Neospora caninum Liverpool  NCLIV_043940 
Theileria parva Muguga  TP04_0689 
Eimeria tenella Houghton  ETH_00010875 
Toxoplasma gondii ME49  TGME49_105450 
 
2. Additional information, input sequence PF3D7_1437000 (EuPathDB, access: 5/5/14) 
Babesia microti RI   BBM_III06015 
Theileria equi WA    BEWA_009490 
Theileria orientalis Shintoku  TOT_040000231 
Theileria annulata Ankara   TA10470 
Cryptosporidium hominis TU502 Chro.30224 
Cryptosporidium parvum Iowa II cgd3_1900 
Toxoplasma gondii GT1  TGGT1_305450 
 
Markers 
      
Figure 37. Prestained Protein ladder    Figure 38. GeneRuler, 1kb+ DNA ladder 
(Fermentas)       (Fermentas)  
 
 
